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Abstract
Functional electrical stimulation (FES) has been used for many years as a method of 
improving walking ability in individuals with neurological damage. In spite of this, its 
use in mainstream physiotherapy practice continues to be limited. One of the possible 
reasons for this may be the persistent belief that FES somehow increases spasticity in 
this subject group.
This study had two main aims: to investigate the effects of FES upon spasticity, and 
upon the walking abilities in the individual with incomplete spinal cord injury (ISCI).
Review of the literature relating to FES, spasticity and gait resulted in the following 
conclusions. FES has not been shown to increase spasticity; in fact it is far more likely 
to decrease it via the activation of spinal inhibitory neuronal mechanisms. FES has been 
found to have an overall beneficial affect on gait parameters. Although it is perceived as 
a substantially disabling impairment, spasticity is a hugely complex phenomenon that 
has proven difficult to measure. Conclusions as to the effects of spasticity upon gait 
need to be made with care. Due to this final point consideration was also given to the 
theoretical links between spasticity and gait.
As the measurement of spasticity was shown to be substantially problematic, a review 
of the psychometric properties of the measures chosen to answer the research questions 
was undertaken.
Given the stated aims of the project, two research questions were asked:
1. What changes in spasticity does an individual who receives FES as a treatment 
experience?
2. What changes in gait does an individual who receives FES as a treatment 
experience?
The chosen methodology was that of a single subject experimental design. Ten subjects 
with incomplete spinal cord injury were recruited to the study; eight completed the 
programme. FES systems were applied cutaneously to improve the walking abilities of 
all subjects. The Modified Ashworth Scale (MAS) and isokinetic dynamometric 
analysis of lower limb resistance to movement were used as measures of spasticity. The 
Rancho Los Amigos Observational Gait Analysis System (OGA) was chosen to analyse 
walking ability. TELER Gait Indicators were developed, also to analyse gait, due to the 
perceived issues with the Rancho Los Amigos system.
The results of this study show that spasticity, when measured by the MAS, did not 
increase in 7 out of 8 subjects. When considered as a group, the subjects demonstrated 
substantial improvement in their walking abilities. When considered individually the 
degree of improvement varied substantially.
The overall conclusion is that FES can be a useful treatment option for the subject with 
ISCI. However, careful assessment and application is needed to optimise benefit for the 
individual. This study also adds to the literature regarding FES, spasticity and gait in its 
use of a methodology that allows the clinician to consider potential benefits to the 
individual subject.
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CHAPTER 1: INTRODUCTION
1.1 Background to this study
The purpose of this study was to investigate the use of functional electrical stimulation 
applied to subjects with incomplete spinal cord injury to improve their walking ability. 
The effects of this treatment upon spasticity and gait were considered.
Spinal cord injury (SCI) is seen as a result of trauma or pathological damage to the 
spinal cord. There are an approximated 600-900 new injuries in this country every year. 
The majority of injuries treated in Spinal Injury Units are due to trauma, the age group 
often young. SCI results in a very substantial degree of disability for the individual, 
having a devastating impact upon all areas of their lifestyle. Damage to the spinal cord 
may result in a complete or incomplete injury. Incomplete injuries (ISCI) have some 
degree of either motor or sensory sparing below the level of damage to the cord.
Functional electrical stimulation (FES) has been used as a treatment modality for 
subjects with neurological conditions, including spinal cord injury, since Liberson’s 
work in the early 1960’s. Kidd (1992) defined FES as:
“A form  o f  electrical stimulation that will cause a muscle to generate a force  
adequate to perform an artificial function expected o f  it ”
Electrical stimulation can also be used for pain relief, muscle training and diagnostic 
nerve testing. For the purposes of this study FES was cutaneously applied to the lower 
limbs to enhance gait in the chosen subject population. Whilst most literature relating to 
the subject suggests that FES is likely to decrease spasticity, there are some articles that 
report increases in spasticity.
Spasticity is an impairment that may occur following injury to the central nervous 
system (CNS). Many people who sustain spinal cord injury go on to develop a 
significant level of spasticity. Spasticity has been linked to decreased ability to produce 
normal movement, to the development of joint and soft tissue contractures, to pain and 
to the development of pressure sores. All o f these issues can substantially limit 
functional abilities and therefore add to the level of disability and handicap experienced 
by these individuals. Physiotherapists working in the field of neurology spend much
l
time attempting to decrease and control its effects. Any intervention that may be 
considered as increasing spasticity is likely to be discarded as a viable treatment option. 
With spasticity as one variable under consideration, its valid and reliable measurement 
was seen as the key to the overall validity of the study. Definitions of spasticity and 
tools for its measurement are varied and disparate. Spasticity is often used not as an 
exclusive term, but rather as an umbrella term for the features of the upper motor 
neurone syndrome (a complex collection of pathological sequelae to CNS damage). To 
avoid confusion and aid clarity in this thesis Lance’s (1980) definition of spasticity was 
used:
‘Spasticity is a motor disorder characterised by a velocity dependent increase in 
tonic stretch reflexes ( ‘muscle tone’)  with exaggerated tendon jerks, resulting 
from  hyperexcitability o f  the stretch reflex, as one component o f  the upper motor 
neurone syndrome ’
The research study for this thesis ran in conjunction with a three-year European Union 
funded study titled ‘Clinical Rehabilitation using Electrical Stimulation via Telematics’ 
(CREST). This project ran from 1997-2000 and investigated both the use of FES for 
gait enhancement in spinal cord injury and the exchange of computerised clinical 
information between treatment centres. The Princess Royal Spinal Injuries Unit at the 
Northern General Hospital Trust in Sheffield was one of five European Centres, 
specialising in the treatment of spinal cord injuries, involved in the CREST study. The 
ten CREST study subjects chosen for Sheffield’s part in the project were used for this 
authors study. The chosen methodology of the CREST study was that of repeated single 
case studies. A large variety of parameters were measured for the CREST project -  for 
example - muscle strength, spasticity, gait and disability status. The Modified Ashworth 
Scale and Rancho Los Amigos Observational Gait Analysis System specified in the 
CREST study were therefore two of the measures used in this authors study. Due to the 
perceived issues with these tests further measures of spasticity and gait were chosen. 
Isokinetic dynamometry was used to quantify spasticity during passive movement of the 
knee joint. TELER® Normal Gait Indicators were developed as an observational gait 
analysis tool.
In undertaking a Master of Philosophy degree, the issue of evidence-based practice 
comes into focus in three key areas: the findings of the already existing evidence-base in
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the literature, the potential place for the findings of this study within that evidence-base 
and the implications for clinical practice. In 1993 the Department of Health’s Research 
and Development Strategy for the National Health Service stated that its main aim was 
‘to see that research became an integral part of healthcare’. This was so that 
practitioners, managers and other staff found it natural to rely on the results of research 
in their day-to-day decision-making and long term strategic planning. It went on to 
comment that there remained an issue where ‘belief-based views’ rather than relevant 
knowledge from reliable sources still had a major effect upon the provision of 
healthcare. The clearly stated intent in this document was that research-based evidence 
should become an integral part of healthcare provision. There have been many debates 
in the literature since the publication of this research report regarding the benefits or 
otherwise of evidence-based practice. Detractors fear that it will negatively affect 
clinical autonomy, that treatment would become an oversimplified set of guidelines and 
that clinicians would be reduced to mere technicians. Other authors see this as the 
chance to bring research-based practice more formally into the working lives of 
therapists and to enhance patient care.
In her article from 1997, Newham took the view that research is of vital importance to 
direct treatment. However, little attention appears to be given to the experience of the 
clinician in the process of treatment. Other authors, whilst promoting the need for 
evidence-based practice (EBP), emphasise the role of the clinician. Sackett et al (1996) 
defined evidence-based medicine as ‘ the conscientious, explicit and judicious use o f  
current best evidence in making decisions about the care o f  individual patients The 
authors went on to discuss the importance of the expert clinician in the interpretation of 
research data and the appropriate application or rejection of it dependent upon the 
individual patient’s situation.
The research strategy of the Chartered Society of Physiotherapy (Chartered Society of 
Physiotherapy, 1995) stated that research is an integral and essential aspect of 
physiotherapy. Many authors concur with this statement (Moore, 1997, Bury & Mead, 
1998, Barnard & Wiles, 2001). There is a perceived need to increase the profile of 
research within the profession at a clinical level -  an acknowledged need to break down 
some of the barriers to research findings being implemented in clinical practice and to 
increase collaboration between clinicians and academics (Moore op. cit.). Within this 
recognised need for improvements in research dissemination and integration into day-
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to-day clinical practice, Sumsion (1997) echoes Sackett et a ls’ (1996) emphasis on the 
importance of the patient in this process. Due to increased levels of awareness, patients 
are less and less the passive recipients of clinicians perceived ‘best practice’. Any 
intervention must be appropriate to their needs.
Evidence-based practice should ensure the use of research to optimise patient care 
appropriate to the individual. For research to be directed towards improving care, 
clinicians and academics must collaborate to benefit from each other’s specialist 
knowledge and to ensure dissemination of research findings. However, Bannigan & 
Bryar’s (2002) recent review of research utilization, the final stage of the evidence- 
based practice process, discovered that allied health professionals in clinical practice 
seldom use research findings. A number of possible reasons were given for this, 
conflicting reports and lack of clarity of implications for practice in the literature being 
two stated possibilities. There remains a gap between research and clinical practice. The 
pinnacle of research is often seen as the randomised controlled trial. The results from 
such research may be of limited use to the therapist working in a clinical setting and 
dealing on a daily basis with a host of enmeshed, possibly confounding issues. By its 
very nature the randomised controlled trial gives information on the ‘average’ in a very 
sanitised setting. Within a clinical neurorehabilitative setting treatment is not ‘by rote’ 
or ‘applied’, but rather an active process of informed negotiation that directs treatment 
towards the individual’s needs and particular problems.
1.2 Aim s and O bjectives
The above key themes (incomplete spinal cord injury, FES, spasticity and the need for 
clinically applicable findings in research), and the links with the CREST Project, 
directed the course of this study. The initial purpose of this study was to investigate the 
effects of functional electrical stimulation (FES) applied to the lower limb upon 
spasticity in the individual with incomplete spinal cord injury. In clinical practice 
spasticity is considered to have a negative effect upon walking ability. Whilst FES, 
applied as a dynamic orthosis, has been shown to improve gait, spasticity may be an 
undesirable side-effect of such treatment. The initial aims of this study were therefore to 
investigate the effects of FES upon spasticity in subjects with spinal cord injury, and in 
particular the effects of any such changes upon gait. However, review of the literature 
relating to spasticity, and in particular to the valid measurement o f spasticity,
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necessitated a change in direction as a natural development of the study. The reviewed 
objectives were therefore to:
1. Investigate the effects of FES upon spasticity in the individual with incomplete 
spinal cord injury
2. Investigate the effects of FES upon the walking abilities of the individual with 
incomplete spinal cord injury
Consideration was also given to the theoretical links between spasticity and walking 
ability.
As the purpose of this project was to evaluate the effects of FES in the individual, the 
chosen methodology was that of a single subject experimental design (SSED). 
Measurements were taken at initial and final baselines (AB design). Ten subjects were 
initially recruited, giving a multiple baseline design across subjects (Ottenbacher, 1986). 
Whilst the chosen methodology may not meet the upper echelons of the hierarchy of 
research evidence as recognised by the Chartered Society of Physiotherapy (table 1.1), it 
is hoped that the strength of the SSED in answering clinical questions for the individual 
will be demonstrated.
Table 1.1: Hierarchy of strength of evidence (Ref. Moore, 1995)
I Strong evidence from at least one systematic review o f multiple w ell-designed random ised 
control trials
II Strong evidence from at least one properly designed randomised control trial o f  appropriate size
III Evidence from well-designed trials without randomisation, single group pre-post, cohort, time 
series or matched case-controlled studies
IV Evidence from well-designed non-experimental studies from more than one centre or research 
group
V Opinions o f respected authorities, based on clinical evidence, descriptive studies or reports o f 
expert committees
1.3 Sum mary
This thesis will present a review of the effects of FES upon spasticity and upon gait for 
ten individuals with incomplete spinal cord injury. The following chapters will define 
spasticity and its effects upon spinal cord injury, review the literature relating to FES, 
spasticity and gait, describe the methodology and measurement tools used, present 
results and draw conclusions for these subjects. Where possible, implications for 
clinical practice from these findings will be discussed.
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CHAPTER 2: LITERATURE REVIEW
The intent of this study was to investigate the effects of functional electrical stimulation 
(FES) upon spasticity. In this instance FES was applied to improve the gait of 
individuals with incomplete spinal cord injury, so the effect of spasticity change upon 
gait was also to be considered. This chapter presents a review of the literature relating to 
spinal cord injury (SCI), FES, spasticity and gait, pulling together links between all four 
topics.
The aetiology and incidence of spinal cord injury are introduced, along with the 
resultant effects of the pathology upon the individual. The increasing population 
sustaining, and living with, incomplete spinal cord injury is also presented, as this was 
the subject group under study.
The clinical uses and physiological effects of FES as a treatment for neurological 
conditions are explored. The final sections of this chapter consider the literature relating 
FES to spasticity and to gait, and to the links between spasticity and gait.
The section relating to spasticity is substantial. Initial reading on the subject of 
spasticity showed that the subject is hugely complex and poorly understood. Given that 
this was one of the phenomena to be measured the author considered that a 
comprehensive understanding of the neuropathology of spasticity was necessary both to 
be able to chose appropriate outcome measures and to be able to consider the possible 
effect of FES upon this impairment.
2.1 Spinal Cord Injury
2. l .a  A n  Overview:
Spinal cord injury (SCI) occurs due to traumatic or pathological damage to the spinal 
cord or cauda equina. It may result in a loss of motor, sensory or autonomic function, or 
any combination of these, below the level of the injury. Normal bladder, bowel and 
sexual function may also be lost.
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In the UK, patients with SCI are managed in one of the ten Spinal Injury Units scattered 
across the country. Sir Ludwig Guttman, a neurologist, set up the first Spinal Injuries 
Unit at Stoke Mandeville Hospital in Aylesbury in 1944 for the treatment of ex- 
servicemen. He prescribed systems for the management and prevention of the major 
complications of SCI and emphasised the importance of specialist nursing and therapy 
management of such injuries. He strongly advocated that these patients should be 
managed within specialist units. Other units in the UK, the United States and Australia 
soon opened. This approach to the management of SCI brought about huge positive 
change in the life and health expectancy of those sustaining spinal cord damage 
(Bedbrook, 1985).
2.1. b A etio logy and Incidence:
The incidence of SCI in this country is 10-15 cases per million of the population 
(Grundy et al, 1986). This means that there are approximately 600-900 new injuries per 
annum: 80% of these injuries are due to trauma; 20% to pathology. The main cause of 
traumatic injury is road traffic accidents (up to 50%). Industrial accidents, falls at home, 
sport, assaults and self-harm are some of the other main causes. There are two peak age 
ranges: 16-30 year olds and the 60-plus age group. The male to female ratio is 4:1.
Cervical spine injuries result in tetra/quadriplegia - a paralysis that involves all four 
limbs. Neck injuries account for up to 50% of all Spinal Injury Unit admissions. Injuries 
to the thoracic, lumbar or sacral spine result in paraplegia -  a paralysis that affects lower 
limbs and trunk to a greater or lesser degree. Level of injury is described in terms of the 
last intact neurological segment, for example, C5 complete (an injury complete below 
the 5th cervical level) and T9 incomplete (an injury with some degree of sparing below 
the 9th thoracic level).
Zejdlik (1992) reports spinal cord injury statistics for the USA similar to those in the 
UK. The main difference seen in the States is the percentage of injuries due to gunshot 
wounds and assault in some sectors of the population.
Admission statistics for a five-year period from 1995-2000 (Ash, unpublished) are 
shown in figures 2.1 to 2.4, inclusive, for the Princess Royal Spinal Injuries Unit
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Princess Royal Spinal Injuries Unit 
Admission Statistics 1995-2000
D T raum atic 
Pathological 
a  P o s t  Surg ical
Figure 2.1: Causative Factors
□  RTA Driver 
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□  Domestic Fall
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□  Other
Figure 2.2: Mechanism of Injury
25
20
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0
Figure 2.3: Age at Injury
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Age
Figure 2.4: Gender
n  M ale 
B  F em ale
(PRSIU), where this project was conducted. The statistics are similar to those for the 
UK (Grundy et al, 1986).
2.1. c  In co m p le te  In ju ries:
An incomplete injury is one in which any combination o f  motor, sensory or autonomic 
function remains intact below the level o f the lesion. There are a number o f ways o f 
defining incomplete injuries -  either by describing the pattern o f  paralysis following 
injury (Figure 2.5) or by categorising the neurology remaining to the patient such as the 
American Spinal Injuries Association Impairment Scale (Maynard et al, 1997).
T a b le  2.1: A S IA  Im p a irm en t S ca le  (M ayn ard  e t a l  1997)
Classification Neurological sparing
A -  complete No motor or sensory function is preserved below the level of the lesion
B -  incomplete Sensory but not motor function is preserved below the neurological level and 
includes the sacral segments S4-5
C -  incomplete Motor function is preserved below the neurological level, more than half of key 
muscles below this have a muscle grade less than 3
D -  incomplete Motor function is preserved below the neurological level, at least half of key 
muscles below the level have a muscle grade of 3 or more
E - normal Motor and sensory function is normal
For the purposes o f  this study the American Spinal Injuries Association (ASIA) 
impairment scale definitions (Table 2.1) were used to give a broad definition o f  the 
level o f  neurology remaining to the subject. This is a widely recognised scale, which is 
in frequent use in clinical practice. This scale was used in the CREST project.
° A
■ B
□c 
□  d  
■  e
Figure 2.6: ASIA Grades on 
admission to PRSIU
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A nterior C ord Syndrom e -  the anterior part o f the cord is damaged 
due to a flexion injury, producing an anterior dislocation or a 
compression wedge fracture. Corticospinal and spinothalamic tracts 
are damaged due to direct trauma and spinal artery compression leads 
to ischaemia. Clinical picture is o f loss o f power and reduced pain and 
temperature sensation below the level o f the lesion.
Central Cord Syndrome -  typically seen in older patients with 
cervical spondylosis. Mechanism is a hyperextension injury that 
compresses the cord between osteophytic vertebral body and 
intervertebral disc and the ligamentum flavum. Grey matter at the 
level o f the lesion and centrally situated cervical tracts are most 
damaged. Classic picture is o f flaccid weakness o f arms with 
relatively strong but spastic trunk and legs.
Posterior Cord Syndrome -  most common in hyperextension injuries 
where the spinal arch has been damaged. This results in loss of 
proprioception due to posterior column damage. Patients may have 
good power and pain and temperature but profound ataxia.
Brown-Sequard Syndrome -  classically due to stab injuries but also 
occurs where the lateral mass fractures o f the vertebrae have occurred. 
Signs are those o f a hemisection o f the cord. Reduced or absent power 
and proprioception but good pain and temperature on the side o f the 
injury as the spinothalamic tract decussates in the cord. The uninjured 
side has good power and proprioception but reduced or absent pain 
and temperature.
F igure 2.5: Incom plete Syndrom es (Ref. G rundy e t al, 1986)
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Edwards (1991) stated that a considerable percentage of patients with spinal cord injury 
had incomplete injuries- on average 50% of patients on a SIU at any one time may have 
some degree of sparing. Unpublished work from the Princess Royal Spinal Injuries Unit 
(Ash, unpublished) showed that approximately 70% of the admissions to the Unit 
during the period 1995-2000 were incomplete injuries (Figure 2.6). This work mirrors 
the findings of the author in a small study over an 18-month period in the early 1990’s 
where it was again found that over 70% of admissions to the Unit were incomplete.
Incomplete spinal cord injuries can also be divided into upper or lower motor neurone 
lesions. Upper motor neurone lesions occur where the spinal cord is damaged at or 
above the level of the first lumbar vertebrae. The spinal cord terminates at this level in 
the conus medullaris, then cauda equina, which compromises the nerve roots of the 
lumbar, sacral and coccygeal segments. Damage below T12 therefore results in a lower 
motor neurone lesion whose clinical presentation is effectively that of a peripheral 
injury -  with a complete loss of spinal reflexes and often profound muscle wasting.
Subjects for this project were all classified as either ASIA C or D lesions. All had 
injuries above the level of T12.
2.1. d  H ealth and L ife E xpectancy;
An Egyptian physician noted the first recorded case of spinal cord injury in 2500BC 
when he described the signs and symptoms of a young man with tetraplegia. His final 
words were ‘...an ailment not to be treated’. This very much remained the popular 
perception, as the prognosis following injury was so poor. Statistics from World War I 
showed that 90% of patients suffering a spinal cord injury died within one year. 
Approximately 1% were still alive 20 years post-injury. The main causes of death were 
either early complications such as respiratory distress, paralytic ileus or deep venous 
thrombosis, or ‘any time’ complications such as decubitus ulcers leading to septicaemia 
or poorly managed bladder and bowel leading to renal failure or bowel complications.
However, since Ludwig Guttman’s pioneering work following the Second World War, 
with the setting up of specialist units, life and health expectancy has gradually 
increased. Improved management at the scene of the accident, in Accident and 
Emergency Units, the early transfer of patients to SIU’s and other developments in
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medical science have undoubtedly also added to life expectancy for this patient 
population.
Bedbrook (1985) emphasised the need for total care in specialist units. It is not just the 
acute management that is of importance but the provision of a comprehensive 
rehabilitation package and follow-up, which ensures early identification, and treatment 
of possible complications. The Princess Royal Spinal Injuries Unit, like many others, 
provides a ‘cradle to grave’ service. Following discharge from hospital, patients return 
for annual review. They can also self refer for assessment. Where complications 
develop -  such as pressure sores, urological problems, fractures or long term respiratory 
problems -  patients are managed on the Spinal Unit.
Where septicaemia following pressure sores and urological complications leading to 
renal failure were once the main causes of mortality, vascular disease and cancers are an 
increasing cause of death in individuals with spinal cord injury. Life expectancy is now 
within a few years of the expected average for the rest of the population.
2.1.e Spasticity in the Spinal Cord In jured Subject
Spasticity in spinal cord injury is a topic to which much time and space in literature is 
devoted. Studies show that approximately 78% of people with spinal cord injury 
develop some level of spasticity by discharge from hospital. 40% of these subjects 
report it as ‘problematic’- that is affecting activities of daily living, linked to pain, and 
not well controlled by medication. Reports of problematic spasticity correlate with level 
of injury (cervical and upper thoracic injuries) and degree of incompleteness (ASIA C 
and D categories). All the subjects for this study are categorised as ASIA C or D 
injuries. There is therefore a substantial possibility of these candidates already having a 
‘problematic’ level of spasticity. This is of importance as it is these categories of 
subjects, who have some ability or potential to walk, who are subjects for this study.
A small number of studies have been published which consider the epidemology of 
spasticity. Maynard et al (1990) published the results of two studies they had 
undertaken. Spasticity was considered to be present if deep tendon reflexes were 
increased, if muscle tone was increased during passive movement, and if involuntary 
muscle spasms were present. The assessments were undertaken on discharge and at the
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subjects’ first annual follow-up. The scale used was an ordinal one, where no spasticity 
was graded as 0 and ‘problematic’ spasticity (that which had been treated with 
unsatisfactory results) was graded as 3. The assessing physician graded spasticity. The 
second study followed the same basis as above. 466 patients with traumatic spinal cord 
injury were assessed. Both sets of results were collated by level of injury and by Frankel 
grading for classification of degree of incompleteness. Study 1 found that 67% of 
subjects developed spasticity by discharge from hospital with 37% needing medication 
by that time. By follow up 78% presented with spasticity with 49% medicated. Study 2 
found that 26% of subjects were medicated by discharge and 46% by follow up. The 
most frequently medicated subjects fell into Frankel categories C and D with 50% and 
52% respectively being treated. The ASIA classification system is based upon that 
developed by Frankel, C and D grades from each system are very similar.
Skold (1999) gained similar results. This author studied 354 SCI subjects and found that 
65% of subjects reported developing spasticity, 43% of who said their spasticity was 
problematic. Skold’s operational definition of spasticity was as above but included 
pathological radiation of reflexes. There were significant links between reports of 
problematic spasticity and incomplete injuries. As well as subjects’ self reports on 
spasticity levels, assessment was undertaken using the Modified Ashworth Scale (MAS) 
(Bohannon & Smith, 1987). Only 60% of the subjects reporting it were found to have 
elicitable spasticity on assessment.
Johnson et al (1998) again corroborated the above findings. They undertook initial 
assessments then telephone questionnaire follow-ups over a five-year period and found 
that approximately 30% of subjects reported spasticity as problematic.
Maynard et al (1990) identified some of the main issues with their studies: the 
subjectivity of the measurement scale, the discrepancy between the two sets of subjects 
being medicated by discharge (37% and 26%). They believed that this could have been 
due to different criteria used for indications for treating spasticity. Skold (1999) 
suggested that the reason for the discrepancy between self-reported and clinician 
elicited spasticity could be that the MAS may only measure one aspect of spasticity.
All three papers use different clinical scales or other investigative methods. The scales 
may raise questions as to their validity as true measures of spasticity. Different
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understandings -  operationalisation - of what spasticity is between groups of clinicians 
and subjects may also be expected to cause differences in results. However, in spite of 
these issues these three independent studies have produced remarkable similar findings 
as to the epidemiology of ‘spasticity’ within the spinal cord injured population. The 
accurate definition of spasticity and its valid measurement are key issues to this thesis.
2 .1 .f  Section Sum m ary
SCI affects a very small but significant percentage of the population each year. Life 
expectancy is now almost normal, and there is a growing population o f people living 
with SCI. The relative percentage of incomplete injuries - who may have the potential to 
walk - is increasing. Spasticity is significantly problematic following injury, in 
particular amongst those with incomplete injuries, adding to disability levels. The main 
group affected by SCI is the young. The percentage returning to work is low. As 
Trieschmann (1986) states SCI is a ‘low-incidence but high-cost disability that makes 
tremendous changes in a person’s lifestyle’. Treatments, such as FES, which may have 
a beneficial impact upon levels of handicap and disability need to be fully explored and, 
if appropriate, considered as possible treatment options.
2.2 Functional E lectrical Stimulation
Early experiments by Swammerdam and Galvani in the 17th and 18th centuries 
respectively demonstrated that the electrical excitation of nerve caused muscle to 
contract. The knowledge needed to evolve neural prostheses of a size small enough to 
be practical in a clinical setting became available with the development o f the transistor 
in the 1950s. Since that time there has been a substantial development in the technology 
needed to produce function via electrical stimulation. FES has found its way into 
everyday clinical practice in the form of pacemakers, bladder stimulators and phrenic 
nerve stimulators. Other applications have included its use in the facilitation of standing 
and gait.
FES has been used in the treatment of many neurological conditions. Burridge et al 
(1997a) reported on their work with stroke patients. Bajd et al (1999) and Granat et al
(1993) are amongst many who have used FES extensively with spinal cord injured 
patients. There are also references to be found in the use of FES with cerebral palsy,
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head injury and multiple sclerosis (e.g. Dimitrijevic & Dimitrijevic, 1992). Any 
pathology that results in motor loss due to damage to the upper motor neurone is 
potentially responsive to FES.
Electrical stimulation has been used for many years in the treatment of SCI. The 
literature records a wide variety of possible uses in both upper and lower limb 
rehabilitation. In the 1980’s a group of bio-engineers based in Ljubljana, Slovenia, 
produced a large body of work relating to the use of electrical stimulation, particularly 
for SCI. The therapeutic effects of electrical stimulation and its use in the management 
of spasticity have also been investigated by authors such as Vodovnik (1981).
FES is now used in both research centres and specialist clinical centres. Its more general 
use in the clinical field however is still limited. The potential demand for FES as a 
treatment option and possible reasons for its limited use in clinical practice shall be 
considered in the following section.
2.2. a D em an d fo r  Functional E lectrical S tim ulation in S pinal C ord Injury
Patient demand for FES systems has been assessed in two studies. Jaeger et al (1990) 
undertook a retrospective study of medical records for 192 patients with spinal cord 
injury. They estimated a minimum of 10.4% and a maximum of 25% (dependent upon 
relaxation of some inclusion criteria) of their subjects as possible FES users. However, 
they were considering FES for complete injuries from T4-T12 spinal levels. These 
authors also estimated their subject group to make up 45% of the SCI population. The 
above study was therefore of limited use to this thesis where the aim was to enhance 
gait in incomplete subjects who already had some walking ability. The percentage of 
incomplete spinal cord injury (approximately 70%) apparent in recent studies may also 
make the above study less relevant in the present day. As part o f the CREST project, 
Maxwell et al (1999) published the results of a questionnaire survey looking at the 
potential demand for FES devices. Whilst 19% of respondents stated that they had used 
functional electrical stimulation, only 2% had done so for walking. 16% of respondents 
stated that they could walk independently but less than half of these could do so for 
more than 50 metres. 13% had used some form of orthosis. Whilst this article was 
slightly confusing in its data presentation and should have included a section on level of 
lesion (FES not being applicable for injuries to the cauda equina), it would appear to be
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reasonable to conclude that only a tiny percentage of potential users were using FES 
systems for gait enhancement. The sample group were self selected members of the 
Spinal Injuries Association.
In spite of the apparent potential population who could benefit from FES and the 
increasing sophistication of commercially available systems this is not a treatment 
option that is often chosen in clinical practice. In this author’s opinion the following 
reasons may add to the general reluctance of physiotherapists to use such systems:
• Lack of underpinning knowledge in and the potential uses of FES
• Few reliable, flexible systems available for purchase
• A generally held belief that FES increases spasticity -  ‘in clinical practice there 
even exists a widespread attitude that one should not stimulate an already 
‘overstimulated’ spastic muscle’ (Stefanovska et al, 1989)
Whatever the actual underlying issues, FES is infrequently used in the clinical 
workplace. Given the emphasis put upon controlling and decreasing spasticity in the 
clinical management of neurologically damaged subjects, the final point may well be 
enough to prevent physiotherapists exploring this as an option for treatment.
2.2.b P hysiological effects o f  FES:
The FES systems used for this project make muscle contract via stimulation o f nervous 
tissue. Whilst it is possible to stimulate denervated muscle, this is not practical in the 
clinical setting at present because the amplitude of current or stimulus pulse width needs 
to be far greater than that which will stimulate muscle with an intact nerve supply. 
Electrical stimulation can be applied via surface or implanted electrodes. There are 
benefits and potential risks with both options. This study used surface applied 
electrodes. This is a non-invasive technique that is relatively simple to apply.
Electrodes can be placed either directly over the muscle to be stimulated to effect a 
contraction, or over an afferent nerve to produce a reflex movement. Excitation of the 
nerve axon (depolarisation) occurs principally at the cathode (negative electrode). 
Hyperpolarisation occurs at the anode (positive electrode). The placement and size of 
electrodes and the electrode to skin impedance all need careful consideration to ensure a 
given stimulus causes an action potential. Electrodes should be placed in close 
proximity to the nerve. When a stimulus of sufficient intensity and frequency is applied
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to the nerve temporal and/or spatial summation of action potentials occur and the 
muscle is caused to contract. Stimulation will travel both proximally and distally from 
the point of stimulation. Muscle contraction can therefore be directly affected by the 
motor efferent or indirectly by a reflex response to the stimulation.
Electrical stimulation initially recruits large diameter axons as they offer lower 
impedance to current (Baker, 1993). Smaller diameter axons are likely to be the last 
recruited into activity. This is the opposite pattern of recruitment to that seen in normal 
physiological muscle contraction. Electrical stimulation is not specific when applied to 
peripheral, mixed nerve. All types of nerve fibres will potentially be excited. As well as 
alpha motor neurones, group la and II afferents from intrafusal muscle fibres, lb 
afferents from golgi tendon organs, sensory, cutaneous and sympathetic nerve fibres are 
all likely to be stimulated. The effect of electrical stimulation is therefore complex.
Figure 2.7 summarises the potential effects of electrical stimulation (Vodovnik & 
Stefanovska, 1992). The fourth effect of electrical stimulation ‘change in cell membrane 
transport’ relates to trophic systems within nerve and muscle and is not addressed by 
this thesis. Restorative functional stimulation is also known as therapeutic stimulation.
The potential effects of FES can be considered in two timescales. In the short-term, FES 
will produce a contraction of muscle and potentially functional movement. This is often 
described as orthotic stimulation. With continued use over time, many other therapeutic 
physiological effects have been reported
FES can address the loss or negative aspects of upper motor neurone damage seen in 
SCI - that is fatigue, weakness and atrophy (Dimitrijevic & Dimitrijevic, 1992). SCI 
subjects demonstrate a decreased ability to produce smooth, efficient contraction of 
muscle and they fatigue quickly. Relatively smaller percentages of fatigue-resistant 
motor units are present in the muscles of SCI subjects than in the ‘normal’ population. 
Disturbances in motor unit recruitment and modulation of anterior horn cell firing rates 
have also been shown (Heckman, 1994). Reported benefits with the use of FES have 
included changes in muscle phenotype from fast-fatiguable to fatigue-resistant fibres 
(e.g. Pette & Vrbova, 1999,Gordon & Mao, 1994), increases in muscle bulk (e.g. Mohr 
et al, 1997), improved muscle strength (e.g. Ferguson & Granat, 1992) improved blood 
flow (e.g. Daly et al, 1996) and improved sensation.
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As well as the negative features that are related to a loss of motor activity, FES has been 
reported as having an effect on the ‘motor overactivities’ (see table 2.2) that follow 
central nervous system damage. Evidence of both increases (e.g. Robinson et al, 1988) 
and decreases (e.g. Burridge et al 1997b, Stefanovska et al, 1989) in spasticity have 
been reported. Daly et al (1996) described the use of electrical stimulation as a tool for 
neuroplastic change and motor ‘learning’ at cord level.
2.2.c Section Sum m ary
FES has been used as a therapeutic tool for many years in the treatment of a variety of 
neurological conditions. It has not, however, come into widespread use in clinical 
practice. This may be for a variety of reasons, one of which may be a lack of 
understanding of its complex neurophysiological effects. The above review would 
suggest that FES is capable of improving gait by both its immediate orthotic effect of 
producing movement by making muscle contract and in applying a ‘training effect’ -  
improving muscle bulk, phenotype and blood supply. It may also be that FES can 
address the effects of spasticity at a synaptic level. To understand the possible effects of 
FES upon spasticity an understanding of its underlying neurophysiology -  what 
spasticity is, how it develops and how the central nervous system attempts to 
compensate for it -  is necessary.
2.3 Spasticity
2.3.a D efinition:
Spasticity is a much discussed phenomenon in the field of neuroscience and 
rehabilitation literature. It occurs following damage to the upper motor neurone within 
the brain or spinal cord. Sheean (1998) described spasticity as hypertonia that shows as 
an increased resistance to movement. In spite of its being a common sequela to 
neurological disease, and its being recognised by many practitioners in the field as a 
substantially disabling one, it is poorly defined in the literature. According to Young
(1994) this is ‘presumably because the neurobiology o f  the motor system remains 
largely a mystery
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The term spasticity is frequently used as a generic one to describe an increase in muscle 
tone or other tonal abnormalities in individuals with central nervous system (CNS) 
damage. This confusion does not assist in the definition of the impairment. Clarity of 
definition is of vital importance in the recognition and measurement of spasticity so that 
clinicians can direct treatment appropriately (Sheean, 1998). From a research viewpoint 
definition is important so that the validity of measurement tools can be ensured. If 
validity is considered in its broadest sense as ‘the extent to which an item actually 
measures what the researcher purports it to measure’ (Krebs, 1987) then the importance 
of definition becomes apparent. Accurate measurement depends, in part, upon a clear 
definition of the dimension in question. If this is clearly defined appropriate 
measurement tools can be chosen. Much of the literature relating to spasticity is unclear 
in its definition and therefore hazy in its use of measurement tools and outcomes.
To clarify this issue and for the purposes of this project Lance’s (1980) definition of 
spasticity will be used:
‘Spasticity is a motor disorder characterised by a velocity dependent increase in tonic 
stretch reflexes ( ‘muscle tone’) with exaggerated tendon jerks, resulting from  
hyperexcitability o f the stretch reflex, as one component o f the upper motor neurone 
syndrome ’
This definition, although under some debate, is still the most commonly referred to in 
the literature relating to spasticity.
The stretch reflex has both phasic and tonic components. The phasic stretch reflex is a 
(mainly) monosynaptic response to quick muscle stretch such as the tendon tap. The 
tonic stretch reflex implicated in spasticity is an oligo- or polysynaptic reflex 
compromising a complex variety of possible pathways. Young (1994) stated that the 
stretch reflex arc includes la afferent interneurones, Renshaw recurrent inhibition, 
disynaptic inhibition, nonreciprocal autogenic lb inhibition, presynaptic inhibition onto 
primary afferents, remote inhibition and excitation onto motorneurones and a variety of 
other poorly understood circuitry. He described these interneuronal systems as acting 
like pre-motor neuronal integrating centres.
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Given the extremely complex nature of spasticity, the often apparently confused use of 
the term in both clinical practice and research literature, and its importance to this study 
as the impairment being investigated, a deeper knowledge and understanding of this 
impairment was necessary to ensure valid measurement and therefore study validity.
2.3.b Spasticity as p a r t o f  the Upper M otor N eurone Syndrom e:
The upper motor neurone syndrome (UMNS) is a useful but non-specific concept which 
describes a number of phenomena seen when the upper motor neurone is damaged. 
Upper motor neurones (UMN) are motor neurones in any long, descending tract that 
control or influence movement and muscle tone. They have a variably direct influence 
upon the excitability of the lower motor neurone (LMN) or anterior horn cell. The LMN 
has an enormous dendritic tree with a large surface area covered with thousands of 
synaptic boutons. The main role of these neurones is to ‘translate the huge variety of 
input from afferent and descending fibres and from interneurones into an output that 
will precisely control the contraction of muscle fibres in the development of force or 
patterns of movement’ (Burke 1990). The influence of UMN’s is effected by either 
direct synapse onto the LMN or, more commonly, via a network of interneurones. They 
modulate important segmental motor reflex activity in the spinal cord. The majority of 
the positive phenomena (Table 2.2) of the UMNS are due to interruption of supraspinal 
control of these reflexes (Sheean, 1998).
From the breakdown shown in Table 2.2, it can be seen that spasticity is a positive 
feature of the UMNS. The other positive features, which result in motor overactivities, 
are frequently mislabelled ‘spasticity’. Whilst they tend to occur together, there are clear 
differences in the pathophysiology of many of these phenomena. It is beyond the scope 
of this project to describe these differences. Sheean, in ‘Spasticity Rehabilitation’ 
(1998), gives a good overview. The use of the terms ‘positive’ and ‘negative’ is 
unfortunately misleading. Both terms relate to abnormal pathological changes, positive 
to excessive activity, negative to a resultant lack of activity. A positive change in this 
context is not beneficial.
The positive and negative features are interdependent. Many of the negative features 
may result from the effects of the positive. The loss of the central nervous system’s 
ability to produce a cohesive input to the LMN may prevent normal efferent activity and
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therefore appropriate, efficient functional movement. Effectively a ‘disuse’ atrophy of 
musculature is seen with attendant soft tissue change.
Table 2.2: Features of the upper motor neurone syndrome (Sheean 1998)
N e g a t i v e
Acute Hypotonia (Shock)
W eakness due to inadequate muscle activation 
Loss o f dexterity 
Loss o f cutaneous reflexes 
Fatiguability
P o s i t iv e
At rest in response to peripheral stimulation
Proprioceptive
Increased tendon reflexes with radiation 
Clonus 
Spasticity
During movement (spastic dystonias)
Dyssynergic patterns o f co-contraction 
Associated reactions 
Flexor withdrawal reflexes 
Positive support reaction 
Extensor thrust 
‘Pushing’ reactions
The next section shall consider the pathophysiological changes that are believed to lead 
to spasticity.
2.3. c Pathophysiology o f  spasticity
Motor systems have three levels of control: the spinal cord, the brainstem and the brain. 
The spinal cord is considered as the lowest in the hierarchy. These systems are 
organised serially and in parallel. Spinal segmental mechanisms have an important role 
to play in the production and control of movement. They are modulated by both 
proprioceptive and higher centre input through a complex system of interneurones. 
(Kandel, Schwartz & Jessell, 2000). In the case of CNS damage the normal balance of 
these mechanisms is lost, spasticity being one of the possible results from this damage.
There are many descending tracts within the brainstem and spinal cord. Those believed 
to be particularly involved with the development of spasticity and other features of the 
UMNS are the dorsal reticulospinal tract (inhibitory to spinal stretch reflexes) and the 
ventral reticulospinal and vestibulospinal tracts (mainly excitatory). These tracts have 
an effect on the lower motor neurone (LMN) or anterior horn cell via a complex system
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Nociceptive 
Positive Babinsky 
Extensor spasms 
Flexor spasms 
Mass reflex
of interneurones. It is the balance between these descending tracts which controls the 
spinal stretch reflexes and flexor and extensor reflexes. Loss or partial loss results in an 
imbalance of this normal control mechanism.
Sheean (1998) states that spasticity is believed to result from an enhanced tonic stretch 
reflex (TSR). The TSR is a polysynaptic reflex which occurs in response to a stretch of 
a relatively long duration (when compared to the phasic or ‘tendon jerk’ reflex). In the 
normal neurological system, the excitability of this reflex is dependent upon the balance 
of higher centre input as described above. It is believed that should a movement need to 
be adjusted the stretch reflex can be enhanced or diminished, as the situation requires to 
fine-tune activity (Davidoff, 1992). In spasticity, the individual may be unable to 
control the reflex which then responds to stretch whether it is relevant or not (Carr & 
Shepherd, 1998). The tonic stretch reflex can therefore be considered as having an 
important role to play in functional activity.
There are three key elements likely to affect the sensitivity of TSR pathway:
1. The muscle spindle sensitivity
2. Intrinsic excitability of the alpha motorneuron
3. Interneuronal processing of the la afferent information within the spinal cord
Where it was previously believed that the muscle spindle caused the increase in muscle
tone due to enhanced fusimotor drive, more recent work has shown that there is no 
increase in this. It has been shown that it is the processing of la afferent information that 
is enhanced (Sheean 1998).
As well as changes in descending input and its effect upon spasticity, the role of 
neuroplastic change as a result of pathology or injury has to be considered. Heckman 
(1994) described subjects with spasticity as suffering from two movement deficits: 
transmission of voluntary movement commands are impaired, and commands which do 
reach the spinal cord encounter abnormal and hyperexcitable circuitry. This suggests 
both a change in descending input and in alterations at a spinal level occurring 
concurrently.
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2.3 .c .i C hanges in neural inhibitory m echanism s fo llow in g  neurological injury
Much has been written about the spinal mechanisms controlling stretch reflex 
excitability. Kandel, Schwartz & Jessell (2000) stated that inhibitory interneurones 
played important roles in the co-ordination of reflex activity and therefore normal 
control of movement. Loss of such inhibition is believed to lead to the development of 
spasticity and other positive, or overactivity, features (see table 2.2) of the UMNS. This 
section considers the effects that damage to the CNS has upon the function of specific 
interneurones.
Although many complex and poorly understood mechanisms have been implicated (see 
section 2.3.a), current literature concentrates particularly upon the activity of the la 
inhibitory interneurone. This mechanism is involved with the control of reciprocal 
inhibition of muscle agonist-antagonist activity and therefore in the degree of co­
contraction around joints during movement.
Ia fibres from muscle spindles excite motor nerves from that muscle and also those with 
a similar action. At the same time Ia fibres inhibit antagonistic muscles via Ia inhibitory 
interneurones (Figure 2.8A). This is the basis for reciprocal inhibition. This system is of 
importance to the production of controlled voluntary movement. Inhibition can be 
increased or decreased to allow freer movement (increased reciprocal inhibition) or to 
increase stability (co-contraction or co-activation) at a joint. Ia inhibitory interneurones 
also receive both inhibitory and excitatory information from descending pathways.
Studies investigating the activity of the Ia inhibitory intemeurone have shown (Morita, 
et al, 2001, Crone, et al, 1994) that subjects with neurological injury are less able to 
control co-contraction of the soleus muscle in response to active dorsiflexion of the 
ankle joint. Both authors found that the short-latency inhibition of the ankle planter 
flexors (antagonist muscle group), present in the normal subject group at the onset of 
ankle dorsiflexion (agonist muscle group), was not present in the group with spasticity. 
It was hypothesised that this lack of reciprocal inhibition added to functional movement 
deficits seen in subjects with neurological damage. Boorman et al (1996) investigated 
‘natural reciprocal inhibition’ in patients with spasticity following incomplete spinal 
cord injury. The authors stated that reciprocal Ia inhibition and presynaptic inhibition of 
Ia afferents by higher centres both play a role in natural reciprocal inhibition.
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Figure 2.8: Spinal inhibitory interneurons
A -  la inhibitory interneuron
B -  Renshaw cell ( Rf Kandel, Schwartz & Jessel, 2000)
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They found that, compared to their control group of normal subjects, the subjects with 
ISCI demonstrated impaired reciprocal inhibition and a related large degree of co­
activation of soleus during dorsiflexion. This effect was particularly active during fast, 
alternating ankle movement, such as those seen during walking.
Faist et al (1994) also investigated the effect of changes in Ia presynaptic inhibition 
upon spasticity development. They found that the subject group with SCI demonstrated 
a decreased level of presynaptic inhibition. They did not however find a correlation 
between this and their clinical measure of spasticity -  the Ashworth Scale (Ashworth 
1964). This led them to deduce that the changes in presynaptic inhibition did not have a 
substantial effect upon spasticity. This conclusion begs the question as to whether or not 
the Ashworth Scale can be considered as more of an analogue to true spasticity than 
electrophysiological testing of interneuronal activity. The discrepancy between research 
laboratory and clinical measures of spasticity is one which many authors highlight. This 
is an important issue and will be returned to in the section upon measurement of 
spasticity later in this chapter.
The part of Renshaw cells (RC) in regulating the activity of the Ia inhibitory 
interneurone also needs consideration. RC’s are spinal interneurones that produce 
recurrent inhibition of motor neurons. They are excited by collaterals from 
motorneurones and form a negative feedback loop to inhibit those same motorneurones 
thus regulating their excitability and stabilising firing rates. These cells also send 
collaterals to synergist motor neurons and Ia inhibitory interneurones. They therefore 
exert an inhibitory influence upon all the motorneurones around a joint by their links to 
agonist, antagonistic and synergistic muscle groups (Figure 2.8B). Mazzocchio & Rossi 
(1997) studied the activity of the Renshaw cell (RC) in subjects with spasticity. They 
stated that these subjects lack in task dependent modulation of RC activity. During 
normal movement, descending commands provide a variable regulation of RC activity 
dependent on the motor task. RC activity is maintained by the reticulospinal systems, 
working in parallel with the corticospinal tracts. A lesion of the reticulospinal tract 
would lower the level of RC excitability, the result of which is inappropriate co­
activation of muscles around a joint. The net result of these changes is again believed to 
have an effect upon patient function.
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This section has summarised the role of the Ia inhibitory interneurone in reciprocal 
inhibition and therefore co-contraction of muscle groups during active movement in 
normal subjects and those with spasticity. The role of the Renshaw cell and presynaptic 
inhibition upon Ia intemeuronal functioning has also been considered.
2.3 .c.ii P lasticity o f  the spinal cord
Immediately following spinal cord injury a period of spinal shock is seen. Hiersemenzel 
et al (2000) investigated the development of upper motor neurone syndrome features 
with patients in the acute stages of spinal cord injury. They undertook a series of 
clinical and electrophysiological tests. Three phases were described:
Spinal Shock: this phase lasted up to three weeks. It was identified clinically by 
loss of tendon reflexes and hypotonia.
Transition Phase: this lasted for 3-8 weeks in the group studied. Clinically 
identified by increasing excitability of tendon tap reflexes, increasing muscle 
tone and frequency of spasms.
Spastic State: clinically shows as exaggerated tendon taps, increased muscle 
tone and involuntary muscle contractions.
The authors stated that there was a smooth transition from one state to the next. 
Chapman & Wiesendanger (1982) saw this period as the time in which plastic 
adaptation of the nervous system took place.
Where higher centres have long been accepted as being capable of plastic adaptation to 
injury the spinal cord has not been considered as such (Wolpaw & Tennissen, 2001). 
However research into the recovery of spinal cord function suggest the presence of four 
mechanisms active in this process:
• Sprouting
• Synaptogenesis
• Restoration of function to uninjured and uncrossed fibres
• Remyelination of demyelinated injured fibres, as well as restoration of the 
ability to conduct impulses through injured fibres in the absence o f myelin 
(Dimitrijevic, 1988)
Muir & Steeves (1997) concurred with the above mechanisms. These authors stated that 
spinal cord circuits are capable of significant reorganisation in the form of both activity-
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dependent and injury-induced plasticity. There was evidence that spinal circuitry 
undergoes significant and widespread alterations after spinal injury. These changes 
include an increase in responsiveness and amplitude of both mono- and polysynaptic 
stretch reflexes. However, not all injury-induced physiological changes are detrimental. 
These authors believed that it was possible for plastic change to be guided by activity, 
even in the damaged spinal cord, and that to modify spinal circuitry for a specific task 
movement performed during rehabilitation should be executed as normally as possible.
Wolpaw and Tennissen’s (2001) article reviewing the plasticity of the spinal cord 
reiterated the above points. The authors also stated that the spinal cord is capable of 
activity-dependent plasticity. The guidance of positive plastic change following spinal 
cord injury is important in maximising function.
There is therefore a growing body of evidence to support the plastic capabilities of the 
spinal cord. The spinal cord is capable of both neural and synaptic plasticity. Higher 
centre and peripheral inputs can direct this plasticity. Physiotherapists aim to maximise 
positive change via mainly peripheral inputs directed towards producing goal-orientated 
movement in as normal a manner as possible. It may be that the use of electrical 
stimulation in a functional setting such as used in this study, gait enhancement, may 
bring about positive plastic change within the spinal cord.
2.3. c. iii Sum m ary o f  pathophysiological changes
Insult to the spinal cord results in a variable degree of damage to segmental spinal 
circuitry, and to suprasegmental and supraspinal control mechanisms. A period of spinal 
shock follows with a gradual progression to the features of the upper motor neurone 
syndrome. It may not be possible to gain a true picture of the severity of the spinal 
injury until this period of shock is over. These features are due to loss of both 
descending, especially inhibitory, control and to plastic changes of spinal circuitry. Loss 
or disruption of normal control mechanisms leads to adaptive plastic changes in 
interneuronal functioning, not necessarily always for the worst. Whereas it was once 
believed that spinal cord circuitry was ‘hard wired’, research evidence has shown that it 
is modified in response to activity- or injury-induced changes.
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2.3. d  M easurem ent o f  spasticity
The complexity of the underlying neurophysiological mechanisms, the gaps in our 
knowledge of some of these systems, and the lack of correlation between laboratory and 
clinical measures (e.g. Priebe et al 1996, Hiersemenzal et al 2000) make the 
measurement of spasticity problematic. However the quantification of this substantially 
disabling phenomenon is seen as important by those working in research and clinical 
fields so that efficacy of treatment can be ensured.
Haas (1994) undertook a postal questionnaire in an attempt to survey current clinical 
practice of healthcare professionals involved in the management of spasticity. The main 
pathologies involved included stroke, spinal cord injury and multiple sclerosis. Over 
94% of all respondents agreed or strongly agreed that it was important to measure 
spasticity as a part of treatment. Over 94% of respondents also said that physiotherapy 
should be the profession to measure spasticity. However the number of physiotherapists 
who actually did measure spasticity was low (less than 40%). Haas suggested some 
reasons for this disparity: subjective and unreliable outcome measures, complexity of 
some measures making them unrealistic in a clinical setting and the need for improved 
education at undergraduate and postgraduate levels.
Krebs (1987) suggested another possibility:
‘quantitative spasticity data have eluded physiotherapists because the concepts and constructs
have not been operationalised, which in turn...is because we cannot agree on what to detect ’
This echoes both Sheean’s (1998) and Carr & Shepherd’s (1998) plea for clarity of 
definition when the term is used, to ensure that clinicians can communicate with each 
other and appropriate treatment can be instigated. The definition of spasticity in the 
literature and in clinical practice can be far from obvious and may consist of a variety of 
the phenomena of the upper motor neuron syndrome (UMNS).
In spite of, or perhaps because of, this apparent confusion, measures of spasticity are 
plentiful. Table 2.3 lists some of those referred to in the literature. Measures vary from 
simple clinical assessment scales (such as the Ashworth Scale) to highly technical 
neurophysiological and biomechanical measures. Pierson’s (1997) review article
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discussed a variety of aspects related to the use of outcome measures in spasticity. The 
author stated that no one test is superior to another. Richardson (1998) said that there is 
no definitive, clinical measure of spasticity that meets the requirements of a test to be 
valid, sensitive (responsive) and reliable. Both authors suggested choosing a variety of 
appropriate measures to attempt to compensate for the deficiencies of any one test. 
Some authors (e.g. Skold, 1999) also discuss the need for patients’ perceptions of the 
severity of their spasticity and its effect on function to be taken into consideration. From 
a clinician’s viewpoint the patients’ perception of the problem is of great importance in 
any intervention. Some individuals may live with substantial levels of spasticity that 
they do not perceive as a problem: others (with what a clinician may assess as a minor 
increase in tone) that this has a serious affect on their level of functioning on a daily 
basis. Treatment should be aimed at alleviating the individual’s problem.
Table 2.3 Examples of outcome measures used in spasticity management
H-Reflex Pendulum Test Ashworth Scale & 
Modified Ashworth Scale
Clinical Gait Scores 
(e.g. 10m timed walk test)
Electromyography Torque Measures Oswestry Scale Functional Ambulation 
Classification
F-Wave Amplitude Penn Spasm Frequency 
Score
Barthel Activities of Daily 
Living Index
Vibration Inhibitory Index Simple Grading Scales 
(e.g.+,++,+++)
Functional Independence 
Measures
There are a number of studies that report a lack of correlation between laboratory and 
clinical measures of spasticity (Priebe et al, 1996, Pierson 1997).
Priebe et al (1996) investigated a variety of clinical scales purporting to measure 
spasticity. Those considered were the Modified Ashworth Scale (MAS), the Penn 
Spasm Frequency Scale, planter stimulation response and tendon tap reflexes. They 
found poor correlation between the scales and suggested that they measured different 
aspects of spasticity. It may have been that their initial definition of spasticity, which 
was not stated in the paper, was not sufficiently clear. Tests investigated included 
measures of spasms, hypertonia and tendon hyperreflexia. These are varied symptoms 
of an upper motor neurone lesion, not classically spasticity.
Some of the more complex electrophysiological measures such as the FI-reflex have no 
proven links to the actual clinical state of the patient (Pierson 1997). Hiersemenzel et al
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(2000) found similar issues in their in-depth exploration of spasticity following spinal 
cord injury. These authors investigated changes in the H-reflex, M and F wave and 
electromyography immediately following SCI. They looked at links between these 
electrophysiological measures and their supposedly correlating clinical scales -  the 
MAS, the Penn Spasm Frequency Scale, and tendon tap reflexes. It was recommended 
that care be taken in the direct extrapolation of electrophysiological tests results when 
making references regarding the clinical state of patients:
‘clinical signs o f  increasing spasticity, such as muscle tone and spasms, can
hardly be related to the electrophysiological recordings ’
Hiersemenzel et al (2000)
The combination of variable definitions and lack of correlation between measures 
highlights the need for clarity in the use of the term ‘spasticity’. It would appear that the 
clinical tests used for both papers address different aspects of the UMNS, not 
specifically spasticity. The lack of correlation between clinical and laboratory measures 
may be one of the reasons that physiotherapists seldom attempt to measure spasticity in 
clinical practice. A test may show an increase in spasticity but unless this is definitively 
linked to a negative effect on a patient’s ability to function or quality of life, it has no 
relevance to clinical practice.
A variety of issues may act as variables in the measurement of spasticity. Those 
potential confounds specific to this study are considered more fully in Chapter 4. Other, 
more general, issues that have been identified include non-reflex mediated hypertonia 
and the critical velocity for initiating spasticity. These are issues that need to be 
considered in test methodology.
Spasticity is described as hypertonia, that is, an increased resistance to movement of a 
body part. Spasticity however, is only one part of hypertonicity. Resistance to 
movement is also produced by inertia of the part to be moved and by soft tissue 
changes. Many authors (e.g. Carey & Burghardt 1993, Goldspink & Williams 1990, 
Hufschmidt & Mauritz 1985) have documented the effect of soft tissue changes on tone. 
As well as changes in the non-contractile elements of muscle, ligaments and joints of 
limbs immobilised completely or partly as a result of an UMNL, muscle displays 
thixotropic change. Thixotropy relates to the formation of abnormal crossbridge
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connections between actin and myosin filaments. The result of these connections is an 
abnormal stiffness in the muscle upon attempted movement. It is generally recognised 
that these peripheral changes may play a substantial part in perceived hypertonicity. 
Definitive testing for reflex-initiated hypertonicity rather than that from non-reflex is 
dependent upon the velocity of testing. Resistance felt at slow rates of movement is said 
to be due to soft tissue changes, those at greater velocities due to spasticity (Sheean 
1998).
Lance’s (1980) definition of spasticity states that it is velocity dependent. Where no 
movement is present, or where it is present at low velocities, there is no spasticity 
(Sheean 1998). The critical velocity of movement however is not so clear. Some authors 
suggest angular velocities as low as 40° per second (Powers et al, 1988), others as high 
as 100° per second (Burke et al, 1970) being needed to trigger spasticity. Whilst the 
actual velocity is unclear, it is obvious that the velocity at which tests are undertaken is 
of importance in recognising spasticity.
All of the above points to potential problems with the validity of both tests (clinical and 
technical) as measures of spasticity; to the need for clarity in definition of spasticity to 
address this issue; and to the actual effects of spasticity upon function. Whilst 
electrophysiological nerve testing may give information about the activity of the tonic 
stretch reflex, the use of clinical or functional activity scales can seldom be linked 
directly to the effects of spasticity alone. The factors that may act as potential confounds 
in clinical testing are many. Wherever possible they should be considered and addressed 
in test methods, but realistically may need to be accepted as present and uncontrolled.
2.3. e Spasticity and Physiotherapy
Spasticity is an impairment that physiotherapists who work in the field of neurology 
spend much time in attempting to alter and control. The therapeutic goal of 
physiotherapy is to limit its effects on patient function, in an attempt to improve 
recovery following such damage.
Historically physiotherapists working with the neurologically disabled concentrated on 
maximising the patients remaining abilities. Little, if any, attempt was made to facilitate 
recovery. Emphasis on treatment was rather aimed at teaching compensation for
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neurological loss. Over time there have been substantial changes to this method of 
treatment. Compensation for neurological loss is still taught where appropriate, but is 
far from being the initial treatment of choice. Two of the current main treatment 
concepts in the management of this patient group are those following the Bobath 
Concept (Bobath, 1990) and Carr & Shepherds Motor Relearning Concept (Carr & 
Shepherd, 1998).
In the 1950s, Karl and Berta Bobath, working in the UK, devised a treatment concept 
with the intent of controlling the development of spasticity and facilitating more normal 
movement patterns. The Bobath approach to the treatment of neurologically damaged 
patients is the most frequently used and taught at both undergraduate and postgraduate 
level in this country. Bobath stated that spasticity ‘creates a major problem in the 
management of the patient’ with CNS damage, and adds that spasticity must be held 
responsible for much of the patient’s motor deficit. This approach emphasises the need 
to control the positive features (due to excessive motor activity) o f the UMNS. 
However, in Bobath’s book from 1990 the term spasticity seems to be used as an 
umbrella term for these positive features. The Bobath Concept advocates the ‘inhibition 
o f abnormally released patterns o f  co-ordination and the facilitation o f  the higher 
integrated automatic reactions o f normal postural control and those o f  more voluntary 
activity’ i.e. the inhibition of abnormal reflex activity following CNS damage and the 
facilitation of normal patterns of movement. More recently the Bobath Centre has 
clarified its definition of spasticity as one part of, not synonymous with, the UMNS 
(Lynch-Ellerington, 2001, Mayston, 2000). Whilst motor overactivities are still seen as 
causing main problems following UMN damage the Bobath Centre (Mayston, 2001) 
now puts an increasing emphasis upon the management of the negative features (due to 
reduced motor activity) of the UMNS. The use of normal movement is promoted to 
ensure optimal recovery of function.
Many other authors (e.g. Edwards, 1996, Kidd, Lawes & Musa, 1992) have also 
advocated the control of the positive features of UMNS in the facilitation of normal 
movement.
Carr & Shepherd’s (1998) Motor Relearning concept places the emphasis on treatment 
of the negative features of the UMNS, which they describe as ‘weakness, slowness of 
movement, loss of dexterity and fatigability’. They believe that these features are far
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more disabling than changes in muscle tone or hyperreflexia. The negative features are 
said to result from loss of descending fibres to the motor neurone population, meaning 
that there is not enough innervation to allow complex movements by graded activation 
of co-ordinating muscles, or the high frequency discharges needed for tetanic 
contraction strength. They postulate that many of the positive signs of the UMNS can be 
mistakenly identified changes in muscle rheology, or as behavioural adaptations to the 
negative signs.
All current forms of physiotherapy treatment would claim to bring about positive plastic 
changes to the CNS by the manipulation of peripheral and higher centre (where 
possible) input to enhance patient recovery. Mayer (1997) summarised the need for 
therapy to address ‘the balance o f  positive and negative symptoms ’ according to the 
needs of the individual patient. The use of functional electrical stimulation is one 
treatment option available to physiotherapists in the treatment of neurologically 
damaged patients. Given the emphasis, in the UK, on treatment of the effects of motor 
overactivites this treatment option may not be considered due to the dogma that FES 
will increase ‘muscle tone’. In spite of the emphasis on the management and control of 
spasticity in physiotherapy treatment, Haas’s (1994) study shows that therapists 
apparently seldom measure it.
2.4 Measures for this Study
Given the number of potential confounding factors in any attempt to ‘measure’ 
spasticity, and the underlying and critical issue with the concepts and constructs of 
spasticity, one must question whether or not it is possible to measure that which Wade 
(1991) describes as an ‘epiphenomenon’. This description may be more o f a reflection 
on the fact that spasticity is so difficult to measure, and to link to function, rather than it 
being an irrelevant by-product of an upper motor neurone lesion. Krebs’ (1987) 
suggested a paradigmatic approach to measurement. Table 2.4 attempts to give a 
structure and background to the process of measurement choice for this study through 
the operationalisation of spasticity. Lance’s (1980) definition is used as the theoretical 
basis for spasticity.
As previously stated, this project was closely linked to a larger study -  ‘Clinical 
Rehabilitation by Electrical Stimulation via Telematics’ (CREST). Two o f the measures
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for this study were dictated by the CREST project. The Modified Ashworth Scale 
(Bohannon & Smith, 1987) an ordinal clinical grading scale, was to be used as a 
measure of spasticity. The Modified Ashworth Scale (MAS) is one of the most 
frequently used clinical scales for grading spasticity. The Rancho Los Amigos 
Observational Gait Analysis system was used as a measure of walking ability.
Table 2.4: Schematic Illustration of Paradigmatic Approach to Quantitative measurement of
Spasticity -  after Krebs (1987)
General
Description abstract thinking ^ ^ concrete
measurement
Formal
Description
theory concept construct operationalised
variable
Thought
Process
W hat ideas and 
physiological 
evidence relate to 
spasticity?
What variables 
should I 
measure?
How should I measure 
them?
W hat units o f 
measurem ent 
should be used?
Behaviour Velocity related 
hypertonia -  
resistance to 
movement
Velocity 
related 
resistance to 
movement
Clinical scale m easures 
Biomechanical 
force/torque measures
Ordinal scale 
measures 
Torque in 
N ewtonm etres 
Velocity in 
“/second
Results from 
increase in tonic 
stretch reflex 
activity
Changes in 
reflex threshold
Electrophysiological 
nerve testing
Voltage
Functional deficit in 
ADL related to 
increased resistance 
to movement
Choose an 
appropriate 
ADL to the 
individual
Define necessary ADL 
param eters (scales may 
already exist)
Compare 
individual 
function to norm
This author chose two further measures -  resistance to passive movement using 
isokinetic dynamometry and TELER Gait Indicators. Isokinetic dynamometric 
measurement of spasticity has been used by many authors (e.g. Akman et al, 1999, 
Perell et al, 1996, Firoozbakhsh et al, 1993). The author chose this measure of spasticity 
to give quantitative, instrumented data about passive resistance to movement, as it was 
known that the Modified Ashworth Scale had been criticised for its subjectivity. 
TELER® Normal Gait Indicators were developed in response to the perceived problems 
with the feasibility and analysis of the Observational Gait Analysis data.
No neurophysiological measurement of spasticity was used in either the CREST project 
or for this study. The CREST study proposed to investigate the effects o f functional 
electrical stimulation used in a ‘clinical’ setting to improve walking ability, therefore
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clinical or functional scales were chosen. Equipment, expertise and funding for 
neurophysiological measures were not available. Also, as previously stated 
(Hiersemenzel et al, 2000), there may also be concerns regarding the correlation 
between some electrophysiological and clinical tests.
Using Krebs’ (1987) paradigm as a template for choice of measures, the MAS and 
isokinetic dynamometry measurements of torque were used as measures of velocity 
related hypertonicity during passive limb movements. The functional deficit in question 
was walking ability, the Rancho Los Amigos Observational Gait Analysis system and 
TELER Normal Gait Indicators were used to measure gait deficit.
Many issues with measurement of spasticity have been raised in this review of the 
literature; variable or unclear definitions, lack of correlation between measures, a 
perceived need to measure in clinical practice but a failure to do so. A critique of the 
validity o f the measures chosen for this study will therefore be presented in the chapter 
dealing with measurement (Chapter 3).
2.5 Functional Electrical Stimulation and Spasticity
There is a large body of evidence in the literature relating to electrical stimulation and 
its effect upon spasticity. Studies from the early 1980s by Alfieri (1982) and Bajd et al 
(1985), upon hemiplegic and SCI subjects respectively, reported decreases in spasticity 
following electrical stimulation. Since that time many other authors have also 
investigated spasticity and electrical stimulation. The articles vary hugely in the 
pathology of the subjects, in the stimulation parameters used, in their methods of 
application and in their choice of measures for spasticity. Relatively few studies 
consider the effects of stimulation upon spasticity in a truly functional setting. Some 
authors have studied stimulation at low intensity levels (sub-muscle contraction levels) 
(e.g. Potisk et al, 1995), some the effects of stimulation for exercise purposes (e.g. 
Skold et al, 2002), some the effects of alternating agonist-antagonist muscle stimulation 
(e.g. Shindo, 1987) as treatments for spasticity. The variation of possible applications 
undoubtedly adds to the conflicting reports of improvements, deteriorations and ‘no 
change’ in this impairment. Vodovnik (1981), Yarkony et al (1992) and Daly et al
(1996) have all reviewed the therapeutic effects of electrical stimulation, including its 
effects on spasticity, and proposed possible mechanisms for changes.
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The following is a review of articles relating to FES applied to the lower limb and 
spasticity. As well as the variation in applications and methods of measurement 
discussed above, definitions of spasticity vary. Lance’s definition from 1980 is most 
often used, but some definitions include flexor and extensor spasms and clonus.
Stefanovska et al (1989) reviewed the long-term effects of FES on spasticity in a group 
of eight hemiplegic subjects. The subjects had implanted drop foot stimulators. 
Electromyographic and torque measurements of tibialis anterior and triceps surae 
activity were undertaken over a six-month period. The authors found that, for each 
subject, the tonic component of spasticity in the calf muscle decreased significantly 
when the anterior tibial muscles were stimulated over the testing period, whereas phasic 
activity increased. No control group was used and subjects were considered 
individually, with measures being repeated over time. The authors concluded that the 
use of FES decreases the tonic component of the stretch reflex. They also suggested that 
articles that report FES as increasing spasticity may be measuring the phasic component 
of the stretch reflex. It is the tonic stretch reflex that is mainly implicated in spasticity.
Seib et al (1994) investigated the use of electrical stimulation on a combined group of 
spinal cord injured and head injured subjects. Stimulation was applied cutaneously to 
tibialis anterior with the subject sitting. The stimulation parameters were set to ‘mimic 
the gait cycle’. The authors developed their own measurement tool, the Spasticity 
Measurement System, which included electromyography and torque measurements of 
anterior and posterior calf muscles. Subjects acted as their own controls -  only one leg 
was stimulated. They found reductions in the levels of spasticity in the spinal cord 
injured group. The authors’ hypothesised that reciprocal inhibition was possibly 
responsible for the decrease in spasticity. There may be a problem in the use of subjects 
as their own controls -  any data gained cannot be truly independent - which may affect 
the statistical validity of their study.
Burridge et al (1997b) undertook one of the largest studies of hemiplegic patients 
treated with functional stimulation. 32 subjects were split into control and treatment 
groups. FES in the form of a cutaneously applied drop-foot stimulator was the 
intervention for the treatment group. Spasticity of the quadriceps was assessed using the 
Pendulum Test (Bajd & Vodovnik, 1984). Results showed a significant reduction in
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spasticity in the treatment group. They hypothesised that this reduction may be due to a 
number of factors:
1. Reciprocal inhibition of the quadriceps via hamstring Ia inhibitory interneurones 
and Renshaw cell activity (the hamstrings are activated during drop-foot stimulation 
if the flexor withdrawal response is recruited to improve hip and knee control). Over 
time this repeated inhibition may lead to neuroplastic changes causing a decrease in 
quadriceps spasticity.
2. Improved foot position during walking which allowed for better lower limb 
alignment through the stance phase of gait, may have had an indirect effect on 
spasticity
3. Decreased effort in walking (which was measured by Physiological Cost Index) may 
also have had an indirect effect in the reduction of spasticity
Burridge & McLellan (2000) studied the effects of drop-foot stimulation in a group of 
subjects with hemiplegia. Their comprehensive investigations, which included EMG 
and biomechanical measurements, concluded that the sub-group of subjects who most 
benefited from stimulation demonstrated poor control of ankle movement and spasticity. 
Gait parameters measured included speed and Physiological Cost Index. As results for 
the entire group varied (those with a mechanical resistance to movement responded less 
well to stimulation), the authors hypothesised that stimulation of the tibialis anterior 
muscle via the common peroneal nerve led to inhibition of the antagonistic calf 
muscles.
In 1993, Granat et al studied the effects of multi-channel FES-assisted-gait in six 
subjects with incomplete spinal cord injury. A single subject experimental design was 
used with multiple baselines pre- and post- intervention. Aspects of gait, voluntary 
muscle contraction and spasticity were investigated. Spasticity was measured using the 
Ashworth Scale (Ashworth 1964) and the Pendulum Test (Bajd & Vodovnik 1984). No 
significant change was identified with the Ashworth Scale results. It is not clear from 
the paper if the lower limb as a whole was graded, or just one muscle group. The 
Pendulum Test, which quantifies quadriceps muscle spasticity, showed a significant 
decrease in spasticity when subjects were analysed as a group. When considered 
individually one subject presented with a significant increase. Unfortunately, no 
explanation was given for the spasticity increase in this subject. In spite o f the spasticity 
increase in this subject, functional gait measures improved. All subjects received
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peroneal stimulation, with most also receiving at least one other channel of stimulation 
-  usually of the quadriceps muscle group.
Papers by Swain (1992) and Robinson et al (1988) reported finding increases in 
spasticity due to the use of electrical stimulation. Swain found increasing ‘spasms’ 
problematic in some subjects with spinal cord injury. At this point further intervention 
was stopped. No information was given as to type or duration of stimulation or how the 
‘spasms’ were assessed. Stimulation was being applied to condition muscle. Swain 
believed that the increase in spasticity was due to increased ‘strength’ of the stimulated 
muscles. In this case the term ‘spasms’ might have been being used interchangeably 
with spasticity. Flexor and extensor spasms are other positive features (see table 2.2) of 
the UMNS, not spasticity.
Robinson et al (1988) studied 31 subjects with complete and incomplete spinal cord 
injury. Electrical stimulation was used to recondition the quadriceps muscle. Quadriceps 
spasticity was again assessed by the Pendulum Test and by torque measurements. 
Repeated initial baseline measurements were undertaken followed by regular testing 
throughout the intervention then final repeated baselines. Only eight of the subjects 
completed the eight-week training schedule. The authors stated that they did not have 
enough data for meaningful statistical analysis but described an increasing trend in 
spasticity for the group. The electrical stimulation was applied for muscle conditioning, 
not functionally. They recommended that caution should be used in the use of electrical 
stimulation.
Crone et al (1994), whilst studying disynaptic reciprocal inhibition of the ankle 
planterflexors in normals and subjects with spasticity discovered that four of the spastic 
subjects had relatively more normal inhibition of this muscle group during active 
dorsiflexion. All four of these subjects regularly used a drop foot stimulator. The 
authors theorised that the use of such stimulation may enhance spinal inhibitory 
networks responsible for reciprocal inhibition.
An article by Daly et al (1996) is relevant as it reviews the effects o f FES on neural 
plasticity and ‘learning’. The authors studied conditioning of the Hoffman reflex (H- 
reflex) (Brown, 1984) in animal experiments and concluded that two phases o f change 
occurred. The H-reflex is evoked when la afferents from intrafusal muscle fibres are
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stimulated at low intensities. The monosynaptic, or phasic, stretch reflex is activated 
causing a contraction of extrafusal fibres. This muscle activation is measured by 
electromyography. Phase I was a short-term change that responded to task dependent 
modulation. Phase II developed gradually and was believed to result from persistent 
altered neuronal activity in response to phase I. Increases and decreases in la excitatory 
post synaptic potentials were noted to occur dependent upon the task imposed. The 
authors hypothesised that changes in interneuron activity resulted in the changes they 
found. They believed that this reinforces the fact that the spinal cord demonstrates some 
ability to plastically adapt to tasks. Observations by Muir & Steeves (1997) that the 
spinal cord is capable of task-dependent plasticity would suggest that using electrical 
stimulation in a functional setting might encourage more normal movement.
Comparison of the existing literature is made difficult by the lack of clarity in definition 
of spasticity and due to the variety of measures used. The majority o f the literature 
(Stefanovska et al, 1989, Seib et al, 1994, Burridge et al, 1997, Burridge & McLellan 
2000,Crone et al, 1994) supports the hypothesis that spasticity is more likely to be 
decreased rather than increased by FES due to the reciprocal inhibition of spastic 
antagonistic planterflexor muscle groups when the ankle dorsiflexors are active. The 
two articles (Swain 1992, Robinson et al, 1988) which found an increase in spasticity 
used stimulation for conditioning muscle rather than functionally. In both cases 
quadriceps muscles were being stimulated and assessed for their level of spasticity. For 
the effects of possible reciprocal inhibition the hamstring (antagonistic) muscle group 
should have been assessed, but this did not appear to have been done.
Few articles addressed the effect of stimulation and changes in spasticity upon gait by 
including a measure of gait within their studies. Those that did included Burridge et al
(1997), Burridge & McLellan (2000) and Granat et al (1993). The following section 
summarises the literature relating to FES and its effects on gait.
2.6 Functional Electrical Stimulation and Gait
Liberson et al (1961) first used a simple one-channel stimulator to enhance ankle 
dorsiflexion during the gait cycle of a patient who had suffered a hemiplegia. Since that 
time systems have been developed for production o f ‘synthetic’ gait in complete injuries 
both with (e.g. Isakov et al, 1992, Thoumie et al, 1995), and without (e.g. Bajd et al,
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1983, Graupe & Kohn, 1994), the use of orthoses. In recent years the emphasis has been 
more upon systems for gait enhancement in ISCI. In this country teams based in 
Salisbury and Glasgow have been very active in the research and clinical fields. 
Salisbury in particular have been involved in the development and use of a wide variety 
of FES systems for subjects with spinal cord injury. This team have experience in the 
application of fully implanted and cutaneous systems for gait production or 
enhancement.
A number of gait outcomes have been studied following the use of FES for gait 
enhancement. Reported changes in temporal parameters such as step length, swing to 
stance ratios and step symmetry appear to be inconclusive with Granat et al (1993) and 
Stein et al (1993) reporting little change. Improvements in walking speed were however 
reported by Granat (op.cit.), Stein et al (op.cit), Taylor et al (1999) and Burridge & 
McLellan (2000).
Burridge & McLellan (2000), Taylor et al (1999) and Stein et al (1993) assessed the 
effort involved in walking with and without FES. Burridge & McLellan and Taylor et al 
used the Physiological Cost Index. Stein et al studied oxygen consumption values. All 
authors found a decrease in the energy required to walk in their respective subject 
groups, suggesting that walking takes less effort when FES is used.
Granat et al (1996) considered the effects of FES intervention upon quality of gait and 
upon activities of daily living. The quality of gait was assessed by the incidence of heel 
strike at initial contact and the presence or otherwise of inversion during swing phase. A 
clear heel strike being a positive outcome, inversion through swing phase being 
negative. The Barthel ADL Index was used to measure global disability. Results for 
both outcome measures improved for all six subjects.
Taylor et al (1999) and Stein et al (1993) also considered the ‘carry-over’ effects of 
FES upon gait. Gait was assessed without FES to see if there were improvements when 
compared to the initial baseline measures. Stein et al found little improvement. Taylor 
et al found that even walking without stimulation showed significant improvement for 
their patient group. These differences may be due to differing pathologies of subject 
groups -  Stein et al studied a small group of subjects with incomplete spinal cord 
injuries, the other group in the main had sustained hemiplegia following a stroke. Taylor
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et al interestingly hypothesised that the use of FES may enhance the activity of the gait 
central pattern generator.
Consideration of time since injury needs to be considered for all groups o f subjects. The 
study involving ISCI recruited subjects who were a minimum of one-year post-injury. 
Granat et al (1996) and Taylor et al (1999) investigated subjects relatively soon after 
their injury. Natural recovery may have played a part in these two studies.
In summary, the use of FES would appear to improve many aspects of walking ability 
in subjects with a variety of disabilities. The underlying mechanisms for these 
improvements may include:
♦ Direct orthotic benefit -  the FES effectively works as a dynamic splint allowing the 
subject to produce movement they would otherwise be unable to, or have difficulty 
in being able to produce voluntarily. This means that a more normal gait pattern can 
be achieved, with more normal limb alignment and reduced effort of walking.
♦ Control of movement may be improved by increases in muscle strength either 
through direct or indirect stimulation (Granat et al, 1993, Stefanovska et al, 1989, 
Daly et al, 1996). Granat et al noted improvements in hip flexor muscle power even 
though these muscles had not been directly stimulated. They hypothesised that the 
repeated motor activity gained by stimulating the flexor withdrawal response 
actually strengthened the hip flexor muscle.
♦ Muscle phenotype has also been shown to change as a result of long-term 
stimulation. SCI subjects have relatively fewer slow oxidative motor units in their 
muscles than the norm, with a preponderance of fast glycolytic fibres. Stimulation 
has been shown to reverse this trend (Mohr et al, 1997, Pette & Vrbova, 1999), 
which would suggest that muscle develops a more fatigue-resistant profile.
♦ Improvements in reciprocal inhibitory mechanisms decrease spasticity allowing the 
production of better movement (e.g. Burridge et al 1997, Burridge & McLellan, 
2000).
It is the final one of these points that is core to this study -  alterations in levels of 
spasticity caused by the use of FES and their effects on the functional abilities of the 
individual. In this case, walking ability. The effects of spasticity upon gait therefore 
need to be considered.
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2.7 Spasticity and Gait
The effect of spasticity upon gait and other functional abilities remains a debated topic. 
Some authors (Ada et al, 1998, Carr & Shepherd, 1998, Wade, 1990) have stated that it 
has no effect upon the functional abilities of patients. However there is a growing body 
of evidence (Morita et al, 2001, Knuttson et al, 1997, Crone et al, 1994, Corcus et al,
1986) that spasticity will negatively affect voluntary movement and therefore function. 
‘Spastic restraint’, caused by inappropriate activity of antagonistic muscle groups, has 
been shown to occur during activity in subjects with spasticity. Studies of calf muscle 
activity for these subjects during active dorsiflexion of the ankle joint have shown a 
decrease in reciprocal inhibition of the soleus, with this muscle being active when in the 
normal subject it would be at rest (Morita et al, 2001).
Gait assessment measures effects, not causes (Rose, 1983). Wade (1992) echoes this 
with his observations about activity of daily living (ADL) indices. The fact that ADL 
scales have been developed in response to a ‘perceived clinical need’ enhances their 
validity, however they do not address the underlying cause as to why a subject fails to 
achieve a goal. Gait analysis cannot therefore be seen as measure of spasticity, but of a 
function that may be negatively affected by spasticity.
Individuals with incomplete spinal cord injuries may present with a variety of the 
features of the upper motor neurone syndrome. These features include positive and 
negative features such as spasms, clonus, spasticity, decreased selectivity o f movement, 
muscle weakness due to inadequate activation, and fatigue. As Perry (1993) highlighted 
all the above are likely to have a negative effect on gait.
Untangling the effects of spasticity upon an activity as complex as walking from the 
other aspects of the UMNS is unlikely to be simply answered. If gait is affected by 
spasticity, a spasticity measure should correlate with an independent measure of gait. 
The issue with the outcome measures chosen in this study is that both measures of 
spasticity (the MAS and isokinetic dynamometry) are passive tests. As stated earlier, the 
effect of spasticity during passive movement is not the same as that during voluntary 
movement (McLellan, 1977, Knuttson & Martensson, 1980). Spastic restraint during 
active, especially fast active movement was found to be substantially greater than 
during passive movement. As the physiotherapist is interested in the effects o f spasticity
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upon function (in this case walking), a passive test that does not correlate to function 
becomes redundant for this purpose.
The issue of walking speed also needs to be addressed when considering the effects of 
spasticity upon gait. Spasticity is velocity dependent; velocities of limb movement in 
the subject group may not be fast enough to trigger the tonic stretch reflex. The subjects 
chosen for this study displayed a variety of walking abilities, some walked everywhere; 
others were very limited in their abilities and walked only for exercise. These subjects 
therefore may never walk at velocities fast enough to actually trigger spasticity. In 
‘normal’ walking the human knee joint travels through 60° of movement in about 0.2 
seconds. This gives an approximate velocity of 300° per second. All of the study 
participants walked at speeds substantially slower than ‘normal’. The range of velocities 
above which spasticity is supposedly triggered was previously discussed as likely to be 
between 40°-100° per second. Knuttson et al (1997) found that ‘spastic restraint’ of 
agonist activity in concentric knee extension increased with increasing velocity of 
movement. Theoretically subjects with spasticity attempting to walk more quickly are 
likely to increase the resistance to leg movement and therefore slow their walking 
speed, or to use an increasing number of compensatory movement strategies in an 
attempt to maintain their speed. If spastic restraint was reduced by the use of FES, due 
to improved reciprocal inhibition between antagonistic muscle groups, more normal 
movement may be possible leading to improved walking speeds.
It is not possible to use gait as a direct measure of spasticity. There are many other 
factors which may affect walking ability and which may also be changed by FES.
2.8 Summary
The initial intent of this study was to investigate the effects of FES upon spasticity. FES 
is the use of electrical stimulation to produce functional movement. In this case FES 
was being used as an intervention to improve gait in individuals with incomplete spinal 
cord injury therefore gait measures were to be used as one of the outcomes. The 
measures of spasticity used were the Modified Ashworth Scale (MAS) and resistance to 
passive lower limb movement using an isokinetic dynamometer to give objective data 
about spasticity levels. The measures of gait were the Rancho Los Amigos 
Observational Gait Analysis System and TELER Gait Indicators.
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Review o f the literature relating to FES, spasticity and gait can be summarised as 
follows:
• FES may decrease spasticity -  most probably via the reciprocal inhibitory 
mechanisms that play a role in the activity o f the tonic stretch reflex.
• FES improves many aspects of gait -  there are many ways in which this may 
occur. Gait may be improved by the orthotic effect, training effect or due to the 
changes in reciprocal inhibitory mechanisms as stated above.
• Spasticity is a hugely complex phenomenon that has repeatedly proven to be 
difficult to measure. Although many measures exist there is apparently little or 
poor correlation between them.
• The measures chosen for this study can be split into passive measures (MAS and 
isokinetic dynamometry) and active measures (gait). The response o f spastic 
muscles in passive and active situations is different.
• Gait cannot be considered as a measure o f spasticity but rather needs to be 
considered as a function that may be affected by it.
Although the possible link between gait and spasticity has been discussed, the measures 
chosen for this study can offer no direct link. The effect o f disordered reciprocal 
inhibition upon a passive system has been shown to be substantially different to that of  
an active system. Gait may be affected by inappropriate co-contraction but a large 
number o f other factors will also affect gait speed and quality. The ultimate importance 
of spasticity is its effect upon the functional abilities of the individual -  does it prevent 
one walking, dressing or performing personal care?
The research direction therefore had to change from what the effects o f FES 
intervention were upon spasticity for the individual with ISCI, using gait as a measure 
of this, to separately considering the effects of FES upon spasticity and upon gait for 
these subjects.
Given the issues raised in this Chapter with the measurement o f spasticity, and with the 
importance o f measurement validity to study validity, Chapter 3 will present a 
comprehensive review of the measures used in this study.
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Chapter 3: Measurement
Review of the literature raised questions regarding the valid measurement of spasticity 
and highlighted the importance of appropriate measuring tools in research. This Chapter 
reviews the two measures of spasticity, the Modified Ashworth Scale and isokinetic 
dynamometry, and the two measures of gait, the Rancho Los Amigos Observational 
Gait Analysis System and TELER Gait Indicators, used in this study.
Measurement theory is ‘the conceptual foundation of all scientific decisions’ (Krebs
1987). If  a measurement is flawed, analysis and interpretation based on that 
measurement would be wrong. In short, in clinical practice, inappropriate treatment may 
be given. Krebs described measurement as 'the assignment o f  numbers to events 
according to rules’. Events are measured in healthcare practice and research in an 
attempt to show that a treatment has had a beneficial, or otherwise, effect over and 
above the expected outcome of a disease process. Pierson (1997) stated that the goal of 
an outcome measure is to allow the quantification of physical status and change in a 
‘standardised and reproducible way’. Wade (1991) however noted that, in the context 
of neurological rehabilitation, ‘measurement in the pure scientific sense is rarely 
possible’. Few aspects of neurological rehabilitation are easily quantifiable, standard 
units are generally absent. In spite of this, outcome measures proliferate in the literature 
relating to neurology (e.g. Pierson, 1997). With the promotion of evidence-based 
decision-making to direct clinical practice coming from both Government and 
Professional bodies, the need for good quality outcome measures, which meet the 
psychometric properties necessary for such scales, is ever important. An understanding 
of the level of measurement data being collected - nominal, ordinal, interval or ratio - is 
of importance in the construction of measures, final analysis of results and therefore the 
validity of conclusions drawn from study results. The properties necessary for any 
measure are described slightly differently in the literature, however the main issues that 
need to be assessed and considered can be summarised as validity, reliability, 
responsiveness and feasibility.
3.1 Criteria of measuring scales
Any measurement can be considered as consisting of the true measure plus the level of 
error and bias contained in the measurement (Le Roux, 2002). A truly valid measure
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will give as exact a value as possible to the object or event under consideration. The 
chosen measure will be capable of measuring the said event. It needs to give 
consistently reliable results when used repeatedly or by different observers - sources of 
error and bias will be decreased to a minimum. The effects of possible confounding 
factors that may alter outcomes will be controlled. Valid measures are gained from valid 
measuring instruments. A measuring instrument consists of a translating medium and a 
calibrated scale. A translating medium translates the extent of an attribute from an 
object to a point on a measuring scale. Each calibrated point of a measurement scale 
needs to be unambiguous and clearly defined, to have a unique meaning (McKenzie & 
Charleson, 1986). Each point on a scale must also assess the same phenomenon and be 
organised in a reasonable hierarchical manner. There also needs to be a logical chain of 
reasoning if the object is not to be measured directly -  e.g. the effects of the upper 
motor neurone syndrome upon function, spasticity upon gait. This occurs in many 
clinical scales where the effects of a pathology or impairment upon function are being 
considered.
Validity relates to the ability of a measure to measure that which it purports to measure 
(Gould, 1994, Seale & Barnard, 1998). In this section, validity refers to the measures 
rather than the methodological validity of the study. Validity and reliability are 
interlinked concepts. They are of vital importance in data collection to ensure that the 
conclusions being drawn from them are ‘true’. Validity is a complex issue that includes 
many different components. There are four main types of generally recognised validity: 
face, content, construct and criterion validity. Face validity is perhaps the simplest form 
-  the subjective assessment of the measurement tool to ensure that it is relevant and 
unambiguous. That is, it can measure the dimension in question and all the points on the 
scale are clearly defined and discrete. The last point is of particular importance to 
ordinal scales, which are often used in physiotherapy practice. If one is uncertain as to 
which rank an observation should be classified, errors will occur in results. Content 
validity requires more objective assessment of the concepts behind the tool, ensuring 
that it has the ability to measure the phenomena in question. Construct validity also 
relates to content validity and the theoretical concepts that underlie the test, a logical 
chain of reasoning from the concept to the measure needs to be explicit. Criterion 
validity consists of two parts: the ability of the test to correlate with other similar 
measures (concurrent validity) and the ability to predict outcomes (predictive validity).
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Reliability is the extent to which a measure will give consistent results -  both intra- and 
inter-observer. The concepts of error and bias are also encompassed within reliability. 
These issues need to be addressed within measurement. Error is a random or variable 
deviation from the true value and is due to the observer. Bias is a constant deviation 
from the true value and may result from the measuring instrument or from the observer.
Responsiveness relates to the ability of a scale to detect the change you are attempting 
to measure, if measurement points are too gross then clinically meaningful change may 
go undetected. Guyatt et al (1987) stated that responsiveness also had a direct link to 
validity and reliability. The scale used should be capable of detecting the observed 
value. If not, it is not likely to be a valid or reliable measure.
Feasibility addresses issues of simplicity of use and ease of incorporation into practice. 
This is of particular importance if a tool is to be used in a busy clinical setting.
Clinical significance is also a recurrent theme in measurement within a clinical setting. 
Hicks (1997) described clinical significance as ‘the degree to which a set of results have 
clinical meaning or relevance’. The example that is given related to training for pelvic 
floor muscles. Training may show a statistically significant increase in muscle strength 
but if the patient remained incontinent, the results would show no clinical benefit to the 
patient. Other authors (Testa, 1995, Le Roux, 1993, Bain & Dollaghan, 1991) 
emphasised the need for measurement scales to be responsive to clinically significant 
change. All research findings should be considered in terms of their clinical significance 
to the subject group.
The following sections will critique the four measures used for this study in relation to 
the above criteria.
3.2 The Modified Ashworth Scale (MAS)
The MAS (Table 3.1) is a six-point ordinal scale that describes increasing levels of 
resistance to passive movement of a limb. Bohannon & Smith first described this scale 
in 1987. It was a modification of Ashworth’s 1964 scale (Table 3.2) that was used to 
give a simple clinical quantification of the effects of a drug intervention in patients with 
multiple sclerosis. The authors introduced a further point on the scale (1+) due to what
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they in their clinical experience considered the ambiguity of grade 1 on the original 
scale. Although this scale is much maligned for its subjectivity it is very frequently used 
and referred to in the neurological literature. It is a quick and simple test that costs 
nothing to apply, needs no complex equipment and can be simply applied at the 
‘bedside’ -  from this it can be seen that feasibility in terms of ease of use is good. The 
measuring mechanism transfers level of resistance to movement to a measuring scale 
via the therapist’s perception of changes in resistance to passive limb movement.
Table 3.1: Modified Ashworth Scale for Grading Spasticity
GRADE DESCRIPTION
0 No increase in muscle tone
1 Slight increase in muscle tone, manifested by a catch and release, or by minimal 
resistance at the end o f the range o f motion when the affected part is moved in 
flexion or extension
2(1+) Slight increase in muscle tone, manifested by a catch, followed by minimal 
resistance throughout the remainder (less than half) o f  the ROM
3 More marked increase in muscle tone through most o f the ROM , but affected parts 
easily moved
4 Considerable increase in muscle tone, passive movement difficult
5 Affected part rigid in flexion or extension
Table 3.2: The Ashworth Scale
GRADE DESCRIPTION
0 No increase in muscle tone
1 Slight increase in tone giving a catch when the limb is moved into flexion or 
extension
2 More marked increase in tone but limb easily moved
3 Considerable increase in tone but limb easily flexed
4 Limb rigid in flexion or extension
3.2. a. Validity
Issues of validity relating to the Modified Ashworth Scale were comprehensively 
addressed by Pandyan et al (1999). They queried the construct and content validity of 
the scale as a measure of spasticity. The authors described these types o f validity as 
relating to the underlying assumptions and the theoretical basis on which a scale is 
created. They rightly stated that resistance to passive movement is not an exclusive 
measure of spasticity. Changes in the viscoelastic properties of joints and soft tissues, 
the weight of the limb and the participation, intentionally or otherwise, o f the subject 
will all affect resistance to passive movement. Thixotropic changes in muscle with 
repeated movements during the test may also confound. There is, therefore, an issue 
with whether or not the scale is truly a measure of spasticity. The authors suggested that 
the MAS is a valid measure of resistance to passive movement but not specifically of
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spasticity. It does not therefore measure a single phenomenon, but possibly two. Their 
suggestion that test velocities should be kept low would appear to be in direct 
contradiction to the findings of other authors (e.g. Sheean, 1998, Knutsson & 
Martensson, 1980) who stress the fact that spasticity is velocity dependent, not being 
elicitable at low velocities. Resistance to passive movements undertaken at low 
velocities is unlikely to be due to spasticity -  in fact this is more likely to exclude 
spasticity as a factor. Bohannon & Smith (1987) recommended that the elbow joint be 
moved from full flexion to full extension in one second i.e. approximately 150° per 
second. Velocity of testing should be at a level to provoke spasticity in an attempt to 
distinguish between it and other confounding factors. If this is not done the MAS cannot 
be considered as a valid test for spasticity.
Criterion validity -  comparison of the measured scales with other related measures -  
was also addressed. A number of authors have considered the Modified Ashworth Scale 
in relation to other measures of spasticity (e.g. Vattanasilp & Ada, 1999, Skold, 1998, 
Priebe et al, 1996, Katz & Rymer, 1989). Results from these studies vary in their claims 
as to whether or not the MAS correlated with other tests. Part of the problem is that 
there is no recognised ‘gold standard’ test for the measurement of spasticity, so the 
MAS may be being compared to other measures that may have substantial flaws and 
issues with validity of their own. Skold (1998), investigating EMG recordings and the 
MAS in the upper limb of tetraplegic subjects, found a substantial level of correlation. 
Vattanasilp & Ada (1999) suggested that the MAS was a ‘reasonable’ way to quantify 
hypertonia in the clinic. However, they expressed reservations that the scale cannot 
distinguish between spasticity and other factors affecting resistance to movement. In 
testing however they graded ‘slow’ passive movements. So to date, the issue of criterion 
validity has not been fully answered in the literature.
Bohannon & Smith addressed the issue of face validity in 1987. Their concern with the 
original Ashworth test was that the grade 1 was, in their clinical experience, ‘indiscrete’. 
They added an extra grade in an attempt to address this issue. Face validity relates to 
subjective assessment of the measurement tool to ensure that it is relevant and 
unambiguous. There is a hierarchy to the resistance described, but not a unique, 
discrete, meaning to each rank. It is difficult to give definitions to what is effectively a 
continuum. Subjectivity is a major issue. One therapist’s definition of a ‘considerable’
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increase in spasticity may differ substantially from another’s, or indeed may differ in the 
same therapist from day-to-day.
3.2. b Reliability
A small number of articles have addressed both intra and inter-rater reliability issues. 
One of the problems with the MAS scale is the lack of a clear test method in either of 
the definitive articles. For this thesis all subjects were tested in supine on a treatment 
plinth. All subjects could lie fully supine with just a pillow under their head for comfort. 
The testing sequence started at the hip and finished at the ankle joint. A number of 
practice sessions with other CREST physiotherapists and advisors were undertaken to 
standardise test procedure. All the physiotherapists involved were senior staff with 
substantial experience in the treatment of spinal cord injury. In this way, consistency of 
test method was addressed. Gregson et al (1999) undertook studies into the inter- and 
intra-rater reliability of the MAS. They found very good levels o f both types of 
reliability. Bohannon & Smith (1987) also found good inter-rater reliability of the test in 
the assessment of upper limb muscle tone. However Haas et al (1996) investigated the 
inter-rater reliability of the MAS in assessment of lower limb spasticity in spinal cord 
injured subjects, and found poor levels of reliability. Most authors attempted to address 
issues of reliability prior to undertaking testing by discussion of test method with the 
parties involved, attempting to ensure consistency. Although it is o f interest to note 
issues with inter-rater reliability, this was not an issue for this thesis as the author was 
the only assessor. This in itself may cause issues with bias. In an attempt to combat this, 
the author did not review previous test results prior to retesting.
3.2.c Responsiveness
Responsiveness is not an issue that papers relating to the MAS have addressed. The 
scale is fairly crude, but given its subjectivity, breaking it down further may be 
unrealistic and lead to increased problems with face validity -  in particular issues with 
ambiguity - and reliability.
3.2.d Feasibility
The MAS is a very simple test to apply in a clinical setting. No special equipment is 
needed and it takes only a few minutes to complete.
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3.2.e Summary
Whilst the Ashworth and Modified Ashworth Scales undoubtedly have their detractors 
they are also very frequently used in research as a measure of spasticity. There are 
reservations with the validity of the MAS as a measure of true spasticity. It is useful as a 
measure of resistance to passive movement. Aspects of velocity of testing should be 
addressed appropriately in the test technique in an attempt to distinguish between reflex 
and soft tissue resistance to movement. The clinical significance of such a passive test 
of the impairment spasticity is not clear.
3.3 Isokinetic Dynamometry
The isokinetic dynamometer used in this case was the Kin-Com®125 AP, manufactured 
by the Chattanooga Group Inc. (Figure 3.1) The Kin-Com® is an expensive and 
complex piece of equipment that in this case was used to provide interval level data 
relating to resistance to movement in units of torque. Nuyens et al (2001) stated that 
dynamometry provides ‘quantitative, sensitive and objective measurements o f  
resistance against joint movements Torque data were collected through ten continuous 
repetitions of passive knee flexion and extension at two velocities (60° per second and 
120° per second). Quadriceps resistance to movement was quantified as a unit of torque. 
The method used for gaining torque data from the isokinetic dynamometer had 
previously been used by a number of other authors (e.g. Akman et al, 1999, Franzoi et 
al, 1999, Firoozbakhsh et al, 1993). The peak torque for five consecutive knee flexion 
repetitions was statistically analysed by these authors.
3.3. a Validity
Some of the basic issues relating to the validity of the use of the Kin-Com® as a 
measure of spasticity are the same as those which applied to the MAS.
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Figure 3.1: The Kin-Com Isokinetic Dynamometer
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Whilst the Kin-Com® gives very objective, quantifiable information regarding 
resistance to passive movement, how much that resistance is a result of spasticity is 
questionable. The potentially confounding issues of joint and soft tissue rheological 
changes, limb inertia, velocity of testing and subject involvement are all as relevant to 
content validity as they are for the relatively subjective MAS (face validity).
Subjects were tested in the seated position through a range of 25°-85°of knee flexion. 
This range of movement was chosen to avoid the confounding issue o f possible soft 
tissue tightness at the end of joint range. Some concerns however have to be expressed 
as to what the peak torque is actually measuring. In almost every instance it occurs very 
early in the flexion phase of the movement. At the end of range there is a rapid change 
of direction as the machine quickly decelerates, then accelerates into the new phase. 
Choices of three ‘turning’ accelerations are offered by this dynamometer. Initially a 
rapid change was chosen but it was found that the momentum of the limb, in particular 
in subjects with large limbs, was activating the safety cut-out feature and stopping the 
machine. The moderate change option was therefore chosen. The machine no longer cut 
out following this. This issue emphasises the effect momentum due to the rapid 
deceleration then acceleration in a new direction has upon the torque measurement. It 
may also be possible that the phasic part of the stretch reflex is being activated at this 
stage as a protective mechanism due to the sudden rapid change in direction of 
movement, even though the muscle is never actually on stretch due to the chosen joint 
ranges. Firoozbakhsh et al (1993) in their discussion query whether the maximum 
torque value seen is due to the inertia of the limb and its ‘compliant coupling to the 
lever arm of the dynamometer’. Other authors who have copied his technique however 
have found statistically significant differences in peak torque measurements between 
subjects with spasticity due to spinal cord injury and normals (Akman et al, 1999, 
Franzoi et al, 1999, Perell et al, 1996).
Two velocities of movement were chosen in an attempt to differentiate between 
resistance due to soft tissue compliance and spasticity. Initially the speeds of 60° and 
180° per second were chosen to give a substantial gap between high and low velocities 
of testing. However the 180° per second speed was very difficult to tolerate, even in 
normal subjects, and remain ‘relaxed’. Perell et al (1996) found significant differences
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between groups tested at 60° and 120° per second. The second test velocity was 
therefore changed to 120° per second, which all subjects tolerated comfortably.
Little appears to have been written as to the criterion validity of the isokinetic 
dynamometry measurement of spasticity. Interestingly some of the few articles that 
have addressed this issue (e.g. Akman et al, 1999, Franzoi et al, 1999) compare it to the 
Ashworth Scale. Both studies found a positive correlation between Ashworth scores and 
peak torque values. It was noted that subjects presenting lower Ashworth grades (1&2) 
did not appear significantly different from the ‘normal’ control groups in terms of 
torque measurements. Franzoi et al {op. cit.).
3.3. b Reliability:
The reliability of such a technical test lies inherently within the ability of the instrument 
to provide repeatable, reliable information and in the reliability of the test method. In an 
attempt to address issues with tester error and bias, an extended period of training in the 
use of the machine was undertaken under the supervision of a physiotherapy clinical 
specialist.
The test procedure was reviewed and standardised. Ten test sessions on ‘normal’ 
volunteers were performed using the test protocol prior to testing subjects. Franzoi et al 
(1999) reinforce the importance of standardised positioning if results are to be 
compared. Particular care was taken in lining the lever arm with the centre of the knee 
joint and with the positioning of the load cell above the malleoli. This was o f particular 
importance as torque is defined as the turning force about a joint -  the Kin-Com makes 
its calculations relative to the movement and position of the load cell.
Mayhew et al (1994) found that in testing that the Kin-Com® dynamometer was very 
reliable in a variety of situations. Davies et al (1996) however found that their torque 
data results at speeds above 30°/s were too ‘contaminated’ by noise to be analysed. 
Gleeson & Mercer (1996) discuss a number of methodological issues that may affect 
reliability and some aspects of validity. ‘Human’ issues - ‘time-of-day effects’ and 
learning from the test are raised as possible confounds. As the test used in this case was 
a passive one, learning from the machine was not considered as a problem.
55
3.3.c Responsiveness
Whilst the dynamometer may be very sensitive to small changes in torque, the point at 
which this change in torque becomes clinically significant to an individual’s functional 
abilities, is not clear.
3.3.d Feasibility:
As previously stated, this type of dynamometer is a technically complex and expensive 
piece of equipment. Such items of equipment do not tend to be found within 
physiotherapy departments. The Kin-Com needs to be frequently calibrated and tested. 
To test quadriceps and hamstring resistance to passive movement for one subject took 
approximately 40 minutes. The seat of the machine was very high. One o f the subjects 
could not access the Kin-Com as the seat was too high for them -  a hoist would have 
been needed. However the size and shape of the base of the machine would have meant 
that a ceiling mounted tracking hoist would have been the only option. One other 
subject had to transfer onto a height adjustable plinth from their wheelchair and shuffle 
across onto the Kin-Com seat. Whilst the Kin-Com undoubtedly gives quantifiable 
information about resistance to movement in a research setting, it is not an easy piece of 
equipment to use and would not be feasible as an outcome measure in clinical practice.
3.3. e Summary
Isokinetic dynamometry has been used in many research studies to quantify muscle 
activity. Its advantage over the MAS is that it produces quantitative data; the 
disadvantage is that it is complex and time-consuming to set up. Consideration needs to 
be given to speed of testing and other possible confounding factors as for the MAS.
3.4 Observational Gait Analysis
Gait analysis is an important part of daily practice in physiotherapy. It plays a 
substantial part in our clinical decision-making and choice of treatment options for 
patients with movement disorders. The assessment of gait is a complex process with a 
variety of movements occurring in quick succession over a variety of limb segments. It 
involves many phases. Gait laboratories provide highly detailed, objective, ‘gold
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standard’ data regarding gait but are costly, highly sophisticated and seldom accessible 
to most therapists. It can perhaps also be questioned how valid they are in the 
assessment of the very poor walkers often seen within physiotherapy departments. To 
ensure quality data from force plates and videotape subjects often have to make 
repeated walks along a walkway. Detailed analysis is usually made of one step. Subjects 
who fatigue quickly, whose gait is variable from step to step and who support a 
substantial amount of weight through walking aids are all difficult to analyse in a gait 
laboratory setting. In the clinical setting however most gait analysis is observational, 
and done in a very subjective manner (Coutts, 1999). This, in turn, leads to issues with 
assessing efficacy of treatment. For the purposes of this study the Rancho Los Amigos 
Observational Gait Analysis (OGA) form (Figure 3.2) was used to standardise the 
collection of gait data. Gait analysis played a substantial part in the FES strategies 
chosen for the study subjects. The OGA form provided a methodical way of assessing 
gait abnormalities within each phase of gait and at each joint of the lower limb. It 
provides nominal data about gait abnormalities. A mark is made on the form to indicate 
where and when a gait abnormality is present.
3.4. a Validity:
There has been little written as to the validity of observational gait analysis. In terms of 
face validity the Rancho Los Amigos OGA form gives a comprehensive breakdown of 
the phases of gait (as described by Perry (1992)) and of the joint ranges of the pelvis 
and the lower limb. The Rancho Los Amigos physical therapy department developed 
the form using normative gait data that was collated from ‘gold standard’ gait lab 
findings. Gait has been studied in great detail by many authors over many years (e.g. 
Perry, 1992, Sutherland, 1988, Inman, 1981). There is a substantial quantity and quality 
of objective quantitative data relating to normal human gait collated from computerised 
studies. For this thesis, gait was analysed from video recordings of subjects walking 
along a 10m walkway. It is recognised that this is an ‘unnatural’ setting and that the use 
of video may in itself affect the subjects’ gait (Mulder, 1998).
Greenberg et al (1996) addressed the concurrent validity of the Rancho Los Amigos 
OGA form and computerised kinematic data from the Vicon gait analysis system. All of 
the scorers were senior clinicians with substantial experience in the field of gait 
analysis. They found a poor correlation between data from the observational data and
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the Vicon data leading them to question the validity of the observations from the 
therapists.
There are undoubtedly many issue unresolved in the area of validity relating to OGA. 
The following section on reliability also raises issues that impact upon validity. If data 
is unreliable, carries a large degree of random error, it may not give valid (true) 
measures.
3.4. b Reliability:
There are a small number of studies that address the issue of reliability of OGA. None 
of them specifically address the Rancho Los Amigos system. Substantial concerns were 
voiced by all three reviewed articles regarding the lack of reliability found in their 
studies.
Krebs et al (1985) and Eastlack et al (1991) both found only moderate to poor inter- and 
intra-rater reliability in their studies. Coutts (1999) went so far as to state that at present, 
OGA on its own was insufficiently reliable to be clinically acceptable, echoing Krebs’ 
(1985) observations regarding measurement error in gait analysis. The extent of any 
such measurement errors should be addressed before conclusions can be drawn from 
any test. Caution is suggested in analysis and generalisation of results. Sim & Arnell 
(1993), in their article on measurement validity in physical therapy research, used the 
problems with OGA reliability as an example of the importance of the links between 
reliability and validity. For conclusions drawn from data to be valid, the data itself must 
be reliable.
The preceding articles all draw similar conclusions to improve the reliability of OGA 
data:
1. The need for the use of a standardised form - clinicians seldom do, relying on highly 
subject assessment (Coutts, 1999)
2. Therapists must be familiar with normative gait data
3. Terminology used in the description of gait (to describe both phases and 
abnormalities) should be clearly understood
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4. Video should be used wherever possible in OGA, preferably with freeze-frame and 
single-frame-forward options. This would give time for the analysis of multiple joint 
movements over multiple phases of gait and remove the issue of subject fatigue.
The Rancho Los Amigos system addresses the first three of these issues. The author 
underwent a period of training in the use of the form and in the terminology used with 
other CREST project members. This OGA system comes with a substantial training 
pack. The use of video and PC combined allowed for good quality freeze-frame and 
single-frame-advance assessment.
In spite of all the concerns regarding the reliability and validity, the author believes that 
there is a value in the use of OGA. Undoubtedly, care must be taken with any 
conclusions drawn from such data and limitations with reliability and validity must be 
addressed. As previously stated, visual analysis of gait, as part of the patient assessment 
is a common part of physiotherapy practice. Means of analysis without a standardised 
form are very subjective, with no indicator of outcome other than the therapist’s opinion 
and with no evidence base. The other extreme is the use of highly sophisticated gait lab 
equipment, which in most cases is unrealistic, and which may still not give valid 
information regarding poorer walkers within a spinal cord injuries setting.
3.4.c Responsiveness:
One of the issues with the responsiveness of this form is that a huge number of data 
points are collected in any one assessment. The form only applies to one leg. If 
analysing both limbs another form must be completed. The gait improvement that 
effects a clinically important change for the individual may be lost in a welter of 
‘unimportant’ information. The form provides nominal data about gait deviation i.e. an 
abnormality is either present or absent. There is no mechanism for noting improvement 
in performance if the normal is not achieved. Sensitivity to change is therefore low and 
clinical meaningfulness may be lost (Holden, 1984).
3.4.d Feasibility:
The Rancho Los Amigos form is complex. A substantial degree of knowledge/training 
is needed to recognise the different phases of gait, be familiar with normative gait
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values and to have a comprehensive understanding of the described gait deviations. The 
form took approximately 30 minutes to complete even after the assessor improved their 
skills and became familiar with it. The use of video enhanced analysis of gait, in 
particular giving the ability to freeze frame and slow motion down. In the clinical 
setting such a lengthy assessment process would be a luxury. Not every physiotherapy 
department has access to a video camera, or to a video player that can provide a quality 
freeze frame or slow motion option from which to analyse movement.
3.4.e Summary
The Rancho Los Amigos analysis system is based upon gold standard gait laboratory 
measures so should have good validity as a measure of gait. Unfortunately its reliability 
appears to be poor -  possibly due to the complex nature of gait. Reliability is an issue 
with observational analysis of gait. There appears to be little, if anything, published 
regarding the use of this system. This may be an indication o f the potential problems 
with analysis of the data.
3.5 TELER® Gait Indicators
TELER is an acronym for Treatment Evaluation by A Le Roux’s method. Le Roux 
(1993) developed the TELER system in response to the needs of physiotherapy services 
for a measurement tool that would measure effects of treatment in terms of goal 
attainment in the individual. As therapists seldom offer a ‘rote’ treatment, but rather, 
treatment adapted for the needs of the individual, a flexible system that actually 
measured the outcome of the process of rehabilitation was necessary. The system is 
based upon the assessment of the individual patient’s needs and the development of 
treatment indicators from such.
The mechanism of measurement used by the TELER method is observation. This 
translating medium transfers observed activity to a measuring scale. The calibrated 
scale, or TELER Indicator, comprises six ranked, observable and clinically significant 
codes. These codes trace change, or lack of change, in a patient’s abilities. The non­
standard unit of measurement is clinically significant change. The TELER Indicator is 
an ordinal scale. Before an ordinal scale can be considered as the defined codes of a
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TELER Indicator, seven conditions relating to the theory of measuring scales must be 
satisfied (Le Roux, 1999):
1. An intermediate outcome is an essential component of the desired outcome
2. All the intermediate outcomes are essential components of the desired outcome
3. The preceding intermediate outcome is an essential component of an 
intermediate outcome
4. All the preceding intermediate outcomes are essential components o f the desired 
outcome
5. Each outcome is clinically significant
6. The progression from one outcome to the next is clinically significant
7. The outcomes reflect what is actually happening to the patient, as seen by the 
clinician, patient or carer.
An outcome is a TELER code. An intermediate outcome is a point on the hierarchical 
TELER Indicator scale. The first four concepts are linked to the need for each code to 
have a unique meaning in a hierarchy. This relates to the measurement properties of 
connectiveness, asymmetry and transitivity. These properties define the hierarchical 
relationship between codes. An outcome can be considered to be clinically significant 
when it can be justified by clinical or other knowledge, when the change between two 
successive outcomes can be explained with clinical knowledge, and when the time 
needed for change to occur can be explained by clinical or other knowledge. Outcomes 
are defined from the therapists’ clinical and theoretical knowledge of the event under 
consideration; therefore current knowledge of the field is vital to the construction of 
valid indicators. For the outcomes to reflect what is actually happening to the patient the 
title of the TELER Indicator must reflect goals that are important to the patient. Each 
code is effectively a short-term treatment objective towards the stated goal. These goals 
must be understandable to the patient or anyone else reading them. The use of jargon 
should be avoided so that anyone reading the Indicator can understand it.
Another unique feature of the TELER system is that it is capable of showing attribution 
for the individual subject, that is that the observed change was due to the intervention 
chosen. It can only do so however when used in conjunction with a research method 
which controls for possible confounding variables. In a poorly defined measuring scale 
the random error of any measure is unknown and uncontrolled, therefore it is not
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possible to know whether before and after differences are real or an artefact of the scale. 
In research this is allowed for by the use of groups of subjects, preferably as large as 
possible, so that any error is averaged out. In clinical practice the therapist needs to 
know the effect of an intervention upon the individual, not the ‘average’. The TELER 
Indicator is a well-defined measuring scale which follows the above seven rules. The 
minimum of six discrete ranks with five clinically significant change intervals is also an 
important part o f the attribution process. It is not possible to attribute a difference in 
before and after treatment scores for a single subject to a particular cause. If a series of 
intermediate scores between the before and after ones are considered attribution is 
possible. The minimum number of necessary changes is five.
The attribution of TELER Indicators is of particular importance to this study design 
where it is the individual who is under consideration.
TELER is a system of clinical note-taking that provides clinical information that can be 
used to establish the effectiveness of treatment. The TELER Indicator is an ordinal scale 
that traces the effects of an intervention through observable, clinically significant 
change in an individual patient’s, or group of patients’, abilities.
For this study TELER Normal Gait Indicators were developed in response to problems 
with the feasibility of applying the Rancho Los Amigos system within a clinical setting, 
with the problematic responsiveness of the tool and with the analysis issues that will be 
discussed in Chapter 6.
3.5. a Validity
A calibrated TELER Indicator is always valid (Le Roux, 1999) The level o f validity will 
vary dependent upon the level of knowledge used to construct it and upon the number of 
therapists in agreement over its content and construction. The larger and more 
experienced the group the more valid the indicator.
The eight main phases of gait as described by Perry (1992), e.g. initial contact, mid 
swing, were used as the basis for the development of the TELER Normal Gait 
Indicators (Appendix I). TELER Indicators for trunk activity and foot contact through 
the gait cycle were also developed. Each Normal Gait Indicator consists of five
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component parts that described normal limb movement in the saggital plane at the 
pelvis and at the hip, knee, ankle and metatarsophalangeal joints for each phase of 
movement. The saggital view was initially chosen for analysis due to its better 
reliability (Krebs, 1985) when compared to frontal or transverse planes. The 
components have no inherent hierarchy to them, so component rather than functional 
indicators were developed. The structure of a component indicator is shown in figure 
3.3. The use of the codes 0-5 gives a hierarchical structure in keeping with points 1-4 of 
the conditions needed for a TELER Indicator. Each component is a discrete, clinically 
significant and observable feature of that phase of normal gait. The Indicators are based 
upon clinical and theoretical knowledge of the gait cycle. A review of the literature 
regarding normative gait data was undertaken by the author to give a basis for normal 
gait upon which to base the indicators. Normative gait data from ‘gold standard’ gait lab 
studies (Inman, 1981, Sutherland, 1988, Perry, 1992) were used to compile the 
Indicators. Dr Susan Mawson, Senior Lecturer in Physiotherapy, Wendy Dickens, 
Senior Physiotherapist in Gait Analysis, and the author of this thesis collaborated in the 
development of the Indicators. The indicators were therefore based upon both 
experiential and academic knowledge.
Figure 3.3: Format of a Component Indicator
Title
Components Treatment objective
0. Unable to complete any o f the required activities
1. Able to complete one o f the required activities
2. Able to complete two o f the required activities
3. Able to complete three o f the required activities
4. Able to complete four o f the required activities
5. Able to complete all five o f the required activities
Wade (1992) argued that activity of daily living (ADL) scales were inherently valid as 
they address a perceived disability. The TELER indicators point o f origin is the 
patient’s assessment of their problem. As an example ‘I catch my toes and trip’ on 
further assessment could be defined in terms of an inability to dorsiflex the ankle
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sufficiently. The therapist may then describe this as a lack of dorsiflexion through the 
swing phase of gait. In this manner Indicators that are clinically relevant to the 
individual subject’s problems are chosen.
The above addresses issues of face and content validity. TELER indicators also need to 
demonstrate construct and concurrent validity. A small group of senior physiotherapists 
from the Spinal Cord Injury Unit and Gait Laboratory at the Northern General Hospital 
was convened to trial and critique the Indicators. Although this was a very small pilot, 
the indicators were considered by this group as acceptable measures of normal gait and 
usable for the assessment of patients. Further work with larger groups of clinicians with 
expertise in the field of observational gait analysis would need to be undertaken before 
construct and concurrent validity could be shown.
3.5. b Reliability
The reliability of the indicators is linked to their validity. If found to be valid, they 
should also be reliable. The small pilot study described above in part addressed 
reliability. The group analysed videotape of a subject with a spinal cord injury walking. 
Further work would need to be undertaken following this preliminary study to further 
consider both inter- and intra-rater reliability of the indicators.
3.5.c Responsiveness
TELER indicators should demonstrate a high level o f responsiveness to clinically 
important change. The indicators are chosen for the individual patient and are based 
upon their own analysis of their problem. Each TELER code should be based upon a 
clinically significant, observable outcome. The indicators were developed in relation to 
the parameters needed for normal gait. The relatively small number of data points also 
means that a significant change should not be easily overlooked.
3.5. d Feasibility
When compared to forms such as that from the Rancho Los Amigos, the TELER 
indicators are far easier to apply in a clinical setting. A small number of indicators 
appropriate to the subject being assessed are chosen for scoring, focusing on the key
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aspects of gait being treated. The time taken to complete the chosen indicators is 
therefore far less than that of the Rancho Los Amigos, and can easily be incorporated 
into clinical practice.
3.5.e Summary
The TELER system is capable of producing valid, reliable and clinically significant 
data. The Indicators have been developed to provide a more clinically feasible method 
of analysing gait.
3.6 Chapter Summary
This Chapter has considered the criteria it is necessary for measuring scales to 
demonstrate. These were identified as validity, reliability, responsiveness and 
feasibility. The issue of clinical significance was also introduced and its importance in 
giving real meaning to results gained from measures highlighted.
The four measures chosen for this study were reviewed against these criteria. Those 
measures are the Modified Ashworth Scale, isokinetic dynamometry measurement of 
resistance to passive movement of a limb, the Rancho Los Amigos Observational Gait 
Analysis System and the newly developed TELER Normal Gait Indicators.
Despite questions being raised as to aspects of the measurement criteria of some of 
these tools, they are all accepted measurement techniques. The following Chapters 
expand upon the application of these measures and present and discuss the results from 
them.
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CHAPTER 4: METHODOLOGY
The intent of this study was to investigate the effects of the clinical application of 
functional electrical stimulation upon spasticity in the individual with incomplete spinal 
cord injury, and in turn the effects of this change in spasticity upon gait. However, 
following a review of the literature and of the chosen measures it was clear that it would 
not be possible within the remit of this study to determine the effects of FES upon 
spasticity in dynamic activity i.e. gait. Consequently it is necessary to replace the 
original research questions with the following:
1. What changes in spasticity does an individual who receives FES as a treatment 
experience?
2. What changes in gait does an individual who receives FES as a treatment 
experience?
This study will consider both questions separately.
This chapter is split into two parts. The first includes the research hypothesis, study 
design and study validity. The overall validity of the study should not be confused with 
measurement validity, which was addressed in Chapter 3. Measurement validity is one 
aspect of methodological validity, along with internal, external and statistical validity, 
which can affect the veracity of conclusions drawn from the study results. The second 
part details the research process: the pilot study, subject selection, details of the data 
collection process, and of the FES strategies and decision-making process. Finally the 
analysis methods are introduced.
Ethics Committee approval for this study was gained from the Northern General 
Hospital Trust prior to starting.
4.1 Study Design
A single subject experimental design (SSED) was chosen. The main features o f SSED 
design are the sequential application and withdrawal of treatment and the use of 
repeated measures of the dependent variable. Data were collected during initial and then 
final baselines giving an AB design. This type of design is described as quasi- 
experimental (Seale & Barnard, 1998) as it does not meet the full rigor of a true
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experimental design. The reasoning behind this choice of design, rather than a more 
conventional group design, is as follows:
• The aim of the study was to look at the effects of FES on spasticity in the individual 
subject. A clinician is interested in the individual, rather than the group response to 
treatment. Whilst large group studies may give valid information regarding the 
average subject by evening out the effects of random error, the SSED is capable of 
giving information about the individual’s response. If Sacketfs (1996) definition of 
evidence based practice as ‘the conscientious, explicit and judicious use of current 
best evidence in making decisions about the care o f individual patients’ is 
considered valid then this type of design is perhaps more likely to help in answering 
such clinical questions.
• The small group of subjects used was non-homogenous. Each subject had sustained 
an incomplete spinal cord injury. However, clinical presentations and problems 
were all different. All received FES as an intervention for gait problems but the 
parameters and applications were different.
• The incidence of spinal cord injury is very small -  approximately 600-900 new 
injuries per annum in this country. Incomplete injuries capable of ambulating are 
obviously a smaller subsection of this group. Obtaining a large enough group to give 
meaningful data from both control and treatment groups was not practical. Rather 
than undertaking research based on an inappropriate group method upon a small 
subject group, it was seen as more valid to use a SSED. This type of design uses the 
individual subject as their own ‘control’ by the use of repeated measures.
• The conditions in which the study was carried out was closer to a clinical setting 
than a research setting.
4.2. Study Validity
To avoid drawing unjustifiable conclusions from a study, aspects of methodological and 
measurement validity and the control of possible confounding factors must be 
addressed. Black (1999) outlines four types of validity that need to be considered -  
construct, internal, external and statistical. Construct validity relates to the ability of the 
measures used to measure what they are supposed to. This was addressed in Chapter 3. 
Statistical validity relates to the choice of appropriate statistical tests. The statistical 
tests for this study will be introduced at the end of this chapter.
4.2. a. Internal validity
The literature states that, for a study to have strong internal validity, the effects of error, 
bias and potentially confounding factors need to be controlled wherever possible. The 
issue of extraneous variables, that is, variables which may act as competing independent 
variables and which may confound results, should be addressed. Quasi-experimental 
designs have been recognised as not demonstrating the same strength of evidence of a 
causal link between dependent and independent variables as true experimental designs. 
Black (1999) argued that whilst the above may be true, the advantage of this type of 
design is that it can reflect real-life situations more closely than those conducted under 
more experimental conditions. This is likely to be of interest to therapists working in a 
clinical setting who regularly deal with a complex combination of potentially 
confounding factors.
Ottenbacher (1986) highlighted two main issues relating to internal validity to which 
special consideration needs to be given in SSEDs: testing and instrumentation. Where 
repeated measures are used, error related to instrumentation can become a major issue. 
The behaviour of an individual or group is likely to be altered simply by the process of 
being measured (Hawthorne effect). Where repeated measurements are used, as in 
multiple baselines, there is obviously an increased risk of this occurring. Individuals are 
likely to learn from the test itself and therefore improve in their performance. Potential 
problems with instrumentation are also likely to be highlighted by the use of repeated 
measures. The reliability of results become paramount in ensuring that baselines show 
genuine change and not machine or measuring tool instability.
For this study baselines were kept to a minimum. This was in part to address the issue 
Black (1999) described as ‘learning from the instrument’. Doing so also had a practical 
purpose -  many subjects worked and/or had a 100 mile round trip to attend for sessions. 
Other issues with testing relate to the tester/assessor. The researcher was the assessor for 
all measures used. This may obviously leave the study open to experimenter bias. In an 
attempt to address this, a second blinded assessor was used for the Observational Gait 
Analysis section. Other more general assessor issues may play a part e.g. increased 
experience over time may affect measurements, more rigorous or relaxed testing method 
over time may also be an issue.
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4.2.a.i Competing Independent Variables
It can be argued that competing independent variables are not an issue in answering the 
new research questions. The intention is to determine whether there is an association 
between the changes that occurred and FES. It is not the intention to establish a causal 
link between the changes that occurred and FES.
Consideration is however given to some of the many issues, other than FES, that may 
affect spasticity and gait. If these potentially confounding variables are not, wherever 
possible, recognised and controlled there is a risk of drawing invalid conclusions from 
data that may be a result of these variables rather than the one under observation. 
Spasticity in particular is notoriously variable and may be affected by a number of 
issues. Figure 4.1 highlights some of the main identified variables liable to affect 
spasticity in this study. The following section addresses each of these issues and 
indicates how the researcher attempted to address each with the intent of avoiding 
confounding outcomes.
• Disease: This is cited by many authors (e.g. Kirschblum, 1999) as a possible cause 
for increased tone or ‘spasticity’ and should be assessed for prior to commencing 
any treatment. Typical causes include bladder infections, pressure sores, and 
syringomyelia cyst formation. Two subjects (one identified as 014, the other 
unidentified), who were initially assessed as possible candidates for the project 
developed medical complications of spinal cord injury prior to starting baseline 
measurements. They therefore discontinued their involvement with the project.
• Medication for spasticity: Many of the subjects were taking the antispasmodic 
Baclofen. Any medication was noted at initial assessment. Subjects were asked to 
inform the researcher of any changes in their normal medication. No changes were 
reported.
• Physiotherapy treatment: Some subjects attended local outpatient physiotherapy 
departments for maintenance routines. This was again noted and subjects were asked 
to inform their therapists of their involvement in this project. Subjects were also 
asked to inform the researcher of any substantial changes in their therapy routines. 
No changes were reported.
• Test position: Many authors (e.g. Edwards, 1996) state the importance of a 
standardised testing position in the measurement of spasticity; pattern o f tone can
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depend upon the subject’s position. This was addressed in the testing procedures 
that are detailed in section 4.5 of this Chapter.
• Psychological state: This can also be considered a possible confounding issue. 
Anxiety and depression are both believed to have a negative influence on spasticity. 
This was noted but no steps were taken to address this with the subject group.
• Time of day for testing. Wherever possible subjects were kept to either morning or 
afternoon sessions. As a variety of outcome measures were used, which may have 
impacted upon each other the sequence of tests was always constant i.e. Modified 
Ashworth Score, gait analysis and then isokinetic dynamometry.
‘Unanticipated variables’ have also been added as potential competing variables. Whilst 
the researcher has attempted to consider all possible issues in this complex field it is 
possible that some have been overlooked.
Walking ability may have been altered by increased physiotherapy input. Although gait 
re-education did not formally take place, training in the use of the FES system had a 
component of gait re-education within it.
4.2.b External validity
External validity relates to the extent to which results from an experiment can be 
generalised to other subjects and populations. The mechanisms used to ensure this relate 
to sampling and the conditions under which the study is carried out. They should be 
representative of the populations and situations to which the results are to apply.
Ottenbacher (1986) argued that SSEDs might address external validity better than true 
experimental research in that they address the individual rather than the ‘average’. This 
study used subjects as their own controls. Each FES intervention was tailored to the 
individual dependent upon the physical examination and subjective assessment of the 
subjects needs. In this manner, the intervention avoided being described as an 
‘unnatural’ treatment. In the author’s opinion this is undoubtedly a possible threat to 
external validity in many areas of physiotherapy research -  to be effective treatment 
must be appropriate to the individual, rather than a set ‘recipe’. There are, perhaps, few 
examples within the field of neurological physiotherapy where a ‘set’ treatment can be 
appropriately applied. This gives rise to issues with measurement and research
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methodology in this field. Le Roux’s (1993) article highlighted the crux of the matter: 
we should look for appropriate measures and methodologies that investigate what 
physiotherapists do, not adapt practice to suit measures.
The subjects for this study were not sampled as such. Senior physiotherapists audited 
casenotes to produce a list of candidates who met the inclusion criteria. These 
individuals were then contacted as possible subjects.
External validity is not however an issue in answering the new research questions. The 
intention of this study is to obtain data on which to base an hypothesis for the effects of 
FES on spasticity and upon gait. It is not the intention to generalise the findings of the 
study beyond the individuals involved.
4.3 Pilot study
The pilot study for the CREST project, in part, covered the pilot study for this study. 
Five Spinal Cord Injury Units from across Europe participated. Initial meetings were 
held to identify outcomes for the CREST project and then to formalise test procedures. 
These meetings included the protocols for the Modified Ashworth Scale and the Rancho 
Los Amigos Observational Gait Analysis system. Expert external advisors were present 
at these sessions. As research therapist for one of the centres of expertise, this author 
was responsible for the ‘roll-out’ of education in these protocols and in the application 
of the FES systems following these sessions. Meetings were held in Denmark and Spain 
for all clinicians to be involved with the assessment of subjects and the application of 
FES systems. These involved practical sessions to ensure, as much as possible for 
subjective tests, a common understanding and application of the test protocols, and 
familiarity with the application of FES systems.
For the isokinetic dynamometry test procedure the researcher undertook a period of 
education in the use of the equipment from a senior clinician with expertise in the use of 
the Kin-Com. Advice was also taken from the Sports Science and Physiotherapy 
Departments at Sheffield Hallam University regarding data analysis. Ten tests were 
undertaken on ‘normal’ subjects at both test speeds. Data from these tests were 
imported as ASCII data to Microsoft Excel, where they were graphed for data analysis. 
Data were collected from only one test for each subject. Data were also collected from a
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patient volunteer prior to that from the test subjects. Unfortunately repeated data was 
not collected from any of the above volunteers.
The TELER Normal Gait Indicators were developed from ‘gold standard’ gait 
laboratory data regarding normal gait parameters, from clinical experience and from 
experience of observational gait data. As explained in Chapter 3 they were developed in 
conjunction with senior physiotherapists who have substantial experience in the use and 
development of the TELER system and in gait analysis. Practical sessions were 
undertaken involving a group of senior physiotherapists. Video of a patient walking was 
analysed using the Indicators.
The above addressed the consistent application of the test protocols. Extra training in 
the use of the Odstock stimulators was undertaken. The other research groups within the 
CREST project also undertook practical sessions in the application of the FES systems.
4.4 Subject Selection
Possible subjects for the study were identified during a review of physiotherapy records. 
The researcher and a senior physiotherapist from the Spinal Injuries Unit audited all 
records for a ten-year period from 1987-1997. Those meeting the inclusion criteria for 
the project were short listed.
Inclusion criteria were as follows; capable of ambulating -  ASIA C and D categories 
(functional or for exercise purposes), injuries above T12 spinal level i.e. upper motor 
neurone lesions, minimum of one year post-injury, stable neurological condition (no 
recent improvement or deterioration), no medical complications, no substantial lower 
limb joint laxity.
Two staff were involved in the short-listing of potential subjects for the project. The 
selected subjects (see Table 5.1) grossly mirrored the general statistical population for 
individuals with spinal cord injury (see Figures 2.1-4). There were two main age groups 
- the first with a mean of 22.2 years, the second with a mean of 46.5 years. The ratio of 
pathological to traumatic causes was 3:7. There were three paraplegic and seven 
tetraplegic subjects. Two out of the ten subjects were female.
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Letters were sent to this group explaining the purpose and duration of the study and 
inviting them to reply if interested in participating. This letter also briefly outlined the 
commitment required from them in terms of time and activity. Respondents were asked 
to attend for an initial assessment. This assessment included a physical examination 
(muscle power, joint range of movement, sensation and muscle tone), a brief functional 
electrical stimulation test to see if subjects responded to stimulation and found the 
stimulation acceptable, and gait analysis. Subjects were also questioned as to what it 
was they wanted to improve about their walking, and their understanding of the uses 
and limitations of FES. Ten subjects were accepted. Informed consent was gained. All 
travel expenses were paid.
4.5 Process
4 .5. a A n O verview
Table 4.1 Summary of subject attendance and intervention
Attendance Session content
Week 1-2 Initial Baseline Measurements:
• Modified Ashworth Scale -  repeated x3
• Observational; Gait Analysis
• TELER Normal Gait Indicators
• Isokinetic Dynamometry -  repeated x3
Weeks 3-10 ‘Intervention’ Phase -  maximum of ten sessions
• Application and adjustment of FES 
systems
• Subject education in safe application 
and fine adjustment of FES systems
• Gait assessment -  TELER system
• Gait re-education with FES systems
Weeks 11-12 Final Baseline Measurements -  as per initial 
baselines
Once enrolled upon the programme, all subjects attended for assessment then initial 
baseline testing, intervention and final baseline testing with and without FES. Initial 
baseline testing was repeated over three sessions. The purpose of taking baseline 
measurements is to produce a base against which later changes may be evaluated 
(Sjoden, 1987). Initial baseline data illustrates the extent and stability o f the patient’s 
problem prior to intervention. This can assist in concluding whether ‘spontaneous 
recovery’ or placebo effects have had substantial effects on results. Measures taken at 
initial and final baselines included all those detailed in the previous chapter. The 
Modified Ashworth Scale and Isokinetic torque data were recorded on three occasions
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at initial baselines and final baselines (without stimulation) respectively. Saggital and 
frontal plane video was taken on each day of testing at initial and final baselines (with 
and without stimulation). Observational gait analysis and TELER Gait Indicator 
analysis was undertaken once at initial and final baselines both with and without 
stimulation. TELER assessment was also undertaken during the intervention phase. 
Table 4.1 shows timescales for when subjects attended assessment and intervention 
phases following initial assessment and recruitment.
4.5. b Test Protocols
The methods used to ensure that valid measures were obtained was in part addressed in 
the ‘Pilot Study’ section above. Consensus in the methods of test application was gained 
through discussion and practical sessions with groups of therapists and volunteer 
subjects. These sessions resulted in standardised test protocols used by the CREST 
group, and by a refining of the tests used specifically for this study. This was done in an 
attempt to minimise random error and bias in the measurements undertaken. The ability 
of the measures to give valid data about spasticity and gait abnormality was discussed in 
Chapter 3.
The effects of assessor bias were addressed wherever possible. The author was the only 
assessor in all but the Rancho Los Amigos Observational Gait Analysis. The Modified 
Ashworth Scale data was collected on three separate sessions at both initial and final 
baselines. Scores were entered into the CREST personal computer by the project 
bioengineer. The assessor did not see the previous test session results. The MAS is 
undoubtedly a very subjective test, bias may always play a part in the outcomes. Once 
the Kin-Com tests were in progress it was not possible to further affect the results. Any 
issues with observer bias or error occurred at the point of setting the machine up. For 
the Observational Gait Data a senior physiotherapist from the Spinal Cord Injuries Unit 
who had experience in gait assessment provided inter-observer test data for four 
randomly chosen subjects. This tester was told which sessions to assess but did not 
know whether the FES system was on or off for the final baseline sessions, subjects 
wore the FES systems for both sessions. Only the author collected the TELER data. 
Ideally another observer would also have collected this data to check for bias. Bias in 
the choice of possible Indicators was avoided; the chosen indicators are treatment goals 
negotiated with the individual subject and based upon objective and subjective clinical
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assessment. As the researcher collected and analysed all data a blinded observer also 
assessed gait using the OGA form in an attempt to address observer bias. The second 
assessor chose four subjects at random for analysis. Given the large number of data 
points and the known issues with inter-rater reliability of observational gait analysis 
only the ‘swing limb advancement’ phase of the gait cycle was analysed in the saggital 
plane for the hip, knee and ankle joints. This also addressed some of the issues with 
uniqueness of the OGA. For all subjects the FES intervention was intended to facilitate 
specific movements through specific parts of the gait cycle, in considering the entire 
lower limb and pelvic activity the ‘real’ effect of the intervention can be lost. It is 
however recognised that the improvement of one part of the gait cycle may have an 
effect on other aspects of gait. This effectively gave 39 points for scoring.
4.5. b. i The Modified Ashworth Scale:
The Modified Ashworth Scale (Bohannon & Smith, 1987) was the first test applied on 
each day of testing. The subject was positioned in supine upon a height adjustable plinth 
with a pillow under their head. Subjects were asked to ‘relax’ and not attempt to move 
the limb being tested. Passive movement of each limb was undertaken at a brisk pace. 
Each muscle group in the lower limb was individually graded. The data collection sheet 
is shown in Figure 4.2
4.5.b.ii Torque Measurements Using Isokinetic Dynamometry:
Isokinetic dynamometry was undertaken using the Kin-Com® 125 AP manufactured by 
the Chattanooga Group, Inc. The method used by Firoozkbakhsh et al (1993) and later 
by Perell et al (1996) and Franzoi et al (1999) was used as the basis for this study. The 
purpose of this test is to measure the amount of torque generated during passive 
movement on repeated passive flexion and extension of the knee joints with a defined 
subject group. Tests were undertaken on each of the three initial and final baseline 
sessions. Test speeds of 60° and 120° per second were chosen to allow consideration to 
be given to the effects of different velocities of movement upon spasticity.
Subject Position:
The subject was asked to sit on the seat and to ensure that they were comfortable. The 
back rest angle was 78°, the seat tilt angle 15° and the seat depth set so that there was
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Figure 4.2: Data Collection Sheet -  Modified Ashworth Scale
Patient Name: Date:
ASHWORTH SPASTICITY SCORE
Hip flexors
RIGHT
□ □
Hip extensors □ □
Hip abductors □ □
Hip adductors □ □
Knee extensors □ □
Knee flexors □ □
Dorsiflexors □ □
Planterflexors □ □
LEF'
0 No increase in muscle 
tone.
1 Slight increase in muscle 
tone, manifested by a catch 
and release, or by minimal 
resistance at the end of the 
range of motion when 
affected part(s) is moved in 
flexion or extension.
2 (1+) Slight increase in 
muscle tone, through most 
of range of movement, but 
affected part easily moved.
3 More marked increase in 
muscle tone, passive 
movement difficult.
4 Considerable increase in 
muscle tone, passive 
movement difficult.
5 Affected part(s) rigid in 
flexion or extension.
NT Not tested.
Conduct of Test
Nature of Spasm
78
approximately 3cm between the back of the knee and the seat with the lower leg 
hanging free. Once in a comfortable seating position with hip and knee in 90° of 
flexion, the thigh was held in place to prevent unwanted movement using a stabiliser.
The pre-set position for testing the chosen side was attained then fine adjustments to 
align the Kin-Com’s centre of rotation with that of the individual’s knee joint laterally 
was performed. The double pad attachment was positioned 4cm above the lower border 
of the lateral malleolus so that the ankle was allowed free movement. The lever arm 
length was taken as that level with lower border of the load cell. The lever arm was 
aligned with the tibia. Passive testing of the amount of movement of the double pad 
around the lower end of the tibia was performed to ensure that the centre of the 
dynamometer’s axis of rotation and that of the knee joint was aligned. If there was no 
movement of this pad the alignment was taken as correct.
Test Protocol:
The Kin-Com® programme was entered and the ‘Evaluation’ option was chosen from 
the main menu. New subject details were entered as prompted by the programme. The 
Passive Mode was chosen from the next menu, with the knee joint and the muscle group 
for flexion/extension identified. The ‘Handle Jog’ procedure was undertaken to ensure 
that the load cell adapted to read the force in the direction from which it was being 
produced. If first one limb then the other is tested without this procedure being 
undertaken the load cell will read force as if it were still the opposite side or inverted 
position. Gravity correction was performed for each test so that the dynamometer could 
calculate the weight of the leg during each test.
The range of movement to be produced at the knee joint was 60° between 25° and 85° 
of knee flexion. This range was chosen in an attempt to prevent soft tissue tightness at 
full knee extension or in flexion confounding results. Impingement of the seat on the 
back of the knee also was to be avoided. The horizontal was determined by the use of a 
spirit level. Range of movement was gauged from this point by the Kin-Com. As well as 
the computer settings for the limits to the range of movement, the mechanical stops 
were set as a safety back up. Subjects were asked to relax prior to movement, and 
throughout the tests.
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Medium acceleration at the change of direction to reach the test velocity was used. A 
maximum cut out force of 200N was set to allow for any unexpected resistance to 
movement to prevent any possible damage to the subject’s limb during unexpected 
movement. Should that force be overridden the machine automatically cuts out. The 
subject was also given an over-ride ‘panic button’ which would stop the test should they 
become uncomfortable
Tests were performed at two velocities -  60° per second and 120° per second. A warm 
up was performed for each test. This consisted of a set of ten repetitions of flexion 
followed by extension at the speed in degrees per second of the test that was to follow. 
After this one group of ten-repetitions at 60°/s was undertaken. This test was saved. The 
same process was then followed for the test at 1207s.
When tests had been completed for one leg the machine was set up for the other leg and 
the above process was repeated.
4.5. b.iii Rancho Los Amigos Observational Gait Analysis
Observational gait analysis (OGA) was undertaken once at initial baselines and then 
once at final baselines both with and without stimulation.
Subjects were asked to walk along a ten-metre walkway. Sagittal and frontal plane 
video was taken of the subject walking at a their own speed. The video cameras were in 
fixed positions. These were filed on the CREST software on a personal computer. The 
computer had a ‘frame-grabber’ and programme that allowed the video to be slowed or 
stopped at any stage during the gait cycle.
The data capture form used was that devised by the team at the Rancho Los Amigos 
(Figure 3.2). A separate form was filled in for each of the three assessment sessions 
(once at initial baseline and once at final baseline -  both with and without stimulation). 
Only the leg to be stimulated was assessed for each subject. The video session numbers 
used for each assessment were noted on the OGA form.
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4.5.b.iv TELER ® Gait Indicators
On initial assessment each subject was asked to identify what he or she would like to 
improve about the way they walked. Physiotherapy assessment included joint range of
movement, muscle power, degree of spasticity and observational gait analysis. From the
clinical and subjective assessments a list of each individual’s problems were identified 
and negotiated.
From the identified problem list appropriate TELER® Normal Gait Indicators chosen 
for each individual subject. From saggital plane video, gait was monitored against the 
chosen indicators on four occasions:
• Initial assessment
• Within the treatment process
• Final baselines -  without FES
• Final baselines -  with FES
The TELER Normal Gait Indicators developed for this study are shown in Appendix I. 
The bibliography used in the development of these Indicators is included.
4.5. c Intervention
Intervention for each subject was defined from the objective baseline measurements and 
from subjective information from the individuals involved. Intervention included 
muscle training programmes where appropriate, application and adjustment o f FES 
systems, and gait re-education. The FES systems were refined throughout the 
intervention phase so that the timing and intensity of stimulation correlated with the 
individuals gait speed and pattern. This was done to ensure as normal a gait as possible 
and that stimulation parameters were comfortable. Subjects attended for up to a 
maximum of 10 intervention sessions before undertaking final baseline assessments. 
The following is an example of the assessment and intervention process for one subject. 
Appendix II gives a breakdown of the individual interventions by subject.
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Subject 005
45-year-old male with a pathological lesion incomplete at T10. Brown-Sequard lesion. 
ASIA grade D.
Problems Identified
• Catches toes of right foot whilst walking -  unable to ‘shorten’ leg adequately 
during swing phase of gait due to decreased hip knee and ankle flexion
• Frequently ‘goes over’ his right ankle when walking
• Occasionally falls when his right knee gives way -  has quadriceps weakness 
Aims o f  treatment
• To instigate a strengthening regime for quadriceps and ankle evertors
• To provide a stable right ankle during stance
• To provide a stable right knee during stance
• To increase dorsiflexion of the right ankle during swing
• To increase right hip and knee flexion during swing
Treatment:
• Exercise regime for quadriceps and ankle evertors
• Gait re-education with elbow crutches
• FES strategy decision tree see figure 4.3
The electrical stimulators used were the Odstock one (ODFS III) and two channel 
stimulators (OD2CHS -  Figure 4.4), and the CRESTim three channel stimulator (Figure 
4.5). A team of therapists and bio-engineers based in the Medical Physics Department, 
Salisbury District General Hospital, developed both Odstock stimulators. The CREStim 
is a computer programmable stimulator developed for the CREST project by the 
Medical Physics Department at the Royal Hallamshire Hospital in Sheffield. This 
stimulator allowed for a high degree of flexibility in adjustment of stimulation 
parameters. Pals self adhesive electrodes were used.
Final baseline testing was repeated over three days both with and without FES.
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Figure 4.3 Decision Tree for FES Strategy
Subject 005
I
Assessment
i
Gait deviations
Decreased right hip 
and knee flexion
through swing phase 
Decreased right ankle 
dorsi flexion with
inversion
Cathode just posterior 
to neck o f fibula to 
excite superficial 
common peroneal 
nerve (CPN)
Anode over peroneii 
muscles
\
During swing During stance
phase phase
2 channels of stimulation 
needed therefore OD2CHS 
applied
Switch mechanism midway 
along lateral border of right foot 
due to exaggerated inversion 
CPN stimulation on when 
weight removed from the 
switch, quadriceps stimulation 
on for short burst as weight 
taken on switch
Right knee 
occasionally gives 
way during stance 
Initial contact with 
lateral border o f 
right foot 
Right ankle 
inverted during 
stance phase
Quadriceps 
stimulation from 
loading response 
to mid-stance 
phase o f gait
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Figure 4.4 Odstock 2-channel stimulator
task on/off
0  chanl
% chan2
•  chan3
Figure 4.5 CREST Stimulator
84
4.6 Statistical Analysis
Analysis of single subject experimental design is a debated area. For the purposes of 
this study data were initially graphed or tabulated for ease of descriptive analysis. 
Statistical analysis was then undertaken in all cases other than that of the isokinetic data. 
Visual analysis in itself may present some particular problems, as there is no theoretical 
framework to guide interpretation of results. It is the most commonly recognised 
method of analysing information from SSEDs. There is discussion as to the 
appropriateness of statistical analysis of such data because statistical tests were 
developed for group studies and were based on assumptions about the data, which in 
turn may not be applicable to single case studies. However, some authors (e.g. 
Ottenbacher, 1986, Sjoden, 1987) have suggested that after initial visual analysis, it may 
be appropriate to perform statistical analysis on the data as a supplement to visual 
analysis where weak treatment effects are seen. Ottenbacher {op. cit.) also suggested the 
use of statistical analysis where baselines are unstable, or where there are relatively 
small visual changes. Both authors also point to the likelihood that visual analysis that 
shows a strong treatment effect is likely to demonstrate clinical significance - that is, 
show a clinically important change due to the intervention.
Given the two research questions there are two statistical test hypotheses:
1. Ho - there is no association between the changes in spasticity experienced by an 
individual and the use of FES
H, -  there is an association between the changes in spasticity experienced by an 
individual and the use of FES 
This gives a two-tailed statistical hypothesis -  the association between spasticity and 
FES may be positive or negative.
2. Ho - there is no association between improvements in gait experienced by an 
individual and the use of FES
Hi - there is an association between improvements in gait experienced by an 
individual and the use of FES 
This gives a one-tailed statistical hypothesis -  gait will improve with FES treatment.
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The level of significance is set at p<0.05  for both hypotheses. Possible links between 
spasticity and function were addressed at the end of Chapter 2, and will be returned to in 
Chapter 6: Discussion.
There were problems with the independence of data from the MAS -  both in terms of 
repeated testing and testing of different muscle groups from the same limb. A limitation 
in one muscle group is likely to impose a corresponding limitation in another muscle 
group. Measurement of the output of the different muscle groups are therefore unlikely 
to possess the statistical independence required by conventional tests of statistical 
significance, which therefore are likely to produce meaningless results. Before and after 
measurements of the same groups of muscles are also unlikely to possess the statistical 
independence required by conventional tests of statistical significance, with the same 
consequences.
Using the median of a group of measurements eliminates any lack of statistical 
independence between the measurements in the group. A lack of statistical significance 
on the median test invalidates the null hypothesis, as its cause is unlikely to be the lack 
of statistical independence between the before and after measurements. On the other 
hand, statistical significance on the Median test shows that a lack of statistical 
independence between the before and after measures did not contribute to the result of 
the test, such in so far as it inhibited achievement of the result.
Fisher’s exact test was used to test for an association between MAS grades pre- and 
post-FES intervention. The median test was initially used to quantify the number of 
grades above and below the median score pre and post-intervention. Fisher’s exact test 
was chosen rather than the Chi test, as the number of results was small so the ‘rule of 
five’ applied. The rule of five states that 80% of cells in a frequency table should have 
expected values of at least five. This was not the case in this instance.
Due to the inconsistencies in the Kin-com data no statistical analysis was performed 
upon it. Data were graphed and analysed descriptively.
Observational Gait Analysis data were analysed for the subjects as a small group. Data 
collected using the Rancho Los Amigos System could not be analysed for individual 
subjects as the data lacked independence. The paired t-test was used to analyse the data
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for the subjects as a group. Data were collected at initial baselines without stimulation 
and at final baselines with stimulation. The number of gait deviations when walking 
with and without FES was calculated for each individual. The test result was calculated 
from the mean difference between the paired values (number of gait deviations with and 
without FES) for each individual. As the researcher collected all data, a blinded assessor 
also analysed a random selection of the OGA data. Spearman’s rank correlation 
coefficient was used to assess the association between blinded and non-blinded 
assessors scores. The scores were again based on the changes between subjects walking 
with and without FES.
TELER data were analysed for individual subjects and then for the subjects as a group. 
Data were initially tabulated for the individual subject then descriptively analysed. The 
table itself shows which individual indicators show statistically significant change. A 
probability tree analysis was then performed upon three of the most clinically important 
indicators to the subject. The TELER indices Deficit Index, Improvement Index and 
Health Gain Index were calculated. These indices respectively give a measure of the 
overall effect of the presented problems on the individual, the improvement in function 
and the extent to which a subject is free from residual or chronic disability.
The Chi-squared test was applied to the TELER data collected for the subjects as a 
group. The observed values in each cell were tested for association against the expected 
values in each cell.
4.7 Chapter Summary
This Chapter has:
• Stated the research questions to be answered by the study.
• Addressed aspects of study design and validity
• Outlined the pilot work undertaken prior to the start of full data collection.
• Described the study process; including subject selection, the test protocols and data
collection processes, the intervention and decision-making process this was based 
on and the equipment used.
• Stated the statistical test hypotheses and introduced the statistical tests used.
Chapter 5 presents the results from these processes.
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CHAPTER 5: RESULTS
Results from the four outcome measures used for the study will be presented in this 
chapter. The chosen methodology is that o f  a repeated single subject experimental 
design. Due to this results are, wherever possible, initially presented and discussed for 
each subject (n = 8). The two research questions, what are the effects o f  functional 
electrical stimulation (FES) upon spasticity and upon gait, will be considered separately. 
Data will be presented for visual or descriptive analysis, then, where appropriate, for 
statistical analysis. The level o f  significance for all statistical analysis was set at /?<0.05. 
Data for each subject are presented only for the limb that was treated with FES. The 
untreated limb was not used as a ‘control’ as the results do not satisfy the criteria o f 
independence required by tests o f statistical significance, therefore conclusions drawn 
from such results are likely to be flawed. Data will initially be presented for each 
individual test.
5.1 Subjects for this Study
Table 5.1: Subject Demographics
Subject
ID
Age Sex Level of 
injury
Cause Time since 
injury*
ASIA
Grading
Incomplete
Syndrome
1 005 45 M T10 Pathological 3 D Brown-
Sequard
2 006 19 M C4/5 Diving 2 C Brown-
Sequard
3 007 25 F C6 RTA 6 C Brown-
Sequard
4 008 23 F C6 RTA 3 D Brown-
Sequard
5 009 49 M C7 Fall 18 months D Brown-
Sequard
6 010 41 M T4 Pathological 13 C Brown-
Sequard
7 011 28 M C6 Diving 7 D Brown-
Sequard
8 012 61 M C5 Sport 5 D Central Cord
9 013 43 M C6 Pathological 1 D Incomplete
10 014 38 M T7 RTA 10 D Brown- i 
Sequard
*  = Time since injury in years unless otherwise stated
The method o f subject selection was detailed in Chapter 4. Table 5.1 details the subjects 
selected for the study. Age o f subjects on recruitment to the study ranged from 19 to 61, 
with a mean o f  37 years. Two were female, eight male. Seven subjects presented with 
an incomplete tetraplegia, three with incomplete paraplegia. Seven subjects had spinal 
cord damage resulting from traumatic injuries, three as a result o f  pathological change.
The mean time from injury on recruitment to the study was 5.2 years (range 1 to 13 
years). Subjects 006 and 007 had the most substantial degree o f  paralysis and were 
classified ASIA C grades, all others were ASIA D. Eight presented as Brown-Sequard 
lesions, one as central cord syndrome, and one with an unclassified incomplete injury. 
Subject 007 did not complete the study, subject 014 was taken ill before initial baseline 
measurements were undertaken and therefore did not participate. This meant that the 
total number o f subjects to complete the study was eight (N=8).
5.2 FES and Spasticity
The M odified Ashworth Scale (MAS) was used as an outcome measure to give ordinal 
data regarding resistance to passive movement o f  the lower limb. The isokinetic 
dynamometer was used to give interval data relating to resistance to passive movement 
o f the knee joint.
5.2. a The Modified Ashworth Scale
MAS data were first analysed descriptively then statistically using Fisher’s exact test 
based upon the median score. Data for one subject are shown below to demonstrate the 
analysis process. That for all other subjects is shown in Appendix III
5.2.a.i MAS Results fo r  Subject 005
FES was applied to the right leg therefore the results shown relate to this limb.
Table 5.2 Modified Ashworth Scale (MAS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
RPre 0 9 13 2 0 0 24
R Post 0 21 3 0 0 0 24
Total 0 30 16 2 0 0 48
The analysis on Table 5.2 shows an improvement from 15 readings at grade 2 and 3 pre- 
FES to only 3 readings on grade 2 post-FES. As a result the concentration o f  13 
readings on grade 2 pre-FES improved to a concentration o f  21 readings on grade 1.
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The situation post-FES therefore is, firstly, an increase in the concentration on the 
median from 54% on grade 2 pre-FES to 88% on grade 1 post-FES, and, secondly, an 
improvement o f 1 grade in the median.
Analysis o f  the MAS pre- and post-FES changes on the individual readings (Table 5.3) 
shows that 14 pre-FES readings improved by 1 grade, 10 pre-FES readings did not 
change, and no pre-FES readings deteriorated.
Table 5.3 Number and nature of change episodes post FES intervention
Nature of Change 
Improvement No Change Deterioration
Total 14 10 0
These improvements suggest that subject 005 did not suffer a deterioration in spasticity, 
and may even have demonstrated an improvement, following FES. The suggestion 
becomes a conclusion if  the changes could not have occurred by chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
Hi -  there is a difference between the pre- and post-FES deviations from the pooled 
median
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The pooled median = the grade o f the 24 reading. From table 5.2 it can be seen that the 
number o f grade 1 readings = 30, therefore the 24th ordered reading = 1. Fisher’s exact 
test was then used to calculate the probability that the differences between pre- and 
post-FES deviations from the pooled median were due to chance.
Pre Post Total
No of readings below Median code 0 0 0
No of readings above Median code 15 3 18
Total 15 3 18
(A+B)!(A+C)!(B+D)!(C+D)!
N!A!B!C!D!
= (0+0)!(0+15)!(0+3)!(15+3)! =1
18!0!0!15!3!
Therefore for subject 005, p  > 0.05. For this individual the null hypothesis is accepted 
and the alternative rejected. There is no statistically significant difference between pre- 
and post-FES deviations from the pooled median. The validity o f  this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number o f  MAS changes to justify  acceptance o f 
the null hypothesis.
It is not possible to draw conclusions regarding clinical significance for the individual 
from the results o f  the Modified Ashworth Scale, which measures impairment rather 
than disability or handicap. This is an issue that will be expanded upon in discussion in 
Chapter 6 .
5.2.a.ii Sum m ary o f  M A S  results fo r  all subjects
Table 5.5 Summary of descriptive and statistical analysis of MAS data for all subjects
Subject Descriptive analysis Statistical analysis
__________________________ summary_____________________________ summary
005 Suggested decrease in MAS grades post FES Null accepted
006 Suggested increase in MAS grades post FES Null rejected -  deterioration shown
008 Suggested increase in MAS grades post FES Null accepted
009 Suggested decrease in MAS grades post FES Null rejected -  improvement shown
010 Inconclusive Null accepted
011 Inconclusive Null accepted
012 Suggested decrease in MAS grades post FES Null accepted
013 Suggested increase in MAS grades post FES Null accepted
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Table 5.5 shows that, on descriptive analysis, three subjects show an increase, three a 
decrease and two inconclusive results when assessed by the MAS following FES 
intervention. On statistical analysis the null hypothesis is accepted in six out o f  eight 
cases. Subject 006 shows a statistically significant deterioration in MAS grades from the 
median. Subject 009 shows a statistically significant improvement in MAS grades from 
the median.
5,2.b Isokinetic dynamometry
Test data were collected at initial and final baselines (without stimulation). Test data for 
each subject were collated as ASCII data. This was imported from the Kin-Com to 
M icrosoft Excel for analysis. Data for each subject and for the ‘norm al’ test group were 
graphed. A graph was produced for each o f the four test conditions -  pre- and post-FES 
intervention at velocities o f  60° per second and 120° per second. Each graph plots data 
for three consecutive initial or final baseline test sessions. Figure 5.1 shows an example 
o f  graphed torque data for one subject (005) pre-FES intervention at 60° per second. 
This graph has been annotated to highlight the key points it features. Graphed data for 
all other test subjects are shown in Appendix IV for information only. On observation o f 
the graphs it was found that the data displayed substantial errors. Torque data for any 
one subject, at any one test speed, varied hugely along the y-axis. The reliability o f  the 
data therefore has to be questioned.
W hilst variation along the y-axis was in some cases substantial, the excursion and shape 
o f  graphs was often very similar to visual inspection. The author therefore calculated 
range o f  torque for each test. The middle five repetitions were analysed for each data 
set. This was to avoid any initial or final effects o f repeated movements. The intra-test 
ranges are very consistent, to within a few Newton metres, even at the faster velocity o f  
120° per second. This suggests a uniformity o f  resistance to passive movement within 
any one test period. The two exceptions occur within the graphs for subject 005, where 
a substantial increase in torque can be seen in the ‘pre 60°per second’ and ‘post 60°per 
second’ data. In both cases the subject presented with episodes o f  spasm during the test.
Data were only collected for six subjects. One subject (012) could not transfer onto the 
seat due to his poor upper limb function combined with the height o f  the seat. The other 
(008) could not commit the time for this final test o f  the day. For subjects 010, 011 and
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013 data were only collected for two sessions -  again due to time constraints on the part 
o f  the subjects.
Figures 5.2.a and 5.2.b show mean peak torque values for subject 005 at initial and final 
baseline sessions at 60° and 120° per second respectively. At a velocity o f  60° per 
second the mean torque value increased by 16 Newton metres, from 18 pre-FES to 34 
post-FES. At a velocity o f  120° per second the mean torque value increased by 3 
Newton metres, from 71 pre-FES to 74 post-FES. In both cases therefore, resistance to 
movement, when measured by the isokinetic dynamometer, increased following FES
Test Session
Initial Basline 
Final Baseline 
-Initial Baseline  M ean 
-F ina l B aseline Mean
100
•  Initial Baseline
 Initial Baseline Mean
 Final Baseline Mean
■ Final BaselineET 40
Test Session
Figure 5.2.a Torque data details Figure 5.2.b Torque data details
Subject 005 60° per second Subject 005 120° per second
intervention. The increase at 120° per second, however, was very small. Graphs for all 
other subjects are shown in Appendix V. As with the MAS data it is not possible to 
draw conclusions regarding the clinical significance to the subjects o f  changes in 
measured torque.
Table 5.6 summarises the changes in torque data pre-and post-FES for all subjects. 
There is no obvious pattern to any o f  the changes in torque values pre- and post-FES.
Table 5.6: Summary of visual analysis of mean Torque data by subject:
Subject Torque 60°s 1 Torque 120°s 'l
005 ++ +
006 + ++
008 No data No data
009 - +
010 ++ -
011 ++ ++
012 No data No data
013 - -
Key h I- Substantial increase from initial to final baseline
+ Minor increase from initial to final baseline
Minor decrease from initial to final baseline 
Substantial decrease from initial to final baseline
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Given the substantial flaws in the data no further analysis was undertaken.
5.3 FES and Gait
The Rancho Los Amigos Observational Gait Analysis System and TELER Normal Gait 
Indicators were the measures used to consider the effects o f  FES upon gait.
5.3.a Rancho Los Amigos Observational Gait Analysis
The Rancho Los Amigos Observational Gait Analysis (OGA) form presents data, 
relating to gait abnormality within the different phases o f  gait, as nominal data. An 
abnormality is either present or absent. The total number o f  gait deviations for each 
subject was totalled for the initial test and the final test with stimulation (Table 5.7).
OGA data were also collected at final baselines without stimulation. These data were 
not analysed for the purposes o f  this study, as the intent was to investigate the effects o f  
walking with stimulation upon the individual. Data collection sheets are shown in 
Appendix VI. The summed data were initially graphed for ease o f  visual analysis 
(Figure 5.3). The ‘equality’ line shows where gait deviation scores would be the same 
both with and without FES. All o f  the subjects fall below this line, showing a decrease 
in gait deviations for all when walking with FES.
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Figure 5 3  OGA Data pre- and post-FES intervention for all subjects
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W hilst visual analysis shows a decrease in gait deviations for all subjects when using 
FES a statistically significant change must be shown before this change can be 
attributed to this intervention.
The following statistical hypotheses were therefore tested using the paired t-test:
Ho - there is no decrease in the number o f gait deviations when walking with FES 
H i -  there is a decrease in gait deviations when walking with FES
Table 5.7 Paired t-test: data analysis
Subject OGA Results 
Pre-FES (A) With FES (B)
Calculations
(A-B)=d d2
005 52 42 10 100
006 40 14 26 676
008 42 16 26 676
009 33 21 12 144
010 61 27 34 1156
011 46 27 19 361
012 27 9 18 324
013 21 15 6 36
I
mean
322
40.25
171
21.378
151
QTd)2=22801
3473
From Table 5.7 the calculated t-value was 5.65, degrees o f  freedom = 7. The results 
were found to be significant at p  < 0.05, for a one tailed test. The null hypothesis was 
therefore rejected and the alternative hypothesis accepted. The mean value o f the OGA 
deviations when walking with FES was less than that when walking without FES. There 
was therefore a statistically significant improvement in gait, attributable to FES 
intervention for this subject group.
5.3. a,i Results from Inter-observer Testing o f  OGA Data
Figures 5.4.a and 5.4.b show the number o f  gait deviations as noted by both assessors. 
Assessor 1 was the author, assessor 2 the blinded tester. Data collection sheets for the 
blinded assessor are shown in Appendix VI.
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From visual analysis o f these graphs it can be seen that Assessor 1 noted more 
deviations at initial baseline than the blinded assessor did, and less at final baseline. 
There may therefore be an issue with bias in the initial testers scores.
A ssesso r 1
OGA D eviations P re  FES
A ssesso r 1
OGA D eviations w ith  FES
5.4.a. Pre-FES 5.4.b. With FES
Figure 5.4 Observed Gait data from Assessors 1 and 2: a- pre-FES, b- with FES
Spearman’s rank correlation coefficient was the used to analyse the degree o f 
correlation between the two scorers’ results (Table 5.8). The null hypothesis states that 
there is no correlation between the two sets o f data, such that as assessor 1 scores 
increase Assessor 2 ’s scores also increase. The alternative hypothesis is therefore that 
there is a correlation between the two sets, such that as assessor 1 scores increase 
assessor 2 ’s scores also increase.
Table 5.8 Spearmans Rank Correlation Coefficient: Data analysis
Assess 1 Assess 2 
(blinded)
Subject A B Rank
A
Rank
B
d (A-B) d2
008 pre 11 9 7 7.5 0.5 0.25
008 post 5 7 4.5 6 -1.5 2.25
009 pre 8 6 6 5 1 1
009 post 5 5 4.5 3.5 1 1
011 pre 13 9 8 7.5 0.5 0.25
011 post 4 5 2.5 3.5 -1 1
012 pre 4 2 2.5 1 1.5 2.25
012 post 2 4 1 2 -1 1
I d 2 = 9
Using Spearman’s test on the data rs = + 0.893. Where N = 8, p  < 0.05 for a two-tailed 
hypothesis. This means that there is a positive correlation between the scores from 
Assessor 1 and 2. The strength o f the relationship is 0.8932 x 100 = 79.9%. This strong 
positive relationship shows that the two assessors largely agreed on the direction o f  the
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changes. However, the data in table 5.8 shows that they disagree on the size o f  changes. 
The average pre- to post FES change was -5  for Assessor 1, and -1 .25  for Assessor 2. 
The reason for this is that Assessor 1 noted higher pre-FES scores than Assessor 2, and 
lower post-FES scores than Assessor 2. In other words, the assessors disagreed upon 
where the subjects started and where they ended. As a result the effects o f  FES found by 
Assessor 1 was higher than that found by Assessor 2. This discrepancy may be a result 
o f assessor bias, may relate to the problem o f reliability with observational gait analysis, 
or may be suggestive o f problems with the Rancho Los Amigos gait analysis system. 
This will be further considered in the following chapter.
5.3. b TE LE R  ®  Gait Indicators
The TELER Indicators were developed as a result o f  the issues with both analysis o f 
results and the feasibility o f  the Rancho Los Amigos OGA system. Indicators for each 
subject were chosen from the problems identified by the individual. From these 
physiotherapy aims were identified. The appropriate TELER Indicators to monitor 
change were identified for each subject.
TELER data was first tabulated and analysed descriptively. A probability tree was then 
used to test the statistical significance o f the data. Deficit, Improvement and Health 
Gain Indices were then calculated for all subjects (Le Roux, 2003). The analysis for 
subject 005 is shown below, that for all other subjects can be found in Appendix VII.
5.3.b.i Analysis o f  TE LE R  data: subject 005
Analysis is split into two sections: the first being that o f analysis o f  change in each 
indicator, the second being that o f analysis o f  the indicators as a group. Analysis o f 
individual indicators is o f interest to the clinician in identifying the specific results o f 
treatment, the group analysis shows the overall effect o f  treatment, which gives both a 
clinicians and a patient’s perspective on the outcome o f FES intervention for that 
individual.
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Individual Indicators:
Table 5.9 is a summary o f the indicator scores for subject 005. The TELER data 
collection sheet for this is shown in Appendix VII.
Table 5.9 Subject 005: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code before
Code after 0 1 2 3 4 Total
0
1
2 1 1
3 2 2 4
4 ;
5 I
Total 2 1 2 5
Key:   Area under dashed line shows clinically significant change
■■■■■— Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 5.9 shows that the admission codes for subject 005 ranged from 0 to 2, with a 
median code o f  1, and a mode o f 0 or 2 , both o f  these codes occurring twice on initial 
assessment. The admission code o f  two (40%) o f  the five indicators was 0, one indicator 
(20%) was graded at code 1, and two (40%) were graded at code 2.
The discharge or outcome codes ranged from code 2 to 3, w ith a median o f  3 and a 
mode o f  3. The discharge outcome code on four (80%) o f  the five indicators was 3, the 
other discharge code was 2 (20%).
From the table it can be seen that all the indicators showed some im provement in their 
code gradings. All entries showed clinically significant improvements. The magnitude 
o f these improvements ranged from 1 to 3 clinically significant stages, with two 
indicators improving by three codes and three improving by one code. None o f  the 
individual indicators in Table 5.9 showed a statistically significant im provement at the 
95% confidence level.
Indicators as a Group:
W hilst the above analysis o f  the data shows a clinically significant im provement in 
walking outcomes following the application o f FES it is necessary to show a statistically
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significant improvement if  these are to be attributable to the intervention. The indicators 
were analysed as a group to consider the overall effects o f  FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis (Le Roux, 
2003):
H 0 -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a maximum o f  three were selected for analysis. The 
three chosen were considered to be o f  most clinical significance to this subject. These 
indicators were mid-swing, loading response and initial contact. From Table 5.10 it can 
be seen that these indicators had a combined score o f  2 on initial assessment (2 ,0,0 
respectively), there were 7 clinically significant changes by the time o f  discharge, 
giving an outcome score o f 9. The results were therefore found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was rejected and the 
alternative accepted. There was an improvement in TELER gait indicator grades for this 
subject, apparently attributable to the FES intervention.
Table 5.10 shows a decrease in Deficit Index by nearly half from 80 to 44 percentage 
points. The Improvement Index was calculated as 45, meaning that there was an 
improvement in this subject’s identified problems during treatment. The Health Gain 
Index was 36 and therefore smaller than the Improvement Index, denoting a chronic 
disability.
Table 5.10: Worksheet for the TELER Index for Subject 005
Item
Expected
Outcome
Visit
1 2
Pre-swing 5 1 2
Mid-swing 5 2 3
Loading response 5 0 3
Initial contact 5 0 3
Mid-stance 5 2 3
Total number of missing scores
Deficit Index 80 44
Improvement index 45
Health Gain Index i 46
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The clinical significance o f these improvements is inherent w ithin the structure o f  the 
indicators. Each code is a clinically significant outcome needed for ‘norm al’ gait.
5.3.b.ii Summary o f  TELER Analysis fo r  all subjects
Table 5.11 Summary of TELER Data Analysis for all Subjects
Subject No. of clinically
significant
changes
Statistically 
significant at 
95% confidence 
level
Deficit Index 
(improvement 
by percentage 
points)
Improvement
Index
Health Gain 
Index
005 7 Yes 36 45 36
006 4 No 24 40 24
008 2 No 7 22 13
009 3 No 15 25 15
010 7 Yes 40 50 40
011 4 No 20 31 20
012 3 No 20 27 20
013 6 No 35 44 35
From Table 5.11 it can be seen that all subjects showed clinically significant 
improvements in their outcomes. Only two, 005 and 010, showed a statistically 
significant improvement allowing for the changes to be attributable to FES. These two 
subjects had Deficit Indices o f  36 or more. Subject 013 had a Deficit Index o f  35, but 
changes were not statistically significant at the 95% confidence level. So for subjects 
005 and 010 an improvement in 36 or more percentage points in the Deficit Index was 
found to be statistically significant. All subjects showed a positive Improvement Index, 
denoting an improvement during treatment. In the case o f subject 008 however, this was 
minimal at 7 percentage points. In all cases the Health Gain Index was less than the 
Improvement Index, indicating that all subjects still had a ‘chronic’ disability.
5.3.bMi TELER Data: group analysis
Table 5.12 TELER codes pre- and post-intervention for subjects as a group
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1
2 2 6 2 1 11
3 3 4 4 1 12
4 1 1 4 6
5
Total 5 11 7 6 29
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Table 5.12 shows that the admission codes for this group o f subjects ranged from 0 to 3, 
with a median code o f 1, the mode was also 1. The admission code o f  five (17%) o f the 
29 indicators was 0, eleven (38%) were coded 1, seven (24%) were coded 2 and six 
(21%) were coded 3.
Discharge or outcome codes ranged from 2 to 4, with a median and mode o f  3. The 
outcome code on 11 (38%) o f the 29 indicators was 2, 12 (41%) were coded 3, and 6 
(21%) were coded 4.
Visual analysis o f results shows that one indicator showed a deterioration from code 3 
to 2, three showed no change and 26 showed clinically significant improvements. The 
magnitude o f  these improvements ranged from 1 to 3 clinically significant stages.
W hilst the above descriptive analysis shows clinically significant change in walking 
outcomes for the subjects as a group following the application o f  FES, it is necessary to
show a statistically significant improvement if  these are to be attributable to the
. . .  • *2 intervention. The following statistical hypotheses were tested using the Chi test.
Ho -  there is no difference in TELER Gait Indicator grades with FES 
intervention for the subjects as a group 
Hj -  there is a difference in TELER Gait Indicator grades with FES intervention 
for the subjects as a group
The expected values for the Chi test were calculated as shown in table 5.13 (TELER 
Newsletter, Jan 2003).
Table 5.13: Calculation of Chi2 expected values for subjects as a group
Expected Values
[(Probability) x (Number of subjects)] : 
by code before and after
Code after
Code before
Chi2 expected 
values !
0 1 2 3 4
0 0.278x5 0.247x11 0.130x7 0 0 5.02
1 0.351x5 0.340x11 0.241x7 0.111x6 0 7.85
2 0.225x5 0.229x11 0.259x7 0.222x6 0 6.79
3 0.106x5 0.128x11 0.222x7 0.333x6 0 5.49
4 0.034x5 0.048x11 0.111x7 0.222x6 0 2.81
5 0.006x5 0.012x11 0.037x7 0.111x6 0 1.09
Total 5 11 7 6 0 29.05
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The combined expected value for codes 4 and 5 on discharge (after) is less than 4. The 
values o f  codes 3,4 and 5 were therefore combined to give a single outcome, “Code 3 or 
larger” on discharge. This was done in compliance with the ‘rule o f  five’.
Table 5.14 Chi2 Analysis of TELER data for subject group
Discharge outcome code Observed cases (O) Expected cases (E) O-E (0-E)2/E
0 0 5.02 -5.02 5.02
1 0 7.85 -7.85 7.85
2 11 6.79 4.21 2.61
3 or more 18 9.39 8.61 7.89
Total 23.4
The null hypothesis states that FES will have no effect upon TELER outcomes. The 
alternative hypothesis is that the use o f FES will improve TELER outcomes. This is 
therefore a one-tailed hypothesis. Calculated X2 = 23.4, degrees o f  freedom = 6. Results 
were therefore found to be significant at p  < 0.05. The results show a statistically 
significant improvement in TELER outcomes therefore the null hypothesis is rejected 
and the alternative accepted. The group o f  subjects demonstrated a statistically
significant improvement in TELER Gait Indicators, attributable to FES intervention.
5.4 Chapter Summary
•  Analysis o f the Modified Ashworth Scale data for the individual was
problematic due to the data’s lack o f  independence. F isher’s exact test, based 
upon the Median test, was used to analyse this data. Overall results were 
inconclusive.
•  Descriptive analysis o f the isokinetic dynamometry data, based upon the
individual range o f  torque differences, was presented. No further analysis was 
undertaken as the data was flawed.
•  Lack o f independence o f the Rancho Los Amigos Observational Gait Analysis 
data resulted in the data being analysed for the subjects as a group. The paired t- 
test was used to analyse the data. Substantial statistically significant
improvement was shown for the subjects as a group.
•  Inter-observer testing o f the Observational Gait Analysis data using Spearm an’s 
rank correlation co-efficient demonstrated a strong positive correlation between 
the two assessors. On visual and descriptive analysis there was a difference in 
the magnitude o f  change in gait deviations noted by assessors.
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•  TELER data were analysed for subjects individually and as a group. Although 
all individual subjects showed some improvement in the scored TELER 
indicators, only two showed statistically significant improvement on probability 
tree analysis. TELER Deficit, Improvement and Health Gain Indices were 
calculated for all subjects. The Chi-squared test was used to analyse the data 
from the subjects as a group. A substantial statistically significant improvement 
was shown.
These results will be discussed in detail and related to the existing literature in the 
following Chapter.
104
Chapter 6: Discussion
This chapter will address the development of the study, relating this to the changed 
research aims. The results presented in Chapter 5 will be further discussed. As the 
chosen methodology was that of single subject experimental design these results are 
initially considered for the individual subject. Not all measurements could be validly 
analysed for the individual, so there follows a section on analysis for the subjects as a 
group. Findings from this study will be compared, where possible, with results from 
previously published literature. The theoretical basis for changes in spasticity and in gait 
following FES will also be considered. Limitations of this study will be discussed prior 
to final conclusions being drawn.
6.1 Thesis Development
During the course of this study the initial aims of the thesis altered. These were to 
investigate the effects of functional electrical stimulation (FES) on spasticity in the 
individual with incomplete spinal cord injury (ISCI). The measures to be used included 
those which would give data regarding resistance to movement (the Modified Ashworth 
Scale and isokinetic measurement of torque) and to changes in walking abilities (the 
Rancho Los Amigos Observational Gait Analysis System and TELER® Gait 
Indicators). However, following a review of the literature and analysis of the chosen 
measures it was found that it was not possible to draw direct conclusions regarding the 
effect of spasticity change upon gait within the remit of this study. The initial research 
questions were therefore changed to:
1. What changes in spasticity does an individual who receives FES as a treatment 
experience?
2. What changes in gait does an individual who receives FES as a treatment 
experience?
Whilst no correlational analysis was undertaken, possible links between the changes in 
spasticity upon gait were discussed in Chapter 2 and will be returned to later in this 
Chapter.
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6.2 Individual Results by Subject
A single subject experimental design (SSED) was chosen so that the effects of the 
intervention could be considered upon the individual. This methodology can give the 
clinician information regarding outcomes of treatment for specific patients, rather than 
the results of an intervention for the ‘average’ patient, which is the information gained 
from randomised control trials. In this manner the SSED has the potential capacity for 
enhancing clinical decision making for the individual, for enhancing the clinician’s use 
of evidence based practice (‘the conscientious, explicit andjudicious use o f  current best 
evidence in making decisions about the care o f  individual patients’ Sackett et al, 1996).
Only the data for the MAS and TELER were analysed for the individual. A brief 
summary of the individual and the chosen FES strategy are presented before the 
findings are discussed.
6.2.a.i Subject 005
Subject 005 was a 45-year-old male who sustained a Brown-sequard pattern ISCI at T10 
level three years prior to enrolling on the project. He was a community walker who used 
a right long leg splint (KAFO) and elbow crutches to ambulate.
The chosen FES intervention strategy was that of stimulation to his right quadriceps 
during the stance phase of gait and to his right common peroneal nerve during swing 
phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed that a majority (14) of grades improved, with 
ten showing no change and none showing deterioration. On statistical analysis no 
significant change was detected at the 5% two-tailed level. So although there was a 
tendency for the MAS grades to show a decrease following FES intervention this could 
not be attributed to that intervention. The raw MAS data showed a concentration of 
grades at the lower end of the MAS (grades 1 and 2). It may have been that this 
individual highlighted the lack of sensitivity of the Modified Ashworth Scale.
TELER Gait Indicator data showed an improvement in all five indicators. None of the 
single indicators showed a statistically significant improvement, but when the three
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most clinically significant were subjected to a probability tree analysis they 
demonstrated a statistically significant improvement attributable to the use of FES. The 
Deficit Index, which shows the overall effect of the presented problems on the 
individual, showed a decrease by nearly half from 80 to 45 percentage points. The 
Improvement Index, whose values range from -100 to +100 (with 0 denoting no 
change), showed a substantial improvement score of 45 percentage points. The Health 
Gain Index, which shows the extent to which a subject is free from residual or chronic 
disability, was, at 36, lower than the Improvement Index. This score shows that this 
individual still had a substantial degree of disability following treatment. This subject, 
as all others, had a ‘stable’ spinal cord injury, in that there had been little or no obvious 
change in his neurological condition for a substantial time prior to his enrollement onto 
the study. The immediate effects of FES are that of a dynamic orthosis. FES produces 
movement that the individual is unable to perform, either at all or adequately. Over time 
FES may improve volitional control of movement through its potential therapeutic 
effects. The timescales for this project (approximately two-months for an individual 
subject) may not have been adequate for such changes to be obvious. So whilst FES 
may be capable of bringing about a decrease in chronic disability, in this case it was not 
apparent as shown by the Health Gain Index.
The clinical significance of FES intervention for this individual was that he discarded 
the KAFO and used the stimulator for all ambulation.
6.2.a.ii Subject 006
Subject 006 was a 19-year-old male who sustained a Brown-Sequard pattern ISCI at 
C4/5 level two years prior to enrolling on the project. He walked with elbow crutches 
for exercise purposes only, either during physiotherapy sessions or at home with carers.
The chosen FES intervention strategy was that of stimulation to his right quadriceps 
from terminal swing to midstance phase of gait and to his right common peroneal nerve 
during swing phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed a deterioration in 12 of the 24 grades, with 11 
showing no change and one showing improvement. On statistical analysis a significant
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change was detected at the 5% two-tailed level. There was therefore a statistically 
significant increase in MAS grades following FES intervention for this individual.
TELER Gait Indicator data showed an improvement in four of the five indicators, one 
showed no change. None of the single indicators showed a statistically significant 
improvement. When the three most clinically significant were subjected to a probability 
tree analysis no statistically significant improvement at the 5% one-tailed level was 
found. The Deficit Index showed a decrease by nearly half from 60 to 36 percentage 
points. The Improvement Index showed a substantial improvement score of 40. The 
Health Gain Index was, at 24, lower than the Improvement Index. This score shows that 
this individual still had a substantial degree of disability following treatment.
The MAS results were indicative of an increase in spasticity following FES 
intervention. Whilst this must be considered as a possibility and would need monitoring 
for this subject, the validity of the MAS as a measure of spasticity has been questioned. 
It may also be that, due to the timescales of this project, this subject was still learning to 
use the stimulator efficiently when final baseline measurements were undertaken. 
Burridge et al (1997a) found that an initial increase in spasticity whilst subjects were 
learning to use the stimulator was followed by a decrease as the subjects became 
familiar with its use. This subject was a poor walker prior to commencing the project, 
walking only for exercise purposes. Although some decrease in gait abnormality was 
achieved during the study, this subject continued to walk only for exercise purposes in 
the house and with assistance.
6.2. a. iii Subject 00 7
Subject 007 was a 25-year-old female who sustained a Brown-Sequard pattern ISCI at 
C6 level six years prior to enrolling on the project. She walked at home for exercise 
purposes with a KAFO in parallel bars. She needed assistance to don and doff the 
KAFO. This subject had the poorest walking ability on admission to the study. 
Unfortunately she found walking with the stimulator too difficult. Habituation was a 
substantial problem and it was found that her right knee joint hyperextended on 
weightbearing without the KAFO causing discomfort. She did not complete the project 
and therefore no results are presented.
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6.2.a.iv Subject 008
Subject 008 was a 23-year-old female who sustained a Brown-Sequard pattern ISCI at 
C6 level three years prior to enrolling on the project. She was a community walker who 
walked using bilateral walking sticks.
The chosen FES intervention strategy was that of stimulation to her right common 
peroneal nerve during swing phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed that a majority (14) of grades deteriorated, 
with nine showing no change and one showing deterioration. On statistical analysis no 
significant change was detected at the 5% two-tailed level. So although there was a 
tendency for the MAS grades to show an increase following FES intervention this could 
not be attributed to that intervention. It may again have been that this individual 
highlighted the lack of sensitivity of the Modified Ashworth Scale in detecting change.
TELER Gait Indicator data showed an improvement in two indicators, with a 
deterioration in one. None of the single indicators showed a statistically significant 
change. When all three were subjected to a probability tree analysis they demonstrated 
no statistically significant improvement attributable to the use of FES. The Deficit Index 
showed a small decrease from 60 to 53 percentage points. The Improvement Index 
showed a small improvement with a score of 22. The Health Gain Index was, at 13, 
lower than the Improvement Index. This score shows that this individual still had a 
substantial degree of disability following treatment. All of the TELER Index scores 
show a minimal improvement.
In spite of being a functional walker this subject used the stimulation only whilst 
attending outpatient physiotherapy sessions, never functionally as a part of her daily 
routine. This was her personal choice, the reasons for which were not made clear. It may 
have been that the gait improvements achieved during stimulation were not considered 
of enough benefit when compared to the time needed to don and doff the system.
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6.2.a.v Subject 009
Subject 009 was a 49-year-old male who sustained a Brown-Sequard pattern ISCI at C7 
level eighteen months prior to enrolling on the project. He was a community walker 
who used a rollator to ambulate.
The chosen FES intervention strategy was that of stimulation to his right common 
peroneal nerve during swing phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed that a majority (13) of grades improved, with 
11 showing no change and none showing deterioration. On statistical analysis a 
significant change was detected at the 5% two-tailed level. There was therefore a 
statistically significant decrease in MAS grades following FES intervention for this 
individual.
TELER Gait Indicator data showed an improvement in three indicators, one showed no 
change. None of the single indicators showed a statistically significant improvement. 
When the three most clinically significant were subjected to a probability tree analysis 
no statistically significant improvement at the 5% one-tailed level was found. The 
Deficit Index showed a decrease from 60 to 45 percentage points. The Improvement 
Index showed an improvement with a score of 25. The Health Gain Index was, at 15, 
lower than the Improvement Index. This score shows that this individual still had a 
substantial degree of disability following treatment.
Whilst MAS grades demonstrated a statistically significant decrease post-FES 
intervention, TELER Indicators and Indices showed a relatively minimal improvement 
for this subject. This subject continued to use the stimulator on a daily basis when 
walking with the rollator. It may have been that the improvement in toe clearance was 
of enough benefit to offer a real improvement in walking ability for this individual.
6.2. a. vi Subject 010
Subject 010 was a 41-year-old male who sustained a Brown-Sequard pattern ISCI at T4 
level thirteen years prior to enrolling on the project. He used elbow crutches to walk in 
the house and to and from the car, but was otherwise dependent upon his wheelchair for 
mobility.
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The chosen FES intervention strategy was that of stimulation to his left quadriceps from 
terminal swing to midstance to enhance stability on weightbearing and to his left 
common peroneal nerve during swing phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed that a majority (14) of grades did not change, 
with seven showing an improvement and three showing deterioration. On statistical 
analysis no significant change was detected at the 5% two-tailed level.
TELER Gait Indicator data showed an improvement in all four indicators. None of the 
single indicators showed a statistically significant improvement, but when the three 
most clinically significant were subjected to a probability tree analysis they 
demonstrated a statistically significant improvement attributable to the use of FES. The 
Deficit Index decreased by half from 80 to 40 percentage points. The Improvement 
Index showed a substantial improvement of 50. The Health Gain Index was, at 40, 
lower than the Improvement Index. This score shows that this individual still had a 
substantial degree of disability following treatment.
This subject used the stimulator for both exercise and functional purposes in and around 
the house.
6.2.a vii Subject Oil
Subject 011 was a 28-year-old male who sustained a Brown-Sequard pattern ISCI at C6 
level three years prior to enrolling on the project. He walked short distances in the 
house and to and from the car.
The chosen FES intervention strategy was that of stimulation to his left quadriceps 
during the stance phase of gait and to his left common peroneal nerve during swing 
phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed that a majority (15) of grades did not change, 
with four showing an improvement and five showing deterioration. On statistical 
analysis no significant change was detected at the 5% two-tailed level.
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TELER Gait Indicator data showed an improvement in three indicators, one showed no 
change. None of the single indicators showed a statistically significant improvement. 
When the three most clinically significant were subjected to a probability tree analysis 
no statistically significant improvement at the 5% one-tailed level was found. The 
Deficit Index showed a decrease from 65 to 45 percentage points. The Improvement 
Index showed an improvement of 31. The Health Gain Index was, at 20, lower than the 
Improvement Index. This score shows that this individual still had a substantial degree 
of disability following treatment.
This subject made relatively small gains in TELER codes and did not continue to use 
the stimulator following the study. He used his wheelchair for the majority of his 
mobility during the day whilst at work, walking to and from the car to the house and 
round the house in the evenings. The small benefits gained in using the stimulator were 
not perceived as beneficial enough to continue its use.
6.2. a. viii Subject 012
Subject 012 was a 61-year-old male who sustained a central cord pattern ISCI at C5 
level five years prior to enrolling on the project. He walked for exercise purposes using 
an elbow support rollator with assistance from one.
The chosen FES intervention strategy was that of stimulation to his right quadriceps 
during the stance phase of gait and to his right common peroneal nerve during swing 
phase of gait to enhance limb flexion.
Descriptive analysis of the MAS showed that a majority (18) of grades did not change, 
with six showing an improvement and none showing deterioration. On statistical 
analysis no significant change was detected at the 5% two-tailed level. The raw MAS 
data again showed a concentration of grades at the lower end of the scale (grades 1 and 
2). It may have been that this individual, as with subject 005, highlighted the lack of 
sensitivity of the Modified Ashworth Scale.
TELER Gait Indicator data showed an improvement in all three indicators. None of the 
single indicators showed a statistically significant improvement. When these three were 
subjected to a probability tree analysis they demonstrated no statistically significant
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improvement. The Deficit Index showed a decrease from 73 to 53 percentage points. 
The Improvement Index showed an improvement of 27. The Health Gain Index was, at 
20, lower than the Improvement Index. This score shows that this individual still had a 
substantial degree of disability following treatment.
In spite of the minimal gains in TELER Indicator scores this subject continued to use 
the stimulator at home following the project.
6.2.a.ix Subject 013
Subject 013 was a 43-year-old male who sustained a ISCI at C6 spinal level one year 
prior to enrolling on the project. He walked in the house and short distances outside the 
house with elbow crutches.
The chosen FES intervention strategy was that of stimulation to his left quadriceps from 
terminal swing to midstance phase of gait and to his left common peroneal nerve during 
swing phase of gait.
Descriptive analysis of the MAS showed that a majority (12) of grades deteriorated, 
with seven showing no change and five improving. On statistical analysis no significant 
change was detected at the 5% two-tailed level. So although there was a tendency for 
the MAS grades to show an increase following FES intervention this could not be 
attributed to that intervention.
TELER Gait Indicator data showed an improvement in all four indicators. None of the 
single indicators showed a statistically significant improvement. When the three most 
clinically significant were subjected to a probability tree analysis they did not 
demonstrate a statistically significant improvement. The Deficit Index showed a 
decrease by nearly half from 80 to 45 percentage points. The Improvement Index 
showed a substantial improvement score of 44. The Health Gain Index was, at 35, lower 
than the Improvement Index. This score shows that this individual still had a substantial 
degree of disability following treatment.
This subject continued to use the stimulator at all times following the study.
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6.2.a.x Subject 014
Subject 014 was a 38-year-old male who sustained a Brown-Sequard pattern ISCI at T7 
level ten years prior to enrolling on the project. He was a community walker who used a 
walking stick. Unfortunately this subject was taken ill prior to starting the study and 
therefore was unable to participate.
6.2. b The Modified Ash worth Scale -  general observations
The results from the MAS (Table 5.5) show a typically random pattern, both 
descriptively and statistically. There are an equal number of increases and decreases 
shown descriptively, three and three. Six out of the eight statistical analysis results 
support the null hypothesis. Of the two that show statistically significant change one 
shows a decrease, one an increase in MAS grades. It is therefore necessary to question 
what the MAS is actually measuring the effects of -  it may be the effect o f FES upon 
spasticity, but the evidence is insufficient. As was discussed in Chapter 3, the MAS may 
be useful as a subjective guide to the passive resistance offered to the movement of a 
limb, but not necessarily spasticity.
Analysis of the MAS data proved to be difficult due to the lack of independence of the 
data collected. Independence is an essential concept underpinning statistical analysis of 
data. The MAS data was compromised in a number of ways. Data were collected for 
different muscle groups in the same leg. There was therefore no independence between 
these data, spasticity seldom affects only one muscle group in a limb, but rather shows 
as an overall pattern, with some muscle groups being more affected than others. There 
was also the issue of measures being repeated over three days pre- and post-FES 
intervention. Each of the different days’ measures were dependent upon each other.
Fisher’s exact test assumes that the data in each cell of the table are independent of each 
other. As the potential degree of covariance of the number of readings below and above 
the Median code was not know these results had to be stated as dependent upon this 
being of no effect. It may be that the true meaning of the null hypothesis is that there is 
no evidence of an effect due to the potential size of the covariance, rather than genuine 
lack of an effect of the intervention.
114
Ordinal scales should have discrete codes, so that it is clear for the scorer as to which 
category a result falls into. The MAS is effectively a subjective continuum, leading to 
potential difficulties in scoring. There is a difference between the true extent of an 
attribute possessed by an object and the observer’s measure of that extent. The smaller 
the difference between the two the better the validity of the measure. The lack of 
objectivity in the MAS coding is likely to increase the difference between observer’s 
assessment and true extent of the attribute.
As demonstrated by subjects 005 and 012, floor or ceiling effects may occur due to the 
limited sensitivity of the MAS. Where results fall at one end of the scale it may be that 
potentially significant results are masked.
Spasticity is an impairment, that is, a symptom of an underlying neurological pathology. 
The clinical significance of both the MAS (and the isokinetic torque data) test results is 
not apparent. There are no direct functional correlates to an increase or decrease in 
grades. There is an assumption that a gravity ‘eliminated’ (due to test position), 
passively tested increased resistance to movement is an indicator of increased spasticity 
that may in turn have a negative effect upon some aspect of an individual’s function. 
Research has shown (McLellan, 1977, Knuttson & Martensson, 1980) that the effect of 
spasticity during passive movement is not the same as that during voluntary movement. 
Spastic restraint during active, especially fast active movement was found to be 
substantially greater than during passive movement. This may in turn be why 
physiotherapists seldom attempt to measure spasticity in isolation in a clinical setting -  
physiotherapists deal with patients’ clinical problems and are therefore considering the 
effects of a pathology at either a disability or handicap level.
6.2. c TELER Indicators -  general observations
None of the chosen indicators showed a statistically significant change for the 
individual subjects. Many indicators that did show improvement did so by only one or 
two codes. There was not enough data collected for individual subjects, or enough data 
collected for individual indicators, to show statistical significance in most cases. Only 
subjects 005 and 010 demonstrated statistically significant improvements in their gait. It 
can therefore be argued that, for many of the subjects, walking ability improved only 
minimally with the FES intervention. Table 6.1 summarises the changes in TELER
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Deficit Index for all subjects. Although all show a decrease in Deficit Index, all still 
show a substantial degree of residual problems when walking with FES.
Table 6.1: Range of TELER Deficit Index for all subjects with and without FES
Subject Deficit Index Range 
________ In percentage points
005 80-45%
006 60-36%
008 60-53%
009 60-45%
010 80-40%
011 65-45%
012 73-53%
013 80-45%
Where the changes in TELER data are not attributable to FES i.e. are not statistically 
significant the reasons for the changes need to be considered. It may be that, within the 
timescales of the study, the full potential of FES for these subjects was not achieved. It 
may have been that the FES strategies were not optimal for the subjects. Frequency of 
use may also have played a part. The usage of the stimulators out-with the therapy 
environment was only measured subjectively. Subjects varied widely in their use, some 
stating that they used the stimulators functionally every day, some that they only used 
them when attending for treatment or test sessions. It would have been useful to have an 
objective measurement of how often the stimulators were used other than in study 
sessions. The reported subjective usage of the stimulation however did not always 
correspond with the lack of gain in TELER Indicator scores. For example subjects 009 
and 012 continued in their use of the systems with apparently modest gains. It may have 
been that one small improvement, e.g. improved ankle dorsiflexion, was critical enough 
clinically to make a meaningful improvement for the individual. The TELER Gait 
Indicators denote normal gait. Where an improvement is seen but the normal not fully 
achieved in one code of an indicator, e.g. knee flexion of 60° during initial swing, this 
code would not be scored. This is of particular concern where subjects have a 
substantial degree of ‘chronic’ disability, such as those who have participated in this 
study where ‘normal’ may never be achieved. The Gait Indicators need further 
development work, in particular taking into account aspects of their sensitivity and 
reliability.
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All of the above assume that FES was capable of producing an improvement in gait. 
Other factors that may have caused the clinical improvements seen may have included 
learning from the tests -  this is a recognised problem in the use of repeated measures -  
or the fact that subjects received gait re-education as part of the process in learning to 
use the stimulators.
Again the issue of bias may be a concern as the researcher was the only assessor. 
Indicators may have been chosen which demonstrated greatest positive change. 
However, as can be seen from Appendix II, the process behind the choice of indicators 
was directly linked to the subjects’ identification of their gait problems. In this way, the 
subjects’ problems were converted to a treatment plan and the appropriate indicators 
were chosen from this process.
6.2.d Isokinetic Dynamometry
As was shown in Chapter 5 the data from the isokinetic dynamometer tests 
demonstrated substantial flaws. Due to this no descriptive or statistical conclusions for 
the subjects are drawn from these results. Consideration is however given to the 
problems highlighted by this data.
Problems with instrumentation are reported as one of the possible risks to the internal 
validity of SSED (Ottenbacher, 1986). Instrumentation may refer to a mechanical 
device being used for data collection or to the observational technique. The researcher 
needs to be certain that they are measuring the actual parameter in question and not an 
artefact of the machine or scale. In the case of repeated measures any issues with 
reliability of the measuring instrument are of extreme importance. Data were collected 
on three consecutive days at initial and final baselines. The Kin-Com should have given 
the most objective, quantitative data of all the tests used. In this study, it is obvious that 
there was either a problem with the calibration of the dynamometer, or operator error in 
the setting up of the machine.
The pilot study included training in the use of the Kin-Com dynamometer and the 
collection of data from ‘normal’ subjects and one subject with an incomplete spinal cord 
injury. Only one data set for each of these subjects was collected. The data was graphed 
for analysis, but was not subject to further statistical testing. Repeated tests for these
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subjects would have shown potential flaws in data collection prior to formal testing of 
subjects being undertaken.
As with the MAS the clinical significance of such technical parametric data produced 
by the dynamometer has no direct link to functional abilities. The test in this instance 
was also passive.
6.3 Results for Subjects as a Group
The Rancho Los Amigos Observational Gait Analysis System data was analysed for the 
subjects as a group due to problems with the independence of the data. The TELER 
system allowed for data to be analysed for the individual or the group. The TELER data 
is analysed here for the subjects as a small group.
6.3. a Observational Gait Analysis
The Rancho Los Amigos Observational Gait Analysis (OGA) system was one of the 
chosen gait measures for the CREST European project. This author subsequently used 
this data but also developed TELER Gait Indicators. These were developed in response 
to the problems with feasibility and analysis of the Rancho Los Amigos form.
The OGA form covers all joints of the pelvis and lower limbs, for all phases of gait, and 
in all three planes of movement. Realistically, with an FES intervention only certain 
phases of gait and certain ranges of movement are being addressed. It may be that a 
useful treatment effect is being masked by collected data that the assessor was not 
attempting to alter, or was unable to alter, with the given intervention. Both of the above 
issues lead to questions regarding the clinical significance and uniqueness of this test, it 
may be that a useful clinical effect is being lost in a large amount o f ‘superfluous’ data. 
The level of measurement data gained from the form is nominal i.e. an abnormality is 
either present or absent. No allowance can be made for improvement that does not 
achieve the ‘normal’. The sensitivity of the system may therefore also need to be 
questioned, especially where the subjects being treated have a substantial degree of 
chronic disability.
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Data were collected on three occasions: at initial assessment, and once at final baselines 
with stimulation and once without stimulation. The numbers of gait deviations at ‘initial 
baseline’ and ‘final baseline with stimulation’ phases were calculated. When pre and 
post-intervention data was graphed (figure 5.3) and visually analysed it could be seen 
that all subjects showed an improvement in their walking abilities in terms of gait 
deviations. ‘Correctness’ of gait is obviously only one parameter it is possible to 
analyse. Speed and energy efficiency are other aspects that have not been addressed in 
this study. Statistically significant improvement was found between gait deviations, 
when walking with and without FES, when the paired t-test was used to analyse the 
data.
Throughout this study, the author was researcher and assessor, a situation which could 
leave the study open to the accusation of bias. This possibility was addressed for this 
measure by the use of a blinded assessor in the analysis of gait. From the graphed data 
in figure 5.4 it can be seen that the blinded assessor gives relatively better scores (fewer 
deviations) at initial baselines and worse scores (more deviations) at final baselines. 
Correlation between the two assessors using Spearman’s test was strongly positive, 
however the magnitude of the changes noted by the author were much greater than those 
noted by the blinded assessor. This could be the result of a variety of causes e.g. results 
from the first assessor were biased, differences in experience in using the measure. 
However, as discussed in Chapter 3, section 3.4.b, results from observational gait 
analysis have notoriously poor inter-rater reliability (Krebs et al, 1985, Eastlack et al 
1991, and Coutts 1999). Steps were taken to minimise these issues prior to testing. 
Saggital and frontal plane video was taken and both assessors were trained in the use of 
the Rancho Los Amigos System. The video used for gait analysis purposes consisted of 
a short phase of the subject walking -  approximately 4-5 steps. The subjects for this 
study varied greatly in their walking abilities. For some of the poorer walkers there 
could be substantial variation from step to step, therefore deciding which step is 
‘typical’ for the subject could be problematic. In clinical practice, an overall picture of 
gait is built up through observing subjects walking over time. It was felt that for the 
purposes of this study a more valid result was to be gained by allowing the assessors to 
analyse the step they considered most typical for that subject. In this way a fuller picture 
of the subjects gait was gained rather than close analysis of one step that may or may 
not have been typical to the subject. This may also have meant that assessors analysed 
different steps.
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Whilst it can be seen from graphical analysis (figure 5.4) of all eight subjects that they 
improved in terms of gait deviations, it must be remembered that visual observation 
suggests that experimenter bias may be an issue.
6.3.b TELER Gait Indicators
Analysis of TELER data for the subjects as a group showed that all but 3 of the 29 
chosen indicators improved. Two of those that did not improve showed no change, the 
other showed a deterioration of one point. None of the individual indicators showed a 
statistically significant improvement at the 95% confidence level. When considered as a 
group, substantial statistical significance was found. This effectively meant that the 
improvements seen for individual indicators could not be attributed to FES, but when 
the indicators were considered as a group the changes could be attributed to FES.
6.3.c Group versus individual analysis
Both the above tests give data regarding the small group of subjects. It is not possible to 
make conclusions regarding individual subjects from this data. Due to this the results 
from the Rancho Los Amigos OGA System and the TELER data when considered as a 
group are of limited benefit to this study.
6.4 Clinical significance
Whilst statistically significant change has been shown in some of the results this is
meaningless unless the real clinical effect of the changes can be seen as of significance
for the individual.
Bain & Dollaghan (1991) attempted to objectify clinical significance by defining three 
dimensions that such a change should possess:
♦ Shown to result from treatment rather than maturation or other 
confounds
♦ Shown to be real rather than random
♦ Shown to be important rather than trivial -  in terms of the size of
change and its impact upon the subject
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Maturation was a potential concern in this study due to the length of time between 
initial and final baselines for some subjects. However all subjects were a minimum of 
one year post- injury and in a stable physical state. Other potential confounds (e.g. 
disease, medication) have been previously addressed in Chapter 4 (figure 4.1).
Dimension two relates to the validity and reliability of the measures used, these issues 
have been addressed in depth in Chapter 3. The final dimension is perhaps the one that 
holds most interest for clinicians. Both the MAS and the isokinetic data raise questions 
as far as clinical significance is concerned. The stage at which changes in MAS or 
torque values become of clinical significance to the subject, and how these relate to 
function, is not clear. The OGA data also has issues related to size of change and 
specificity. With such a large number of data points, the real effects of the intervention 
may be lost in a plethora of detail that may not be of importance to the individual. The 
TELER indicators demonstrate a number of ‘givens’ (Le Roux, 1993) that relate to 
clinical significance. Indicator codes are each a clinically significant, observable 
outcome of importance to the subject. The indicators were developed from a 
bibliography of ‘normal’ gait data. That is, each point is necessary for the production of 
that particular phase of gait. Indicators for each subject were chosen from their own 
identification of their gait problems and so addressed the issue of a personally important 
rather than a trivial change.
6.5 Valid and Reliable Measurement of Spasticity
Chapter 3 discussed the reliability, validity, responsiveness and feasibility of the four 
chosen measures for this study. Only the MAS and isokinetic data can be considered as 
measures of spasticity. The MAS is considered a relatively valid and reliable ordinal 
measure of resistance to movement, not specifically spasticity. Torque measurements 
for spasticity assessment in this case were unfortunately unreliable due to error. It may 
be that the same issues recur as with the MAS, resistance to movement is measured but 
may not be spasticity specific. Gait parameters are not measures of spasticity, but rather 
of a function that may be affected by spasticity. There are some questions in the 
literature as to whether true spasticity has a substantial effect upon gait. It can however 
be argued that, due to disordered reciprocal inhibition of muscle groups during activity, 
increased co-contraction can negatively affect function.
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Whilst it was not the intent of this study to provide a comprehensive review of all 
possible measures of spasticity, review of the literature gave the author an overview of 
the wide variety of possible measures and the apparent discrepancies between them.
General comments regarding the choice of measures for spasticity include:
1. Clarity of definition in the clinical assessment of the different features of the 
upper motor neurone syndrome (UMNS) is important. The term spasticity 
should not be used as an umbrella term for these features as this leads to 
confusion in identification of the individual subject’s movement disorder. 
Outcome measures appropriate to the problematic UMNS feature should be 
chosen.
2. An understanding of the theories, concepts and constructs underlying these 
features, and of measurement theory, should assist the therapist in the choice 
of valid and reliable measures.
3. Conclusions about the effects of spasticity upon function need to be made 
with care, potentially confounding factors, e.g. soft tissue stiffness, must be 
considered.
6.6 Comparison of results with published literature
Comparison of the results of this study with others is not straightforward due to the 
variety of measures used in different studies, to the differences in stimulation 
parameters and equipment used, and to the variety of pathologies which have been 
treated. Methodologies are also variable, from randomised controlled trials, to small 
group studies, or to single case studies. This study considers the results for individual 
subjects. Where analysis has not been possible for the individual due to problems with 
the independence of data, data have been analysed for the subjects as a small group.
Burridge et al (1997b) randomised 32 subjects with hemiplegia into treatment and 
control groups. A variety of measures were used. The Wartenberg pendulum test was 
used to assess quadriceps spasticity. Other assessments included walking speed and 
effort, and gait analysis. Spasticity was found to be reduced in the treatment group when 
compared to the control group. Gait parameters also improved. However, correlation 
was not found between change in spasticity, as measured by the pendulum test, and
122
change in functional parameters. Burridge assessed quadriceps spasticity, considering 
the effects of reciprocal inhibition o f this muscle group in response to activity of the 
hamstrings through use o f the drop-foot stimulator. The present study considered the 
overall effect o f a variety o f stimulation strategies upon spasticity o f the main muscle 
groups o f the lower limb.
In a more recent article Burridge & McLellan (2000) investigated the effects of 
common peroneal nerve stimulation upon spasticity levels and gait for subjects who had 
suffered a stroke. The electrical response o f muscle to stimulation, the ability of 
subjects to control the activation of muscle groups, and the effort and speed o f walking 
were investigated. They found that subjects with spasticity were likely to respond well 
to stimulation. Subjects with increased resistance to movement due to soft tissue 
stiffness responded less well. They also found that all subjects’ walking improved with 
the use o f FES. The present study did not use neurophysiological tests to consider the 
effects o f stimulation upon nerve conduction.
Granat et al (1993) investigated the effects of FES for gait enhancement on 6 subjects 
with ISCI. A variety of FES strategies were used for this patient group. The Ashworth 
Scale and Pendulum test were used to measure spasticity. Gait measures included speed, 
cadence and Physiological Cost Index. Results were presented and discussed for both 
individual subjects and as a small group. A statistically significant improvement in 
relaxation index was found in the results from the pendulum test for all but one subject 
who demonstrated an increase. Results from the Ashworth Scale were stated as being 
inconclusive. All gait parameters again showed a statistically significant improvement. 
The inconclusive results in the MAS findings and the improvements in gait found in this 
present study are in keeping with the findings of Granat et al (op. cit.).
Robinson et al (1988) and Swain (1992) applied electrical stimulation for training 
purposes to subjects with SCI. Robinson et al (op. cit.) used the pendulum drop test to 
measure spasticity. These authors claimed that a ‘tendency towards increasing 
spasticity’ was found with their subject group. However only eight out o f 31 subjects 
completed the eight-week course. The authors also noted that spasticity decreased after 
8 weeks o f training. Observations of an increase in tone were related to measurements 
taken at 4 weeks of stimulation. Swain (op. cit.) found a tendency for spasticity and 
spasms to increase when such stimulation was applied. In both cases stimulation was
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applied to exercise muscle, rather than to improve walking ability. Whilst it is 
interesting to note the above findings, it is not possible to relate the results from the 
present study (where stimulation was applied to improve functional abilities) to the 
results of either of these studies.
Seib et al (1994) applied electrical stimulation to the tibialis anterior muscle of five 
subjects with traumatic brain injuries and five with SCI. Their measures included the 
Spasticity Measurement System. Results were presented for individual subjects. 
Spasticity was found to decrease post intervention for all subjects, but especially so for 
those with SCI.
Stefanovska et al (1989) investigated the effects of implanted stimulators on spasticity 
and gait in 8 subjects with hemiplegia. Studies of EMG and resistive torque at the ankle 
joint were undertaken. The authors found an increase in phasic stretch reflex activity 
and a decrease in tonic stretch reflex activity (spasticity) for all subjects.
The results of this study can, to a variable extent, be considered as in accordance with 
those previously published. Only one subject demonstrated a statistically significant 
increase in MAS results thus suggesting that FES has no significant negative effect on 
spasticity. However, only one subject presented with a statistically significant decrease 
in MAS scores, suggesting a decrease in spasticity levels. For the majority of subjects 
the null hypothesis was accepted. TELER Indicators showed clinically but not always 
statistically significant improvements for all subjects irrespective of an increase or 
decrease in MAS scores. Only subjects 005 and 010 demonstrated a statistically 
significant improvement in TELER scores. When the subjects were considered as a 
small group statistically significant improvement was found in both OGA and TELER 
Indicators. A general improvement in gait parameters was noted in all articles that 
addressed this (e.g. Burridge et al, 1997a&b, Granat et al, 1993).
Many authors also found little correlation between measures of spasticity, in particular 
passive (e.g. MAS, Pendulum and isokinetic torque) against functional (gait measures) 
tests. The lack of correlation between the many possible measures of spasticity has 
previously been discussed. Priebe et al (1996) related this to the fact that the different 
measures effectively address different aspects of the upper motor neurone syndrome.
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The majority of reviewed articles discuss the statistical significance of the measures 
used. Few address the clinical significance of changes. Where a variety of gait measures 
are considered the clinical benefit to the subject is seldom made explicit.
The effects of FES are complex and incompletely understood. Whilst it is beyond the 
scope of this study to draw definitive conclusions as to the reasons behind the effects of 
FES on spasticity and upon gait, it is interesting to consider possibilities. Vodovnik & 
Stefanovska (1992) summarised the effects of electrical stimulation (Figure 2.7) in 
terms of its orthotic or restorative effects. If this figure is considered, spasticity and gait 
may be improved in a number of ways, at either a peripheral or central level.
Orthotic functional stimulation:
♦ Control of movement may be improved by increases in muscle strength either 
through direct or indirect stimulation (Granat et al, 1993, Stefanovska et al, 1989, 
Daly et al, 1996). Granat et al noted improvements in hip flexor muscle power even 
though these muscles had not been directly stimulated. They hypothesised that the 
repeated motor activity gained by stimulating the hip flexor withdrawal response 
actually strengthened the hip flexor muscle.
♦ Muscle phenotype has also been shown to change as a result o f long-term 
stimulation. SCI subjects have relatively fewer slow oxidative motor units in their 
muscles than the norm, with a preponderance of fast glycolytic fibres. Stimulation 
has been shown to reverse this trend. (Mohr et al, 1997, Pette & Vrbova, 1999)
♦ Improved foot and limb position during gait improves alignment o f limb segments 
allowing for more normal movement (Burridge et al, 1997b).
♦ Effort of walking has also been shown to decrease when assessed by Physiological 
Cost Index (Granat et al, 1993, Burridge et al, 1997a).
Restorative Functional Stimulation:
There are a number of theories relating to the effect of FES on spasticity reduction.
♦ Some authors have reported that stimulation of an agonist muscle group will have an 
inhibitory effect on the antagonist muscle group through the la inhibitory 
interneuron and Renshaw Cell mechanisms. (Burridge & McLellan, 2000)
♦ Stefanovska et al (1989) and Yarkony et al (1992) stated that FES decreases tonic 
stretch reflex activity.
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♦ Dermatomal stimulation also has an effect on decreasing spasticity (Granat et al, 
1993, Daly et al, 1996).
♦ FES can drive plastic change at spinal cord level (Daly et al, 1996), thus potentially 
improving and reinforcing spinal circuitry such as that of the la inhibitory 
interneurone.
Consideration has also to be given to the effect of FES on motor learning and 
relearning. Chronic deafferentation in SCI causes changes in the cortical somatosensory 
and motor representation maps (Topka et al, 1991). ‘Chronic’ FES has been shown to 
alter these cortical maps. Wolpaw & Tennissen (2001) reviewed research relating to 
plasticity of the spinal cord. They stated that the spinal cord is capable of activity- 
dependent plastic adaptation. This concurs with the findings of Muir & Steeves (1997) 
that the spinal cord was capable of plastic change, and that to modify spinal circuitry for 
a specific task, movements during rehabilitation should be executed as normally as is 
possible. It may be that FES, if used regularly enough, and in a functional manner, e.g. 
to produce more normal gait, will promote positive plastic change at both spinal and 
cortical level.
6.7 Limitations to this study
Some of the limitations of this study have been addressed in previous sections of this 
Chapter. These include issues with experimenter bias and with instrument reliability.
The choice of Single Subject Experimental Design posed some problems in analysis and 
conclusions from the data. The statistical independence of data can be threatened due to 
the use of repeated measures. The subject design was such that data was effectively 
collected pre- and post-intervention only, giving an AB design. The small number of 
data points collected may have had an effect on statistical significance. Short baselines 
pre- and post-intervention may have added to these problems. The chosen methodology 
does not allow for extrapolation of results to the wider community o f people with 
incomplete spinal cord injury. The use of a SSED does however allow for results for 
individual subjects to be clarified and discussed in detail. Such information may be of 
direct benefit to the clinician considering such an intervention.
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The lack o f a blinded assessor for all o f the tests may leave this study open to 
accusations o f bias. This was in part addressed by the use o f a blinded assessor for the 
Rancho Los Amigos OGA data.
Full analysis o f the isokinetic data for the test subject prior to full data collection 
starting may have highlighted the problems with the reliability o f this data. It may have 
been that these problems could have been addressed to give useable data.
No conclusions can be made about the effects o f spasticity changes upon walking ability 
due to the effects of FES, as was the initial intent of this study. However the possible 
links have been discussed and assumptions that true spasticity negatively affects gait 
have been questioned.
6.8 Conclusions
Two research questions were posed:
1. What changes in spasticity does an individual who receives FES as a treatment 
experience?
2. What changes in gait does an individual who receives FES as a treatment 
experience?
Investigation of the effects of FES upon spasticity in the individual with ISCI 
demonstrated that the use o f FES decreased or had no statistically significant effect on 
seven out of the eight subjects when assessed by the MAS. The null hypothesis was 
accepted for six out of the eight subjects. One subject showed a statistically significant 
decrease in MAS grades following stimulation, one an increase. Descriptive analysis of  
these six results has two sets of data suggestive o f an increase in MAS grades, two a 
decrease and two sets inconclusive. The results demonstrated a typically random 
pattern. Changes in MAS grades may not have been due to the use o f FES.
Results from the isokinetic passive torque tests are not considered in any conclusions 
drawn from this study.
A clinically applicable, valid and reliable measure of spasticity remains elusive. The 
chosen measures have strengths and weaknesses as tools to measure spasticity.
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Appreciation of these should increase their usefulness to clinical practice. The author 
would suggest that clarity of definition in the clinical assessment of the different 
features of the UMNS is important. The term spasticity should not be used as an 
umbrella term as this leads to confusion in identification of the individual subject’s 
movement disorder. Outcome measures appropriate to the problematic UMNS feature 
should be chosen. An understanding of the theories, concepts and constructs underlying 
these features, and of measurement theory, should assist the therapist in the choice of 
valid and reliable measures. The MAS may be a valid scale for measuring resistance to 
passive movement, its ability to measure spasticity change is debatable.
Measures of gait are not measures of spasticity, but rather of a function that may be 
affected by spasticity. This may be one of the reasons why physiotherapists rarely 
measure spasticity in a clinical setting, but tend consider functional abilities. 
Assumptions that spasticity directly affects function need to be made with care.
The degree of gait abnormality lessened for all eight subjects, irrespective of MAS 
results. However these improvements were often minimal for some subjects.
TELER Indicators could be analysed for the subjects as individuals or as a group. 
Although clinical improvements were seen in all subjects, statistically significant 
improvement was found in only two out of the eight. Reasons for this lack of 
attributable change may include:
• the improvements were not due to FES -  other factors may be responsible
• project timescales may have been too short to allow for maximum possible 
improvements
• the chosen stimulation strategies may not have been optimal for the individual
When the subjects are considered as a group statistically significant improvement was 
found in both Rancho Los Amigos Observational Gait Analysis and in TELER gait 
indicators. However it is not possible to draw conclusions about the individual subjects 
from these results.
FES may work well for some subjects but not for others. The underlying reasons for this 
may be complex, encompassing a host of physical and psychological issues. In terms of 
service provision, optimal effect would be gained by the provision of an FES service
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from specialist centres with a supporting network o f physiotherapists trained in the 
assessment o f potential users and the use o f FES systems who can make appropriate 
referrals to such centres.
This study adds to the body o f literature relating to the effects o f FES upon spasticity 
and upon gait. It perhaps brings an extra dimension in that the single subject 
experimental design allows individual subjects to be considered. In this manner it is 
hoped that findings may have an increased clinical significance and meaning for the 
physiotherapist.
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APPENDIX I: TELER® Gait Indicators
The TELER Gait Indicators developed for this study are shown on the following pages. 
The bibliography used in the development of these Indicators is included.
Appendix 1.1
TELER®
Normal Gait Component Indicators 
Sue Mawson/Elaine Scott
Stance Phase ( R ) & ( L ) leg
• initial contact
• loading response
• mid stance
• terminal stance
• erect reciprocal trunk/pelvic rotation
See trunk in stance
Swing Phase ( R)  & ( L )
• preswing
• initial swing
• mid swing
• terminal swing
• erect reciprocal trunk/pelvic rotation
See trunk in swing
TELER® Stance Trunk
• pelvis rotates forwards (upper trunk reciprocal)
• pelvis returns to neutral (upper trunk reciprocal)
• pelvis rotates backwards (upper trunk reciprocal)
• anterior tilt increase then decreases
• pelvic obliquity increases, returns to neutral then increases
TELER® Swing Trunk
• pelvis rotates backwards (upper trunk reciprocal)
• pelvis returns to neutral (upper trunk reciprocal)
• pelvis rotates forward (upper trunk reciprocal)
• anterior tilt decreases then returns to neutral
• pelvic obliquity drops, increases to neutral then drops again
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Stance Phase
TELER ® Initial Contact
• Erect spine with forward rotation o f pelvis
• Hip flexion 25-45°
• Knee fully extended
• Neutral dorsiflexion of ankle
• Toes in neutral alignment
TELER® Loading Response
• Erect spine with forward rotation of pelvis
• Hip flexion 25-45°
• Knee flexes to 15-20°
• Ankle planterflexes to 10°
• Toes neutral alignment
TELER® Mid Stance
• Erect spine, pelvis returns to neutral
• Hip extends to neutral
• Knee in extends to neutral
• Ankle dorsiflexes 5°
• Toes in neutral
Q
0
Interval 0-2% GC
Q
0
Interval 0-10% GC
Interval 10-30% GC
TELER Terminal Stance
• Erect spine, pelvis rotates backwards
• Hip extends to 20° apparent hyper-extension
• Knee in full extension
• Ankle continues to dorsiflex to 10°
• Toes extend to 30° MTP extension
Interval 30-50% GC
TELER Foot Contact -  Stance
(Use with phases of stance)
• Heel contact
• Weight shift to lateral border of foot
• 5th MT
• 1st MT
• Toe off
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Swing Phase
TELER® Pre Swing
• Erect spine with backward rotation
• Hip returns to neutral
• Knee flexes to 40°
• Ankle planterflexes to 20°
• Toes extend to 60° MTP extension
TELER® Initial Swing
• Spine erect with pelvis in backward rotation
• Hip flexes to 15°
• Knee flexes to 60°
• Ankle returns to 10° planterflexion
• Toes return to neutral alignment
TELER® Mid Swing
• Spine erect, pelvis returns to neutral
• Hip continues to flex to 25°
• Knee extends to 25° of flexion
• Ankle dorsiflexes to plantergrade
• Toes neutral
TELER® Terminal Swing
• Spine erect, pelvis rotates forwards
• Hip flexion 25°
• Knee extends to neutral
• Ankle plantergrade
• Toes neutral
0
Interval 50-60% GC
Q
0
Interval 60-73% GC
Interval 73-87% GC
0
Interval 87-100%GC
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PHASES OF HUMAN GAIT
Normal human gait consists o f a repeated series of limb motions which progress the 
body along an intended path while maintaining weight-bearing stability, conserving 
energy and absorbing the shock of floor impact.
A gait cycle is defined as the time from heel strike to ipsilateral heel strike. The gait 
cycle can be divided into stance and swing phase. Stance is the whole period the limb is 
in contact with the ground, swing begins when the foot comes off the ground.
The gait cycle can be divided into eight phases.
Initial Contact (IC): The moment when the foot contacts the ground
Loading Response (LR): Weight is rapidly transferred onto the outstretched limb, the 
first period o f double support.
Mid-Stance (MSt): The body progresses over a single, stable limb.
Terminal Stance (TSt): Progression over the stance limb continues. The body moves 
ahead of the limb and weight is transferred onto the forefoot.
Pre-Swing (PSw): A rapid unloading of the limb occurs as weight is transferred to the 
contralateral limb, the second period o f double support.
Initial Swing (ISw): The thigh begins to advance as the foot comes off the floor.
Mid-Swing (MSw): The thigh continues to advance as the knee begins to extend: the 
foot clears the ground.
Terminal Swing (TSw): The knee extends; the limb prepares to contact the ground for 
Initial Contact.
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APPENDIX II: Treatment aims and interventions by subject
The following is a summary of the findings following baseline assessments, and 
identified by subjects, as issues to be addressed by the functional electrical stimulation 
interventions.
Subject 005
45-year-old male with a pathological lesion incomplete at T10. Brown-Sequard lesion. 
ASIA grade D.
Problems Identified
• Catches toes o f right foot whilst walking -  unable to ‘shorten’ leg adequately during 
swing phase o f gait due to decreased hip knee and ankle flexion
• Frequently ‘goes over’ his right ankle when walking
• Occasionally falls when his right knee gives way -  has quadriceps weakness
Aims of treatment
• To instigate a strengthening regime for quadriceps and ankle evertors
• To provide a stable right ankle during stance
• To provide a stable right knee during stance
• To increase dorsiflexion o f the right ankle during swing
• To increase right hip and knee flexion during swing
Treatment:
• Exercise regime for quadriceps and ankle evertors
• Gait re-education with elbow crutches
• FES strategy decision tree see figure II. 1
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Figure n .l:  Decision Tree for FES Strategy
Subject 005
I
Assessment
Gait deviations
During swing During stance
phase phase
• Decreased right hip 
and knee flexion 
through swing phase
• Decreased right ankle 
dorsiflexion with 
inversion
•  Right knee 
occasionally gives 
way during stance
• Initial contact with 
lateral border of 
right foot
• Right ankle
/  inverted during 
stance phase
r r
• Cathode just posterior 
to neck o f fibula to 
excite superficial 
common peroneal /  
nerve (CPN) /
• Anode over peroneii 
muscles
• Quadriceps 
stimulation from 
loading response to 
mid-stance phase of 
gait
2 channels of stimulation needed 
therefore OD2CHS applied 
Switch mechanism midway along 
lateral border of right foot due to 
exaggerated inversion 
CPN stimulation on when weight 
removed from the switch, 
quadriceps stimulation on for short 
burst as weight taken on switch
Appendix II.2
Subject 006
19-year-old male with a C4/5 incomplete tetraplegia following a diving accident. 
Brown-Sequard lesion. ASIA grade C.
Problems Identified
• Catches toes of right foot when walking
• Takes a lot of effort to step through with right leg
• Step taken with right leg often short
• Right knee unsteady when takes weight on it
Aims:
• To instigate strengthening regime for quadriceps and ankle dorsiflexors bilaterally
• Top improve right leg flexion throughout swing
• To provide stability during stance
• To reduce the effort o f walking
Treatment:
• CRESTim3 programmed for quads and dorsiflexor exercise programme
• Gait re-education with elbow crutches
• FES strategy decision tree see figure II.2
Appendix II.3
Figure n.2: Decision Tree for FES Strategy
Subject 006
I
Assessment
During swing 
phase
During stance 
phase
Quadriceps 
stimulation 
continued from 
terminal swing to 
midstance
Cathode in popliteal fossa 
Anode over peroneii 
muscles
Quadriceps stimulation 
ramped up from mid to 
terminal swing
CREStim3 programmed for 2 
channels o f stimulation 
Switch placed on left elbow crutch 
handle as subject was a poor walker 
who fatigued quickly and had 
unreliable heelstrike 
CPN stimulation on when pressure 
applied to switch. Cycled 
automatically to quadriceps 
stimulation.
Decreased right hip 
and knee flexion
through swing phase 
Decreased right ankle 
dorsiflexion with
inversion
Right knee still flexed 
at terminal swing
Gait deviations
Right knee 
occasionally gives 
way during stance
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Subject 007
25-year-old female with a C6 lesion following a road traffic accident. Brown-Sequard 
type lesion. ASIA grade C.
Problems Identified
• Wants to be able to walk for exercise without KAFO as cannot put it on or take 
it off herself.
• Has a lot o f right leg weakness
• Is ‘double jointed’ -  has general joint laxity
Aims:
• To walk for exercise without KAFO as cannot don and doff independently
• To allow hip, knee and ankle flexion through swing
• To assist knee extension in stance
• To control knee hyperextension
Treatment:
• Home exercise programme to strengthen quadriceps and ankle dorsiflexors 
instigated
• Knee brace to control knee joint hyperextension
• Gait re-education in parallel bars
• FES strategy decision tree see figure II.3
Subject 007 did not finish the project. She was the most borderline walker o f all those 
involved with the project. Ambulation was too difficult with the prescribed system. She 
continued to use electrical stimulation for a home training exercise programme.
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Figure n.3: Decision Tree for FES Strategy
Subject 007
I
Assessment
During swing 
phase
During stance 
phase
Decreased right hip 
and knee flexion 
through swing phase 
Decreased right ankle 
dorsiflexion
Gait deviations
Right knee 
occasionally gives 
way during stance 
-  weak quadriceps 
muscle
Quadriceps 
stimulation from 
loading response to 
mid-stance phase of 
gait
Cathode in popliteal 
fossa
Anode over tibialis 
anterior
2 channels of stimulation needed 
therefore OD2CHS programmed 
Stimulation triggered by therapist
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Subject 008
23-year-old female with a C6 injury following a road traffic accident. Brown-Sequard 
type lesion. ASIA grade D.
Problems identified
• Catches toes whilst walking -  often trips
• Has large degree o f spasticity which gives problems with knee not bending 
adequately when stepping
Aims:
• Increase flexion o f right hip, knee and ankle during swing phase 
Treatment:
• FES strategy decision tree see figure II.4
• Gait re-education with walking sticks
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Figure II.4: Decision Tree for FES Strategy
Subject 008
I
Assessment
During swing 
phase
Cathode just posterior 
to neck of fibula to 
excite superficial 
common peroneal 
nerve (CPN)
Anode over peroneii 
muscles
One channel o f stimulation needed, 
ODFS III programmed and applied 
Switch mechanism under heel of 
right foot as good heelstrike 
achieved.
CPN stimulation on when weight 
removed from the switch, adaptive 
timing
Decreased right hip 
and knee flexion 
through swing phase 
Decreased right ankle 
dorsiflexion 
inversion
Gait deviations
with
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Subject 009
49-year-old male with a C7 incomplete tetraplegia following a fall. Brown-Sequard type 
lesion. ASIA grade D.
Problems Identified
• Frequently catches toes and trips when walking. Has fallen.
Aims:
• To increase right hip, knee and ankle flexion through swing
• To correct inversion through swing phase and at initial contact
Treatment:
• FES strategy decision tree see figure II.5
• Gait re-education with rollator.
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Figure II.5: Decision Tree for FES Strategy
Subject 009
I
Assessment
During swing 
phase
Cathode in popliteal 
fossa
Anode over peroneii 
muscles
One channel o f stimulation needed, 
ODFS III programmed and applied 
Switch mechanism under heel of 
right foot as good heelstrike 
achieved.
CPN stimulation on when weight 
removed from the switch, adaptive 
timing
Decreased right hip 
and knee flexion 
through swing phase 
Decreased right ankle 
dorsiflexion 
inversion
Gait deviations
with
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Subject 010
41 year old male with a T4 pathological lesion. Brown-Sequard type lesion. ASIA grade 
C.
Problems identified
• Very poor stepping ability due to left leg weakness
• Catches toes o f left foot when walking
• Left leg sometimes gives way when walking
Aims:
• To set up home exercise plan for quads and dorsiflexors
• To increase flexion of left leg throughout swing phase
• To increase stability of left leg during stance.
Treatment:
• CRESTim3 set up with home exercise programme
• Gait re-education with elbow crutches
• FES strategy decision tree see figure II.6
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Figure II.6: Decision Tree for FES Strategy
Subject 010
I
Assessment
Gait deviations
During swing During stance
phase phase
Decreased left hip and 
knee flexion through 
swing phase 
Decreased left ankle 
dorsiflexion with 
inversion
• Left knee 
occasional' 
way during
Cathode over common 
peroneal nerve (CPN) 
at neck of fibula 
Anode over peroneii 
muscles
X
Quadriceps 
stimulation from 
terminal swing to 
mid-stance phase of 
gait
CREStim3 programmed and applied as 
above
Switch mechanism -  graded pressure switch 
on handle of left crutch, as was poor and 
unreliable walker.
CPN stimulation on when pressure applied to 
the switch, quadriceps stimulation ramped up 
as CPN stimulation ramped down. 
Stimulation intensity could be increased by 
increased pressure on switch. This was done 
as habituation was a problem.
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Subject Oil
28-year-old male with a tetraplegia incomplete at C7 due to a diving accident. Brown- 
Sequard type lesion. ASIA grade D
Problems Identified
• Catches toes o f left foot when walking.
• Frequently ‘goes over’ left ankle
• Has very tight ankle planterflexor muscles -  cannot get heel to floor 
Aims:
• To increase flexion at left hip, knee and ankle joints during swing phase o f gait
• To increase left knee extension at terminal swing and through early stance phase of
gait to provide stability for weight bearing
• To correct left ankle inversion through swing phase of gait
• To decrease effort needed for swing phase
Treatment:
• Exercise programme prescribed for left quads and dorsiflexors
• Gait re-education with elbow crutches
• FES strategy decision tree see figure II.7
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Figure II.7: Decision Tree for FES Strategy
Subject Oil
I
Assessment
During swing 
phase
During stance 
phase
• Quadriceps 
stimulation from 
loading response to 
mid-stance phase o f  
gait
Cathode in popliteal 
fossa
Anode over peroneii 
muscles
CREStim3 programmed with two 
channels of stimulation as above 
Switch under first metatarsal head. 
Heel strike was not reliable due to 
tightness o f ankle planterflexors 
CPN stimulation on when weight 
removed from the switch, cycled to 
quadriceps stimulation for short 
burst from loading response to 
midstance
inversion
Gait deviations
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Subject 012
61 year old male with a tetraplegia incomplete at C5 following a sports accident. 
Central cord syndrome. ASIA grade D.
Problems Identified
• Catches toes o f right foot when stepping
• Right knee not reliable when stepping on it -  sometimes gives way
• Walks in a slightly flexed posture
Aims:
• To set up an exercise programme for home use
• To produce right heel strike at initial contact
• To correct right foot inversion throughout the gait cycle
• To gain right knee extension at terminal swing
• To improve right hip extension and stability during stance
Treatment:
• CRESTim3 programmed with exercise for bilateral quads and right evertors and 
dorsiflexors
• Gait re-education with elbow support rollator.
• FES strategy decision tree see figure II.8
A third channel was also set up for hip extension during stance. However this caused 
problems with knee flexion occurring as the hip was extending and so was discontinued.
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Figure II.8: Decision Tree for FES Strategy
Subject 012
I
Assessment
During swing 
phase
During stance 
phase
Decreased right hip 
and knee flexion
through swing phase 
Decreased right ankle 
dorsiflexion with
inversion
Gait deviations
Right knee 
occasionally gives 
way during stance
Quadriceps 
stimulation from 
loading response to 
mid-stance phase of 
gait
Cathode in popliteal 
fossa
Anode over peroneii 
muscles
CREStim3 programmed for 
stimulation as above 
Switch mechanism under right heel 
CPN stimulation on when weight 
removed from the switch, cycles to 
quadriceps stimulation from loading 
response to midstance
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Subject 013
43-year-old male with a pathological tetraplegia, incomplete at C6. No typical spinal 
syndrome presentation. ASIA grade D.
Problems Identified
• Catches toes of left foot when walking
• Initial contact with left foot is made with forefoot
• Left knee does not straighten throughout the gait cycle
Aims:
• To produce a heel strike at initial contact of the left leg
• To improve flexion of the left leg during swing phase
• To gain knee extension of the left leg at terminal swing and through the first part of  
stance phase o f gait
• To decrease the effort of walking
Treatment:
• FES strategy decision tree see figure II.9
• Gait re-education with elbow crutches
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Figure n.9: Decision Tree for FES Strategy
Subject 013
I
Assessment
During swing 
phase
During stance 
phase
Quadriceps 
stimulation from 
terminal swing to 
mid-stance phase of 
gait
Cathode just posterior 
to neck o f fibula to 
excite superficial 
common peroneal 
nerve (CPN)
Anode over peroneii 
muscles
CREStim3 programmed with two 
channels of stimulation as above 
Switch mechanism midway along 
lateral border of right foot due to 
foot position at initial contact 
CPN stimulation on when weight 
removed from the switch, cycles to 
quadriceps stimulation as CPN 
stimulation ramps down.
Decreased left hip and 
knee flexion through 
swing phase 
Decreased left ankle 
dorsiflexion with 
inversion
Left knee does not 
reach full extension at 
terminal swing
Gait deviations
Left knee flexed 
throughout stance
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APPENDIX III: Analysis of Modified Ashworth Scale Data
III.A: Subject 005
Table III. 1: Subject 005 - Modified Ashworth Scale (MAS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
R Pre 0 9 13 2 0 0 24
R Post 0 21 3 0 0 0 24
Total 0 30 16 2 0 0 48
Analysis of Table III. 1 shows an improvement from 15 readings at grade 2 and 3 pre- 
FES to only 3 readings on grade 2 post-FES. As a result the concentration of 13 
readings on grade 2 pre-FES improved to a concentration of 21 readings on grade 1.
The situation post-FES therefore is, firstly, an increase in the concentration on the 
median from 54% on grade 2 pre-FES to 88% on grade 1 post-FES, and, secondly, an 
improvement of 1 grade in the median.
An analysis of the pre- and post-FES changes on the individual readings (Table III.2) 
shows that 14 pre-FES readings improved by 1 grade, 10 pre-FES readings did not 
change, and no pre-FES readings deteriorated.
Table III.2: Subject 005 - Number and nature of change episodes pre and post FES 
Nature of Change 
Improvement No Change Deterioration
Total 14 10 0
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These improvements suggest that subject 005 did not suffer a deterioration in spasticity, 
and may even have demonstrated an improvement, following FES. The suggestion 
becomes a conclusion if  the changes could not have occurred by chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
H, -  there is a difference between the pre- and post-FES deviations from the pooled 
median
thThe pooled median = the grade o f the 24 reading. From table III. 1 it can be seen that 
the number of grade 1 readings = 30, therefore the 24th ordered reading = 1. Fisher’s 
exact test was then used to calculate the probability that the differences between pre- 
and post-FES deviations from the pooled median were due to chance.
Table III.3: Subject 005 - MAS grades above and below the pooled median 
 Pre Post Total
No of readings below Median code 0 0 0
No of readings above Median code 15 3 18
Total 15 3 18
(A+B)! (A+C)! (B+D)! (C+D)!
N!A!B!C!D!
Therefore for subject 005, P > 0.05. For this individual the null hypothesis is accepted 
and the alternative rejected. There is no statistically significant difference between pre- 
and post-FES deviations from the pooled median. The validity o f this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number o f MAS changes to justify acceptance o f  
the null hypothesis.
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III.B: Subject 006
Table III.4: Subject 006 - M odified Ashworth Scale (M AS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
R Pre 0 13 5 6 0 0 24
R Post 0 5 9 9 1 0 24
Total 0 18 14 15 1 0 48
Analysis o f Table III.4 shows a deterioration from 11 readings at grade 2 and 3 pre-FES 
to 19 readings on grade 2,3 and 4 post-FES. As a result the concentration o f 13 readings 
on grade 1 pre-FES deteriorated to a concentration of 9 on each o f grade 2 &3.
The situation post-FES therefore is, firstly, a decrease in the concentration on the 
median from 54% on grade 1 pre-FES to 75% on grades 2 & 3 post-FES, and, secondly, 
a deterioration o f 1-2 grades in the median.
Analysis o f the pre- and post-FES changes on the individual readings (Table III.5) 
shows that 1 pre-FES readings improved by 1 grade, 11 pre-FES readings did not 
change, and 12 pre-FES readings deteriorated.
Table III.5: Subject 006 - Number and nature of change episodes pre and post FES 
Nature of Change
Improvement No Change Deterioration
_ . j
Total 1 11
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These changes suggest that subject 006 suffered a deterioration in spasticity following 
FES. The suggestion becomes a conclusion if the changes could not have occurred by 
chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
Hi -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade of the 24th reading. From table III.4 it can be seen that 
the number of grade 1 readings =18, the number of grade 2 readings =14, therefore the 
24th ordered reading = 2. Fisher’s exact test was then used to calculate the probability 
that the differences between pre- and post-FES deviations from the pooled median were 
due to chance.
Table III.6: Subject 006 - MAS grades above and below the pooled median
Pre Post Total
No of readings below Median code 13 5 18
No of readings above Median code 6 10 16
Total 19 15 34
(A+B)! (A+C)! (B+D)! (C+D)!
N!A!B!C!D!
Therefore for subject 006 P < 0.05. For this individual the null hypothesis is rejected 
and the alternative accepted. There is a statistically significant difference between pre 
and post-FES deviations from the pooled median. The change is that o f a deterioration 
in spasticity as there are an increased number o f MAS grades above the median code 
following FES. The validity o f this conclusion is dependant upon the assumption that 
the co-variance between pre- and post-FES results had no effect and that there are a 
sufficient number o f MAS changes to justify rejection o f the null hypothesis.
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III.C: Subject 008
Table III.7: Subject 008 - Modified Ashworth Scale (MAS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
R Pre 0 7 11 5 1 0 24
R Post 0 3 9 8 4 0 24
Total 0 10 20 13 5 0 48
Analysis of Table III.7 shows a deterioration from 17 readings at grade 2, 3 and 4 pre- 
FES to 21 readings on grade 2,3 and 4 post-FES. As a result the concentration of 11 
readings on grade 2 pre-FES deteriorated to a concentration of 9 on grade 2.
The situation post-FES therefore is a decrease in the concentration on the median from 
46% on grade 2 pre-FES to 37.5% on grade 2 post-FES.
An analysis of the pre- and post-FES changes on the individual readings (Table III.8) 
shows that 1 pre-FES readings improved by 1 grade, 9 pre-FES readings did not change, 
and 14 pre-FES readings deteriorated.
Table III.8: Subject 008 - Number and nature of change episodes pre and post FES 
Nature of Change 
Improvement No Change Deterioration
i i i
Total 1 9 14
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These changes suggest that subject 008 suffered a deterioration in spasticity following 
FES. The suggestion becomes a conclusion if the changes could not have occurred by 
chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
Hi -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade of the 24 reading. From table III.7 it can be seen that 
the number o f grade 1 readings = 10, the number of grade 2 readings = 20, therefore the 
24th ordered reading = 2. Fisher’s exact test was then used to calculate the probability 
that the differences between pre- and post-FES deviations from the pooled median were 
due to chance.
Table III.9: Subject 008 - MAS grades above and below the pooled median
Pre Post Total
No of readings below Median code 7 3 10
No of readings above Median code 6 12 18
Total 13 15 28
(A+B)! (A+C)! (B+D)! (C+D)!
N!A!B!C!D!
Therefore for subject 008 P > 0.05. For this individual the null hypothesis is accepted 
and the alternative rejected. There is no statistically significant difference between pre- 
and post-FES deviations from the pooled median. The validity o f this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number of MAS changes to justify acceptance of 
the null hypothesis.
Appendix III.6
III.D: Subject 009
Table 111.10: Subject 009 - M odified A shworth Scale (M AS) Data by G rade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
R Pre 0 14 9 1 0 0 24
R Post 5 16 3 0 0 0 24
Total 5 30 12 1 0 0 48
Analysis o f Table III. 10 shows an improvement from 10 readings at grade 2 and 3 pre- 
FES to only 3 readings on grade 2 post-FES. As a result the concentration o f readings 
remained at grade 1, but 5 scores were graded at 0, where none had been before.
The situation post-FES therefore shows a small increase in the concentration on the 
median from 58% on grade 1 pre-FES to 67% on grade 1 post-FES.
An analysis of the pre- and post-FES changes on the individual readings (Table III. 11) 
shows that 13 pre-FES readings improved by 1 grade, 11 pre-FES readings did not 
change, and no pre-FES readings deteriorated.
Table III .ll:  Subject 009 - Number and nature of change episodes pre and post FES 
Nature of Change 
Improvement No Change Deterioration
Total 13 11 0
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These improvements suggest that subject 009 did not suffer a deterioration in spasticity, 
and may even have demonstrated an improvement, following FES. The suggestion 
becomes a conclusion if  the changes could not have occurred by chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
H i -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade of the 24th reading. From table III. 10 it can be seen that 
the number o f grade 0 readings = 5, the number of grade 1 readings = 30, therefore the 
24th ordered reading = 1. Fisher’s exact test was then used to calculate the probability 
that the differences between pre- and post-FES deviations from the pooled median were 
due to chance.
Table 111.12: Subject 009 - MAS grades above and below the pooled median
Pre Post Total
No of readings below Median code 0 5 5
No of readings above Median code 10 3 13
Total 10 8 18
(A+B)! (A+C)! (B+D)! (C+D)! 
N!A!B!C!D!
Therefore for subject 009 P  < 0.05. For this individual the null hypothesis is rejected 
and the alternative accepted. There is a statistically significant difference between pre 
and post-FES deviations from the pooled median. The change is that o f an improvement 
in spasticity as there are an increased number of MAS grades below the median code 
following FES. The validity of this conclusion is dependant upon the assumption that 
the co-variance between pre- and post-FES results had no effect and that there are a 
sufficient number o f MAS changes to justify rejection o f the null hypothesis.
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III.E: Subject 010
Table UI.13: Subject 010 - Modified Ashworth Scale (MAS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
L Pre 0 2 11 6 5 0 24
L Post 0 7 7 3 7 0 24
Total 0 9 18 9 12 0 48
Analysis of Table III. 13 shows a slight improvement from 22 readings at grade 2, 3 and 
4 pre-FES to 17 readings on grade 2, 3 and 4 post-FES. The concentration of 11 
readings at grade 2 pre-FES decreased to 7 readings on grade 1 and 2 respectively post- 
FES.
The situation post-FES therefore shows a small increase in the concentration on the 
median from 46% on grade 2 pre-FES to 58% on grade 1 and 2 post-FES.
An analysis of the pre- and post-FES changes on the individual readings (Table III. 14) 
shows that 7 pre-FES readings improved by 1 grade, 14 pre-FES readings did not 
change, and 3 pre-FES readings deteriorated.
Table III. 14: Subject 010 - Number and nature of change episodes pre and post FES
Nature of Change
Improvement No Change Deterioration
1 1 1
1 1 1
1 1
1 1
1 1
1 1
1 1
1
1
1
1
1
1
1
1
Total 7 14 3
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These changes suggest that subject 010 showed little alteration in spasticity following
FES. Fisher’s exact test was used to confirm this finding.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
Hi -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade of the 24th reading. From table III. 13 it can be seen that 
the number o f grade 1 readings = 9, the number o f grade 2 readings = 18 , therefore the 
24th ordered reading = 2. Fisher’s exact test was then used to calculate the probability 
that the differences between pre- and post-FES deviations from the pooled median were 
due to chance.
Table 111.15: Subject 010 - MAS grades above and below the pooled median 
 Pre Post Total
No of readings below Median code 2 7 9
No of readings above Median code 11 10 21
Total 13 17 30
P =  (A+B)! (A+C)! (B+D)! (C+D)!
N!A!B!C!D!
Therefore for subject 010 P > 0.05. For this individual the null hypothesis is accepted 
and the alternative rejected. There is no statistically significant difference between pre- 
and post-FES deviations from the pooled median. The validity o f this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number o f MAS changes to justify acceptance o f  
the null hypothesis.
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III.F: Subject Oil
Table 111.16: Subject O il - M odified Ashworth Scale (M AS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
L Pre 0 7 9 4 4 0 24
L Post 0 8 5 8 3 0 24
Total 0 15 14 12 7 0 48
Analysis of Table 111.16 shows a very slight improvement from 17 readings at grade 2, 3 
and 4 pre-FES to 16 readings on grade 2, 3 and 4 post-FES. The concentration of  
9readings at grade 2 pre-FES altered to 8 readings on grade 1 and 3 respectively post- 
FES.
The situation post-FES therefore shows a decrease in the concentration on the median 
from 37.5% on grade 2 pre-FES to 21% on grade 2 post-FES.
An analysis o f the pre- and post-FES changes on the individual readings (Table III. 17) 
shows that 4 pre-FES readings improved by 1 grade, 15 pre-FES readings did not 
change, and 5 pre-FES readings deteriorated.
Table 111.17: Subject Oil - Number and nature of change episodes pre and post FES
Nature of Change
Improvement No Change Deterioration
1 1 1
1 1 1
1 1 1
1 1
1
1
1
1
1
1
1
Total 4
1
1
1
1
1
15 5
Appendix III. 11
These changes suggest that subject Oil did showed little alteration in spasticity
following FES. Fisher’s exact test was used to confirm this finding.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
Hi -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade o f the 24th reading. From table III. 16 it can be seen that 
the number o f grade 1 readings = 15, the number o f grade 2 readings = 14, therefore the 
24th ordered reading = 2. Fisher’s exact test was then used to calculate the probability 
that the differences between pre- and post-FES deviations from the pooled median were 
due to chance.
Table 111.18; Subject Oil - MAS grades above and below the pooled median 
 Pre Post Total
No of readings below Median code 7 8 15
No of readings above Median code 8 11 19
Total 15 19 34
(A+B)! (A+C)! (B+D)! (C+D)!
F  N!A!B!C!D! UZ52
Therefore for subject Oil P > 0.05. For this individual the null hypothesis is accepted 
and the alternative rejected. There is no statistically significant difference between pre- 
and post-FES deviations from the pooled median. The validity o f this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number o f MAS changes to justify acceptance o f 
the null hypothesis.
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III.G: Subject 0012
Table III. 19: Subject 012 - Modified Ashworth Scale (MAS) Data by Grade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
R Pre 0 16 8 0 0 0 24
R Post 0 22 2 0 0 0 24
Total 0 38 10 0 0 0 48
Analysis of Table III. 19 shows an improvement from 8 readings at grade 2 pre-FES to 
only 2 readings on grade 2 post-FES. As a result the concentration of 16 readings on 
grade 1 pre-FES improved to a concentration of 22 readings on grade 1.
The situation post-FES therefore is an increase in the concentration on the median from 
67% on grade 1 pre-FES to 92% on grade 1 post-FES.
An analysis of the pre- and post-FES changes on the individual readings (Table 111.20) 
shows that 6 pre-FES readings improved by 1 grade, 18 pre-FES readings did not 
change, and no pre-FES readings deteriorated.
Table 111.20: Subject 012 - Number and nature of change episodes pre and post FES 
Nature of Change 
Improvement No Change Deterioration
Total 6 18 0
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These improvements suggest that subject 012 did not suffer a deterioration in spasticity, 
and may even have demonstrated an improvement, following FES. The suggestion 
becomes a conclusion if  the changes could not have occurred by chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
H i -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade o f the 24th reading. From table III. 19 it can be seen that 
the number o f grade 1 readings = 38, therefore the 24th ordered reading = 1. Fisher’s 
exact test was then used to calculate the probability that the differences between pre- 
and post-FES deviations from the pooled median were due to chance.
Table 111.21: Subject 012 - MAS grades above and below the pooled median 
 Pre Post Total
No of readings below Median code 0 0 0
No of readings above Median code 8 2 10
Total 8 2 10
(A+B)! (A+C)! (B+D)! (C+D)!
N!A!B!C!D!
Therefore for subject 012 /?>0.05. For this individual the null hypothesis is accepted and 
the alternative rejected. There is no statistically significant difference between pre- and 
post-FES deviations from the pooled median. The validity o f this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number o f MAS changes to justify acceptance of 
the null hypothesis.
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III.H: Subject 013
Table 111.22: Subject 013 - M odified Ashworth Scale (M AS) Data by G rade pre- and post-FES
MAS
Grade
0 1 2 3 4 5 Total
L Pre 0 5 10 9 0 0 24
L Post 0 7 6 3 8 0 24
Total 0 12 16 12 8 0 48
Analysis of Table 111.22 shows a change from 19 readings at grade 2 and 3 pre-FES to 
17 readings on grade 2,3 and 4 post-FES. As a result the concentration o f 10 readings 
on grade 2 pre-FES altered to a wider spread across grades 1 to 4, with a substantial 
increase in grade 4’s from 0 to 8.
The situation post-FES therefore is a decrease in the concentration on the median from 
42% on grade 2 pre-FES to 25% on grade 2 post-FES.
An analysis of the pre- and post-FES changes on the individual readings (Table 111.23) 
shows that 5 pre-FES readings improved by 1 grade, 7 pre-FES readings did not change, 
and 12 pre-FES readings deteriorated.
Table 111.23: Subject 013 - Number and nature of change episodes pre and post FES
Nature of Change
Improvement No Change Deterioration
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1
1 1
1
1
1
1
1
Total 5 7 12
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These changes suggest that subject 013 suffered a deterioration in spasticity following 
FES. The suggestion becomes a conclusion if the changes could not have occurred by 
chance.
Assuming that there is no co-variation between pre- and post-FES readings the 
following statistical hypotheses are tested:
Ho - there is no difference between the pre- and post-FES deviations from the 
pooled median
Hi -  there is a difference between the pre- and post-FES deviations from the pooled 
median
The pooled median = the grade o f the 24th reading. From table III.7 it can be seen that 
the number o f grade 1 readings = 10, the number of grade 2 readings = 20, therefore the 
24th ordered reading = 2. Fisher’s exact test was then used to calculate the probability 
that the differences between pre- and post-FES deviations from the pooled median were 
due to chance.
Table 111.24: Subject 013 - MAS grades above and below the pooled median
Pre Post Total
No of readings below Median code 5 7 12
No of readings above Median code 9 11 20
Total 14 18 32
(A+B)! (A+C)! (B+D)! (C+D)!
N!A!B!C!D!
Therefore for subject 013 P > 0.05. For this individual the null hypothesis is accepted 
and the alternative rejected. There is no statistically significant difference between pre- 
and post-FES deviations from the pooled median. The validity o f this conclusion is 
dependant upon the assumption that co-variance between pre- and post-FES results had 
no effect and that there are a sufficient number o f MAS changes to justify acceptance o f  
the null hypothesis.
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APPENDIX V: Summary o f Torque Range data
100
90
80
70
? so
Z
* 50
V
4 0
30
20
10
0
•  Initial Basline 
■ Final Baseline
 Initial Baseline Mean
 Final Baseline Mean
Test Session
100 
90 
80 
~  70 
5  60 
0) 50
3
S' 40 O
H 30 
20 
10 
0
0 1 2 3 4 5 6
T e s t S e s s io n
• Initial Baseline
 Initial Baseline Mean
 Final Baseline Mean
■ Final Baseline
1. Subject 005 60°s 2. Subject 005 120°s
100
90
80
?  70 
Z  60
o’ 50
I  40 oH 30 
20 
10 
0
2 3 4
T est s e s s io n
♦ Initial Baseline
 Initial Baseline Mean
■ Final baseline
 Final Baseline Mean
90
80
70F
z 60
« 50
O ' 40o
t - 30
20
10
0
0 1 2 3 4 5 6
T e s t S e s s io n
♦ Initial Baseline
 Initial Baseline Mean
 Final Baseline Mean
■ Final Baseline_____
3. Subject 006 60°s 4. Subject 006 120°s
80 
E 70
z 60
o’ 50
S' 40 oH 30 ■ 
20
1 2  3 4
Test se ss io n
♦ Initial Baseline
 Initial Baseline Mean
■ Final Baseline
 Final Baseline Mean
100
90
80
?  70 
2  60
o 50
S' 40 .o
l- 30
20
10
0
1 2  3 4
T e s t  S e s s io n
Initial Baseline 
- Initial Baseline Mean 
Final Baseline 
■ Final Baseline Mean
5. Subject 009 60°s 6. Subject 009 120°
Appendix V. 1
100
90
80
?  ra' 
Z 60
50
S' 40-
•“  30
20
1 0 -
0-
1 2 3
Test session
♦ Initial Baseline
—  Initial Baseline Mean 
■ Final Baseline
—  Final Baseline Mean
100
90
80
S> 50 
F 40O
*“  30
20 
10 
0
0 1 2 3 4 5
T e s t S e s s io n
♦ Initial Baseline
 Initial Baseline Mean
■ Final Baseline 
 Final Baseline Mean
7. Subject 010 60°s 8. Subject 010 120°s
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Appendix VI: Rancho Los Amigos Observational Gait
Analysis Data
The first eight forms are data from the original assessor; the final four are data collected 
by the blinded assessor.
1 = initial test session without stimulation
2 = final test session without FES
3 = final test session with FES
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RANCHO LOS AMIGOS MEDICAL CEN IKE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
Patient ID ...005
Major Deviation 
Minor Deviation
Trunk I pan- r/f 
Lateral Lean: R/L 
Rotates: B/F
Pelvis HikPfi
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
_______ Contralateral Drop
Hin Flnvinn- I imitpd 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flpxinn- I imitpd 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Fnrpfnnt
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes l in
Inadequate Extension 
Clawed
Weight
Accept
Single Limb 
Support
Swing Limb 
Advancement
1C LR MSt TSt PSw ISw MSw TSw
1,2,3 1,2,3
Major Problems:
Weight Acceptance
© 1996 LAREI, Rancho Los Amigos Medical Centre, Downey. CA 90242
Single limb Support Swing Limb Advancement
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RANCHO LOS AMIGOS MED1GAL GLIM 1'Kb
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
* *
i m ­
patient ID... 006
Major Deviation 
Minor Deviation
Trunk I pan- r/f 
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikps
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
_______ Contralateral Drop
Hin Flpxinn- I imitprl 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flpxinn- I imitpri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Fnrpfnnt
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes I in
Inadequate Extension 
Clawed
Major Problems:
Weight Acceptance
W eight
A ccept
1C LR
Single Limb 
Support
Swing Limb 
Advancem ent
MSt TSt PSw  ISw MSw TSw
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Appendix VI.3
RANCHO LOS AM IGOS MED1UAL GEIN 1KE
PHYSICAL THERAPY DEPARTM ENT
GAIT ANALYSIS: FULL BODY
£
Reference Limb:
L □  R □  lj
* *
Patient ID ...008
n
Major Deviation 
Minor Deviation
Weight
Accept
Trunk I pan- r / f
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikes
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
______ Contralateral Drop
Hin Flexion- I imifprl 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flexion- I imiteri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Fnrpfnnt
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes l in
Inadequate Extension 
Clawed
Single Limb 
Support
Swing Limb 
Advancement
PSw ISw MSw TSwMSt TSt
Major Problems:
Weight Acceptance
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RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
* *
O r e
Patient ID ...009
Major Deviation
Minor Deviation
Trunk lean- R/F
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikes
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
_______ Contralateral Drop
Hin Flexion• I imiteri 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flexion’ I imiteri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Forefoot
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes I Jn
Inadequate Extension 
Clawed
Swing Limb 
Advancement
Single Limb 
Support
Weight
Accept
1,2,?3
Major Problems:
Weight Acceptance
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RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
* *
Patient ID 010
Major Deviation 
Minor Deviation
Trunk lean- R/F
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikes
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
_______ Contralateral Drop
Hin Flexion-1 imiteri 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flexinn- I imiteri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Fnrefnnt 
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes lln
Inadequate Extension 
Clawed
Major Problems:
Weight Acceptance
Weight
Accept
1C LR
Single Limb 
Support
Swing Limb 
Advancement
MSt TSt PSw ISw MSw TSw
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Appendix VI.6
RANCHU LUS AM1UUS MJbUlUAL, UE.IN ik e ,
PHYSICAL THERAPY DEPARTMENT * *
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
if^ -
Patient ID...011
m.
Major Deviation 
Minor Deviation
Weight
Accept
1C LR
Trunk I pan- R/F
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikes
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
_______ Contralateral Drop
Hin Flexion- I imiteri 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flexion- I imiteri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Forefoot 
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes l in
Inadequate Extension 
Clawed
Single Limb 
Support
Swing Limb 
Advancement
MSt TSt PSw ISw MSw TSw
Major Problems:
Weight Acceptance
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RANCHU LUS AM 1UUS MbUlLAL i R t
PHYSICAL THERAPY DEPARTM ENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
Patient ID...012
r \
Major Deviation 
Minor Deviation
Trunk I pan- R/F
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikes
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
______ Contralateral Drop
Hin Flexion- I imiteri 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flayinrv I imiteri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Forefoot 
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes No
Inadequate Extension 
Clawed
Major Problems:
Weight Acceptance
Weight
Accept
Single Limb 
Support
Swing Limb 
Advancement
1C LR MSt TSt PSw ISw MSw TSw
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RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
* *
C K ?  11=' 1 1 =
Patient ID...013
8
L
Major Deviation
Minor Deviation
Trunk I parr R/F
Lateral Lean: R/L 
Rotates: B/F
Pelvis Hikes
Tilt: P/A
Lack Forward Rotation 
Lacks Backward Rotation 
Excess Forward Rotation 
Excess Backward 
Ipsilateral Drop 
_______Contralateral Drop
Hin Flexinn- I imiteri 
Excess
Inadequate Extension 
Past Retract 
Rotation: IR/ER 
Ad/Abduction: Ad/Ab
Knee Flexinn- I imiteri 
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Fnrefnnt 
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes Un
Inadequate Extension 
Clawed
Major Problems:
Weight Acceptance
Weight
Accept
Single Limb Swing Limb
Support Advancement
MSt TSt PSw ISw MSw TSw
2,3 1 1:3 K- 1,2,3 1,2,3.yj 1,2
1,2,3 1,3 1,2
2,3 1,2
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RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □  R □
Appendix VI
 r -----------
11^
Patient ID ...008.
r Major Deviation
i
Minor Deviation
Trunk 1 parr R/F
Lateral Lean: R/L
Rotates: B/F
Pelvis Hikps
Tilt: P/A
Lack Forward Rotation
Lacks Backward Rotation
Excess Forward Rotation
Excess Backward 1
Ipsilateral Drop
I Contralateral Drop I
Hin Flpxinrv 1 imitpri 1
Excess
Inadequate Extension
Past Retract
Rotation: IR/ER
| Ad/Abduction: Ad/Ab |
Knee Flpxinrv 1 imitpri 1
Excess 1
Inadequate Extension 1
Wobbles
Hyperextends
Extension Thurst
VarusA/algus: Vr/VI 1
Excess Contralateral Flex |
Ankle Fnrpfnnt
Foot-Flat Contact
Foot Slap
Excess Plantar Flexion
Excess Dorsiflexion
lnversion/Eversion:lv/Ev
Heel Off
No Heel Off
Drag
I Contralateral Vaulting |
1 T oes 1 In 1
Inadequate Extension 1
Clawed |
Weight
Accept
Single Limb 
Support
Swing Limb 
Advancement
MSt TSt PSw ISw MSw TSw
1,3 1,3 1,3 1,3 1
3 1 1 1,3 3 3
mm 1 1,3 1,3n r n m m m
Major Problems:
Weight Acceptance
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RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □ R □
*  *
!.S^
Patient ID 009.
Major Deviation
Minor Deviation
Trunk 1 pan- R/F
Lateral Lean: R/L
Rotates: B/F
Pelvis Hikps
Tilt: P/A
Lack Forward Rotation
Lacks Backward Rotation
Excess Forward Rotation
Excess Backward
Ipsilateral Drop
Contralateral Drop
Hin Flpyinn- 1 imitpri
Excess
Inadequate Extension
Past Retract
Rotation: IR/ER
Ad/Abduction: Ad/Ab |
Knee Flpyinrv 1 imitpri
Excess
Inadequate Extension 
Wobbles 
Hyperextends 
Extension Thurst 
Varus/Valgus: Vr/VI 
Excess Contralateral Flex
Ankle Fnrpfnnt
Foot-Flat Contact
Foot Slap 
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
T oes I in
Inadequate Extension 
Clawed
Major Problems:
Weight Acceptance
Weight
Accept
Single Limb 
Support
Swing Limb 
A dvancem ent
MSt TSt PSw  ISw MSw TSw
1,3 1 1,3 1,3 : :
1,3 1,3
1 1,3 1,3
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RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L  □  R  □
* *
Patient ID Oil
Major Deviation Weight
Accept
Minor Deviation
1C LR
Trunk 1 earr R/F
Lateral Lean: R/L
Rotates: B/F
Pelvis Hikps
Tilt: P/A
Lack Forward Rotation
Lacks Backward Rotation
Excess Forward Rotation
Excess Backward
Ipsilateral Drop
Contralateral Drop
Hin Flpvinn- 1 imitpri
Excess
Inadequate Extension
Past Retract
Rotation: IR/ER
Ad/Abduction: Ad/Ab | 3
Knee Flpyinrr 1 imitpri
Excess
Inadequate Extension
Wobbles
Hyperextends
Extension Thurst
VarusA/algus: VrA/l
Excess Contralateral Flex
Ankle Fnrpfnnt
Foot-Flat Contact ^ 3  |
Foot Slap
Excess Plantar Flexion 
Excess Dorsiflexion 
lnversion/Eversion:lv/Ev 
Heel Off 
No Heel Off 
Drag
Contralateral Vaulting
Single Limb 
Support
Swing Limb 
Advancement
MSt TSt PSw ISw MSw TSw
1 1 1,3 1 1
1 3 1 1,3 1,3
1 1 1
1 1 1 1
[ 1 1
Toes i in
Inadequate Extension 
Clawed
■ 1 1,3 1,3
_ _ I-----------
I I
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Major Problems:
Weight Acceptance Single limb Support Swing Limb Advancement
Appendix VI. 12
RANCHO LOS AMIGOS MEDICAL CENTRE
PHYSICAL THERAPY DEPARTMENT
GAIT ANALYSIS: FULL BODY
Reference Limb: 
L □ R □
R
E '
Patient ID 012.
r Major Deviation
i
Minor Deviation
Trunk 1 parr R/F
Lateral Lean: R/L
Rotates: B/F
Pelvis Hikps
Tilt: P/A
Lack Forward Rotation
Lacks Backward Rotation
Excess Forward Rotation
Excess Backward 1
Ipsilateral Drop |
I Contralateral Drop |
1 Hin Flpyinn- 1 imitpri 1
Excess 1
Inadequate Extension 1
Past Retract 1
Rotation: IR/ER 1
| Ad/Abduction: Ad/Ab |
Knee Flpyinrr 1 imitpri 1
Excess 1
Inadequate Extension 1
Wobbles
Hyperextends
Extension Thurst
VarusA/algus: VrA/l 1
I Excess Contralateral Flex |
Ankle Fnrpfnnt
Foot-Flat Contact
Foot Slap
Excess Plantar Flexion 1
Excess Dorsiflexion 1
lnversion/Eversion:lv/Ev 1
Heel Off 1
No Heel Off 1
Drag 1
1 Contralateral Vaulting |
1 T oes 1 In 1
Inadequate Extension 1
Clawed |
Weight
Accept
Single Limb 
Support
Swing Limb 
A dvancem ent
MSt TSt PSw  ISw MSw TSw
1,3 1,3 1:3 O '! 1,3 1,3 1,3
1 1 1 1
1
Major Problems:
Weight Acceptance
© 1996 LAREI, Rancho Los Amigos Medical Centre, Downey. CA 90242
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Appendix VII: TELER Data Analysis
1. Subject 005
Table 1 Subject 005: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1
2 1 1
3 2 2 : 4
4
5 _ I
Total 2 1 2 5
Key:   Area under dashed line shows clinically significant change
"" ' Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 1 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 005 ranged from 0 to 2, with a 
median code of 1, and a mode of 0 or 2, both of these codes occurring twice on initial 
assessment. The admission code of two (40%) of the five indicators was 0, one indicator 
(20%) was graded at code 1, and two (40%) were graded at code 2.
The discharge or outcome codes ranged from code 2 to 3., with a median of 3 and a 
mode of 3. The discharge outcome code on four (80%) of the five indicators was 3; the 
other discharge code was 2 (20%).
From the table it can be seen that all the indicators showed some improvement in their 
code gradings. All entries showed clinically significant improvements. The magnitude 
of these improvements ranged from 1 to 3 clinically significant stages, with two 
indicators improving by three codes and three improving by one code. None of the 
individual indicators in Table 1 showed a statistically significant improvement at the 
95% confidence level.
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Indicators as a Group:
Whilst the above analysis of the data shows a clinically significant improvement in 
walking outcomes following the application o f FES it is necessary to show a statistically 
significant improvement if  these are to be attributable to the intervention. The indicators 
were analysed as a group to consider the overall effects o f FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis (Le Roux, 
2003):
Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a minimum of three were selected for analysis. The 
three chosen were considered to be of most clinical significance to this subject. These 
indicators were mid-swing, loading response and initial contact. From Table 2 it can be 
seen that these indicators had a combined score of 2 on initial assessment (2,0,0 
respectively), there were 7 clinically significant changes by the time o f discharge, 
giving an outcome score of 9. The results were therefore found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was rejected and the 
alternative accepted. There was an improvement in TELER gait indicator grades for this 
subject, apparently attributable to the FES intervention.
Table 2 shows a decrease in Deficit Index by nearly half from 80 to 44. The 
Improvement Index was calculated as 45; meaning that there was an improvement in 
this subjects identified problems during treatment. The Health Gain Index was 36 and 
therefore smaller than the Improvement Index, denoting a chronic disability.
The clinical significance of these improvements is inherent within the structure o f the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Appendix VII.3
Table 2: W orksheet for the TELER Index (recovery) for Subject 005
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Pre-swing 5 1 2
Mid-swing 5 2 3
Loading response 5 0 3
Initial contact 5 0 3
Mid-stance 5 2 3
Total number of missing scores 0
Deficit Index 80 44
Improvement index 45
Health Gain Index 36
Appendix VII.4
2. Subject 006
Table 3 Subject 006: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1 ;
2 1 1 2
3 :
4 1 2 [ 3
5 I
Total 2 3 5
Key:   Area under dashed line shows clinically significant change
Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 3 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 006 ranged from 1 to 2, with a 
median code o f 2, and a mode o f 2. The admission code o f two (40%) o f the five 
indicators was 1, three indicators (60%) were graded at code 2.
The discharge or outcome codes ranged from code 2 to 4, with a median o f 4 and a 
mode o f 4. The discharge outcome code on three (60%) o f the five indicators was 4; two 
were coded 2 (40%).
From the table it can be seen that four of the five indicators showed some improvement 
in their code gradings. One showed no change. The magnitude o f the improvements 
ranged from 1 to 3 clinically significant stages, with one indicator improving by three 
codes, two improving by two codes and one improving by one code. None of the 
individual indicators in Table 3 showed a statistically significant improvement at the 
95% confidence level.
Indicators as a Group:
Whilst the above analysis of the data shows a clinically significant improvement in 
walking outcomes following the application o f FES it is necessary to show a statistically 
significant improvement if these are to be attributable to the intervention. The indicators
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Appendix VII. 6
were analysed as a group to consider the overall effects of FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis:
Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a minimum of three were selected for analysis. The 
three chosen were considered to be of most clinical significance to this subject. These 
indicators were initial swing, mid-swing and terminal swing. From Table 4 it can be 
seen that these indicators had a combined score of 6 on initial assessment (1,3,2 
respectively), there were 4 clinically significant changes by the time of discharge, 
giving an outcome score of 10. The results were therefore not found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was accepted and the 
alternative rejected. There was no statistically significant change in TELER gait 
indicator grades for this subject.
Table 4 shows a decrease in Deficit Index from 60 to 36. The Improvement Index was 
calculated as 40, meaning that there was an improvement in this subjects identified 
problems during treatment. The Health Gain Index was 24 and therefore smaller than 
the Improvement Index, denoting a chronic disability.
The clinical significance of these improvements is inherent within the structure of the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Table 4 Worksheet for the TELER Index (recovery) for Subject 006
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Pre-swing 5 3 4
Initial swing 5 1 4
Mid-swing 5 3 4
Terminal swing 5 2 2
Loading response 5 1 2
Total number of missing scores 0
Deficit Index 60 36
Improvement index 40
Health Gain Index 24
Appendix VII.7
3. Subject 008
Table 5 Subject 008: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1 !
2 ; 1 1
3 1 1 : 2
4 [
5 _ . i
Total 1 1 1 3
Key:   Area under dashed line shows clinically significant change
Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 5 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 008 ranged from 1 to 3, with a 
median of 2. The admission code of one (33.3%) of the three indicators was 1, one 
indicator (33.3%) was graded at code 2, the other at 3.
The discharge or outcome codes ranged from code 2 to 3, with a median of 3 and a 
mode of 3. The discharge outcome code on two (66.6%) of the three indicators was 3; 
one was coded 2 (33.3%).
From the table it can be seen that two indicators showed some improvement in code 
grading. One showed a deterioration. The magnitude of the improvements ranged from 
1 to 2 clinically significant stages, with one indicator improving by two codes and one 
improving by one code. Neither of the individual indicators that improved showed a 
statistically significant improvement at the 95% confidence level. The indicator which 
showed a deterioration lost one code grade.
Indicators as a Group:
The above analysis of the data can be considered as showing some improvement in 
walking ability. The indicators were analysed as a group to consider the overall effects 
of FES for this subject. The following statistical hypotheses were tested using a 
probability tree analysis:
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Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
All three o f the chosen indicators were used for analysis. From Table 6 it can be seen 
that these indicators had a combined score o f 6 on initial assessment (1,2,3 
respectively), there were 3 clinically significant changes by the time of discharge, 
giving an outcome score o f 8. The results were therefore not found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was accepted and the 
alternative rejected. There was no statistically significant change in TELER gait 
indicator grades for this subject.
Table 6 shows a small decrease in Deficit Index from 60 to 53. The Improvement Index 
was calculated as 22, meaning that there was an improvement in this subjects identified 
problems during treatment. The Health Gain Index was 13 and therefore smaller than 
the Improvement Index, denoting a chronic disability.
The clinical significance of these improvements is inherent within the structure of the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Table 6 Worksheet for the TELER Index (recovery) for Subject 008
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Initial swing 5 1 3
Mid-swing 5 2 3
Loading response 5 3 2
Total number of missing scores 0
Deficit Index 60 53
Improvement index 22
Health Gain Index 13
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4. Subject 009
Table 7 Subject 009: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1 ;
2 1 1 2
3 1 : 1
4 1 i 1
5 ________________ i_______________  .
Total 1 2 1 4
Key: -------  Area under dashed line shows clinically significant change
— —  Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 7 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 009 ranged from 1 to 3, with a 
median code of 2, and a mode of 2. The admission code of one (25%) of the four 
indicators was 1, two indicators (50%) were graded at code 2, and one (25%) was grade 
3.
The discharge or outcome codes ranged from code 2 to 4, with a median of 2 and a 
mode of 2. The discharge outcome code on one (25%) of the four indicators was 4; one 
(25%) was coded 3, and two were coded 2 (50%).
From the table it can be seen that three of the four indicators showed some improvement 
in their code gradings. One showed no change. The magnitude of the improvements was 
one clinically significant change in all cases. None of the individual indicators in Table 
7 showed a statistically significant improvement at the 95% confidence level.
Indicators as a Group:
Whilst the above analysis of the data shows a clinically significant improvement in 
walking outcomes following the application of FES it is necessary to show a statistically 
significant improvement if these are to be attributable to the intervention. The indicators 
were analysed as a group to consider the overall effects of FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis:
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Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a minimum of three were selected for analysis. The 
three chosen were considered to be of most clinical significance to this subject. These 
indicators were initial swing, mid-swing and terminal swing. From Table 8 it can be 
seen that these indicators had a combined score of 6 on initial assessment (1,2,3, 
respectively), there were 3 clinically significant changes by the time o f discharge, 
giving an outcome score of 9. The results were therefore not found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was accepted and the 
alternative rejected. There was no statistically significant change in TELER gait 
indicator grades for this subject.
Table 8 shows a decrease in Deficit Index from 60 to 46. The Improvement Index was 
calculated as 25, meaning that there was an improvement in this subjects identified 
problems during treatment. The Health Gain Index was 15 and therefore smaller than 
the Improvement Index, denoting a chronic disability.
The clinical significance of these improvements is inherent within the structure o f the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Table 8 Worksheet for the TELER Index (recovery) for Subject 009
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Pre-swing 5 2 2
Initial swing 5 1 2
Mid-swing 5 2 3
Terminal swing 5 3 4
Total number of missing scores 0
Deficit Index 60 45
Improvement index 25
Health Gain Index 15
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5. Subject 010
Table 9 Subject 010: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code before
Code after 0 1 2 3 4 Total
0
1 •
2 1 1
3 1 1 2
4 1 1
5 I
Total 1 2 1 4
Key: --------Area under dashed line shows clinically significant change
Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 9 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 010 ranged from 0 to 2, with a 
median code of 2, and a mode o f 2. The admission code o f one (25%) o f the four 
indicators was 0, two indicators (50%) were graded at code 1, and one (25%) was grade 
2 .
The discharge or outcome codes ranged from code 2 to 4, with a median o f 2 and a 
mode o f 2. The discharge outcome code on one (25%) of the four indicators was 4; two 
(50%) was coded 3, and one was coded 2 (25%).
From the table it can be seen that all the indicators showed some improvement in their 
code gradings. All entries showed clinically significant improvements. The magnitude 
of these improvements ranged from 1 to 3 clinically significant stages, with one 
indicator improving by three codes, two improving by two codes and one improving by 
one code. None of the individual indicators in Table 9 showed a statistically significant 
improvement at the 95% confidence level.
Indicators as a Group:
Whilst the above analysis of the data shows a clinically significant improvement in 
walking outcomes following the application o f FES it is necessary to show a statistically 
significant improvement if these are to be attributable to the intervention. The indicators 
were analysed as a group to consider the overall effects o f FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis:
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Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a minimum of three were selected for analysis. The 
three chosen were considered to be of most clinical significance to this subject. These 
indicators were initial swing, mid-swing and terminal swing. From Table 10 it can be 
seen that these indicators had a combined score of 3 on initial assessment (0,2,1, 
respectively), there were 7 clinically significant changes by the time o f discharge, 
giving an outcome score o f 10. The results were therefore found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was rejected and the 
alternative accepted. There was an improvement in TELER gait indicator grades for this 
subject, apparently attributable to the FES intervention.
Table 10 shows a decrease in Deficit Index by half from 80 to 40. The Improvement 
Index was calculated as 50, meaning that there was an improvement in this subjects 
identified problems during treatment. The Health Gain Index was 40 and therefore 
smaller than the Improvement Index, denoting a chronic disability.
The clinical significance o f these improvements is inherent within the structure o f the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Table 10 Worksheet for the TELER Index (recovery) for Subject 010
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Pre-swing 5 1 2
Initial swing 5 0 3
Mid-swing 5 2 4
Terminal swing 5 1 3
Total number of missing scores 0
Deficit Index 1 80 40
Improvement index 50
Health Gain Index | 40
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6. Subject Oil
Table 11 Subject Oil: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1 ;
2 1 1 : 2
3 : 1 1
4 1 : 1
5 _  - I  _ _ _ _ _ _ _
Total 1 1 2 4
Key: -------- Area under dashed line shows clinically significant change
' 1 Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 11 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject Oil ranged from 0 to 3, with a 
median code of 2, and a mode of 3. The admission code of one (25%) of the four 
indicators was 0, one indicator (25%) was graded at code 1, and two (50%) were grade 
3.
The discharge or outcome codes ranged from code 2 to 4, with a median of 2.5 and a 
mode of 2. The discharge outcome code on one (25%) of the four indicators was 4; one 
(25%) was coded 3, and two were coded 2 (50%).
From the table it can be seen that three of the four indicators showed some improvement 
in their code gradings. One showed no change. The magnitude of the improvements 
ranged from 1 to 2 clinically significant stages, with one indicator improving by two 
codes and two improving by one code. None of the individual indicators that improved 
showed a statistically significant improvement at the 95% confidence level.
Indicators as a Group:
Whilst the above analysis of the data shows a clinically significant improvement in 
walking outcomes following the application of FES it is necessary to show a statistically 
significant improvement if these are to be attributable to the intervention. The indicators
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were analysed as a group to consider the overall effects of FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis:
Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a minimum of three were selected for analysis. The 
three chosen were considered to be of most clinical significance to this subject. These 
indicators were initial swing, mid-swing and terminal swing. From Table 12 it can be 
seen that these indicators had a combined score of 4 on initial assessment (0,3,1, 
respectively), there were 4 clinically significant changes by the time of discharge, 
giving an outcome score of 8. The results were therefore not found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was accepted and the 
alternative rejected. There was no statistically significant change in TELER gait 
indicator grades for this subject.
Table 12 shows a decrease in Deficit Index from 65 to 45. The Improvement Index was 
calculated as 31, meaning that there was an improvement in this subjects identified 
problems during treatment. The Elealth Gain Index was 20 and therefore smaller than 
the Improvement Index, denoting a chronic disability.
The clinical significance of these improvements is inherent within the structure of the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Table 12 Worksheet for the TELER Index (recovery) for Subject Oil
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Initial swing 5 0 2
Mid-swing 5 3 4
Terminal swing 5 1 2
Loading response 5 3 3
Total number of missing scores 0
Deficit Index 65 45
Improvement index 31
Health Gain Index 20
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7. Subject 012
Table 13 Subject 012: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code before
Code after 0 1 2 3 4 Total
0
1 •
2 2 2
3 1 1
4
5 I
Total 2 1 3
Key:  Area under dashed line shows clinically significant change
Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 13 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 012 ranged from 1 to 2, with a 
median code o f 1, and a mode of 1. The admission code o f two (66.6%) o f the three 
indicators was 1, the other (33.3%) was grade 2.
The discharge or outcome codes ranged from code 2 to 3, with a median o f 2 and a 
mode o f 2. The discharge outcome code on one (33.3%) of the three indicators was 3; 
and two were coded 2 (66.6%).
From the table it can be seen that all three indicators showed some improvement in their 
code gradings. The magnitude of the improvements in all cases was only one clinically 
significant stage. None of the individual indicators that improved showed a statistically 
significant improvement at the 95% confidence level.
Indicators as a Group:
Whilst the above analysis o f the data shows a clinically significant improvement in 
walking outcomes following the application of FES it is necessary to show a statistically 
significant improvement if  these are to be attributable to the intervention. The indicators 
were analysed as a group to consider the overall effects o f FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis:
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Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hj -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
All three indicators were included in the analysis. From Table 14 it can be seen that 
these indicators had a combined score of 4 on initial assessment (1,1,2 respectively), 
there were 3 clinically significant changes by the time o f discharge, giving an outcome 
score o f 7. The results were therefore not found to be statistically significant at the 5% 
one-tailed level. The null hypothesis was accepted and the alternative rejected. There 
was no statistically significant change in TELER gait indicator grades for this subject.
Table 14 shows a decrease in Deficit Index from 73 to 53. The Improvement Index was 
calculated as 27, meaning that there was an improvement in this subjects identified 
problems during treatment. The Health Gain Index was 20 and therefore smaller than 
the Improvement Index, denoting a chronic disability.
The clinical significance of these improvements is inherent within the structure of the 
indicators. Each code is a clinically significant outcome needed for ‘normal’ gait.
Table 14 Worksheet for the TELER Index (recovery) for Subject 012
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Terminal swing 5 1 2
Loading response 5 1 2
Initial swing 5 2 3
Total number of missing scores 0
Deficit Index 73 53
Improvement index 27
Health Gain Index 20
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8. Subject 013
Table 15 Subject 013: TELER codes pre- and post-intervention
Number of indicators by code pre (before) and post (after) intervention
Code after
Code before
Total0 1 2 3 4
0
1 ;
2 1 1
3 2 1 3
4
5
Total 1 2 1 4
Key:   Area under dashed line shows clinically significant change
Area under which indicators show statistically significant improvements at the 
95% confidence level
Table 15 summarises the data from the original TELER data collection form (following 
page). It shows that the admission codes for subject 013 ranged from 0 to 2, with a 
median code of 2, and a mode of 2. The admission code of one (25%) of the four 
indicators was 0, two indicators (50%) were graded at code 1, and one (25%) was grade 
2 .
The discharge or outcome codes ranged from code 2 to 3, with a median of 3 and a 
mode of 3. The discharge outcome code on three (75%) of the four indicators was 3; 
one was coded 2 (25%).
From the table it can be seen that all the indicators showed some improvement in their 
code gradings. All entries showed clinically significant improvements. The magnitude 
of these improvements ranged from 1 to 2 clinically significant stages, with three 
indicators improving by two codes, and one improving by one code. None of the 
individual indicators in Table 15 showed a statistically significant improvement at the 
95% confidence level.
Indicators as a Group:
Whilst the above analysis of the data shows a clinically significant improvement in 
walking outcomes following the application of FES it is necessary to show a statistically 
significant improvement if these are to be attributable to the intervention. The indicators
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were analysed as a group to consider the overall effects of FES for this subject. The 
following statistical hypotheses were tested using a probability tree analysis:
Ho -  there is no improvement in TELER Gait Indicator grades with FES 
intervention
Hi -  there is an improvement in TELER Gait Indicator grades with FES 
intervention
To ensure maximum independence between indicators and what they measure, and 
therefore to minimise co-variance, a minimum of three were selected for analysis. The 
three chosen were considered to be o f most clinical significance to this subject. These 
indicators were initial swing, mid-swing and terminal swing. From Table 16 it can be 
seen that these indicators had a combined score of 2 on initial assessment (0,1,1, 
respectively), there were 6 clinically significant changes by the time o f discharge, 
giving an outcome score of 8. The results were therefore not found to be statistically 
significant at the 5% one-tailed level. The null hypothesis was accepted and the 
alternative rejected . There was no statistically significant improvement in TELER gait 
indicator grades for this subject.
Table 16 shows a decrease in Deficit Index by nearly half from 80 to 45. The 
Improvement Index was calculated as 44, meaning that there was an improvement in 
this subjects identified problems during treatment. The Health Gain Index was 35 and 
therefore smaller than the Improvement Index, denoting a chronic disability.
The clinical significance o f these improvements is inherent within the structure o f the 
indicators. Each code is a clinically significant outcome needed for ‘normaF gait.
Table 16 Worksheet for the TELER Index (recovery) for Subject 013
Item Expected
Outcome
Visit
1
Pre-FES
2
With FES
Initial swing 5 0 2
Mid-swing 5 1 3
Terminal swing 5 1 3
Mid-stance 5 2 3
Total number of missing scores 0
Deficit Index 80 45
Improvement index 44
Health Gain Index 35
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